10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________________________________________________

FORM 10-Q

_______________________________________________________________________

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2015

or

o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _______ to _______

Commission File Number 1-2376

__________________________________________________________________________

FMC CORPORATION

(Exact name of registrant as specified in its charter)

__________________________________________________________________________

Delaware	94-0479804
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
1735 Market Street Philadelphia, Pennsylvania	19103
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: 215-299-6000

__________________________________________________________________________

INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS), AND (2) HAS BEEN SUBJECT TO SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS    YES  x    NO  o

INDICATE BY CHECK MARK WHETHER THE REGISTRANT HAS SUBMITTED ELECTRONICALLY AND POSTED ON ITS CORPORATE WEBSITE, IF ANY, EVERY INTERACTIVE DATA FILE REQUIRED TO BE SUBMITTED AND POSTED PURSUANT TO RULE 405 OF REGULATION S-T DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED TO SUBMIT AND POST SUCH FILES)    YES  x    NO  o

INDICATE BY CHECK MARK WHETHER THE REGISTRANT IS A LARGE ACCELERATED FILER, AN ACCELERATED FILER, A NON-ACCELERATED FILER OR A SMALLER REPORTING COMPANY. SEE THE DEFINITIONS OF “LARGE ACCELERATED FILER,” “ACCELERATED FILER,” AND “SMALLER REPORTING COMPANY” IN RULE 12B-2 OF THE EXCHANGE ACT. (CHECK ONE):

LARGE ACCELERATED FILER	x	ACCELERATED FILER	o
NON-ACCELERATED FILER	o	SMALLER REPORTING COMPANY	o

INDICATE BY CHECK MARK WHETHER THE REGISTRANT IS A SHELL COMPANY (AS DEFINED IN RULE 12B-2 OF THE EXCHANGE ACT)    YES  o    NO  x

INDICATE THE NUMBER OF SHARES OUTSTANDING OF EACH OF THE ISSUER’S CLASSES OF COMMON STOCK, AS OF THE LATEST PRACTICABLE DATE

Class	Outstanding at March 31, 2015
Common Stock, par value $0.10 per share	133,534,165

FMC CORPORATION

INDEX

	Page No.
Part I - FINANCIAL INFORMATION	3
Item 1. Financial Statements	3
Condensed Consolidated Statements of Income (Loss) - Three months ended March 31, 2015 and 2014 (unaudited)	3
Condensed Consolidated Statements of Comprehensive Income (Loss) - Three months ended March 31, 2015 and 2014 (unaudited)	4
Condensed Consolidated Balance Sheets - March 31, 2015 and December 31, 2014 (unaudited)	5
Condensed Consolidated Statements of Cash Flows - Three months ended March 31, 2015 and 2014 (unaudited)	6
Notes to Condensed Consolidated Financial Statements (unaudited)	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	29
Item 3. Quantitative and Qualitative Disclosures About Market Risk	43
Item 4. Controls and Procedures	43
Part II - OTHER INFORMATION	45
Item 1. Legal Proceedings	45
Item 1A. Risk Factors	45
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	49
Item 4. Mine Safety Disclosures	49
Item 5. Other Information	49
Item 6. Exhibits	49
Signatures	50

2

PART I - FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

FMC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(in Millions, Except Per Share Data)	Three Months Ended March 31
	2015			2014
	(unaudited)
Revenue	$	659.4		$	756.9
Costs and Expenses
Costs of sales and services	408.7			463.9
Gross margin	250.7			293.0
Selling, general and administrative expenses	297.9			114.6
Research and development expenses	26.6			25.8
Restructuring and other charges (income)	22.3			6.7
Business separation costs	—			3.0
Total costs and expenses	755.5			614.0
Income from continuing operations before equity in (earnings) loss of affiliates, interest expense, net and income taxes	(96.1		)	142.9
Equity in (earnings) loss of affiliates	0.1			(0.3		)
Interest expense, net	14.0			11.6
Income (loss) from continuing operations before income taxes	(110.2		)	131.6
Provision for income taxes	(49.1		)	34.6
Income (loss) from continuing operations	(61.1		)	97.0
Discontinued operations, net of income taxes	15.6			(26.6		)
Net income (loss)	(45.5		)	70.4
Less: Net income attributable to noncontrolling interests	1.3			4.8
Net income (loss) attributable to FMC stockholders	$	(46.8	)	$	65.6
Amounts attributable to FMC stockholders:
Continuing operations, net of income taxes (benefit)	$	(62.4	)	$	93.8
Discontinued operations, net of income taxes	15.6			(28.2		)
Net income (loss) attributable to FMC stockholders	$	(46.8	)	$	65.6
Basic earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.47	)	$	0.70
Discontinued operations	0.12			(0.21		)
Net income (loss) attributable to FMC stockholders	$	(0.35	)	$	0.49
Diluted earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.47	)	$	0.70
Discontinued operations	0.12			(0.21		)
Net income (loss) attributable to FMC stockholders	$	(0.35	)	$	0.49

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

FMC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in Millions)	Three Months Ended March 31
	2015			2014
	(unaudited)
Net income (loss)	$	(45.5	)	$	70.4
Other comprehensive income (loss), net of tax:
Foreign currency adjustments:
Foreign currency translation gain (loss) arising during the period	(39.7		)	0.3
Reclassification of foreign currency translation losses	—			49.6
Total foreign currency translation adjustments (1)	(39.7		)	49.9
Derivative instruments:
Unrealized hedging gains (losses) and other, net of tax of $0.4 and $1.3 for the three months ended March 31, 2015 and 2014, respectively	2.3			2.5
Reclassification of deferred hedging (gains) losses and other, included in net income, net of tax of ($1.2) and $0.4 for the three months ended March 31, 2015 and 2014, respectively (3)	(1.8		)	1.1
Total derivative instruments, net of tax of ($0.8) and $1.7 for the three months ended March 31, 2015 and 2014, respectively	0.5			3.6
Pension and other postretirement benefits:
Unrealized actuarial gains (losses) and prior service (costs) credits, net of tax of ($4.7) and zero for the three months ended March 31, 2015 and 2014, respectively (2)	(5.9		)	0.5
Reclassification of net actuarial and other (gain) loss and amortization of prior service costs, included in net income, net of tax of $6.7 and $3.2 for the three months ended March 31, 2015 and 2014, respectively (3)	11.7			6.0
Total pension and other postretirement benefits, net of tax of $2.0 and $3.2 for the three months ended March 31, 2015 and 2014, respectively	5.8			6.5
Other comprehensive income (loss), net of tax	(33.4		)	60.0
Comprehensive income (loss)	$	(78.9	)	$	130.4
Less: Comprehensive income attributable to the noncontrolling interest	1.3			5.1
Comprehensive income (loss) attributable to FMC stockholders	$	(80.2	)	$	125.3

____________________ 

(1) Income taxes are not provided on the equity in undistributed earnings of our foreign subsidiaries or affiliates since it is our intention that such earnings will remain invested in those affiliates permanently. The amount for 2014 includes reclassification to net income due to the divestiture of our FMC Peroxygens business, see Note 12 for more information. In accordance with accounting guidance, this amount was previously factored into the lower of cost or fair value test associated with the 2013 Peroxygens' asset held for sale write-down charges.

(2) At December 31st of each year, we remeasure our pension and postretirement plan obligations at which time we record any actuarial gains (losses) and prior service (costs) credits to other comprehensive income. The interim adjustments noted above typically reflect the foreign currency translation impacts from the unrealized actuarial gains (losses) and prior service (costs) credits related to our foreign pension and postretirement plans. During the three months ended March 31, 2015, due to the disposal of our FMC Alkali Chemicals division, we triggered a curtailment of our U.S. pension plans. As a result we revalued our pension plans which resulted in adjustments to comprehensive income. See Note 13 for more information.

(3) For more detail on the components of these reclassifications and the affected line item in the condensed consolidated statements of income (loss) see Note 12.

4

FMC CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in Millions, Except Share and Par Value Data)	March 31, 2015			December 31, 2014
ASSETS	(unaudited)
Current assets
Cash and cash equivalents	$	105.2		$	109.5
Trade receivables, net of allowance - 2015: $34.9; 2014: $37.2	1,537.4			1,602.5
Inventories	640.8			607.6
Prepaid and other current assets	287.3			188.8
Deferred income taxes	147.1			222.7
Current assets of discontinued operations held for sale	611.8			203.3
Total current assets	$	3,329.6		$	2,934.4
Investments	4.7			5.5
Property, plant and equipment, net	902.6			930.0
Goodwill	324.1			352.5
Other intangibles, net	233.5			246.9
Other assets	281.5			269.6
Deferred income taxes	235.7			200.1
Noncurrent assets of discontinued operations held for sale	—			401.5
Total assets	$	5,311.7		$	5,340.5
LIABILITIES AND EQUITY
Current liabilities
Short-term debt and current portion of long-term debt	$	907.3		$	525.2
Accounts payable, trade and other	316.5			378.3
Advance payments from customers	24.2			190.2
Accrued and other liabilities	271.2			407.2
Accrued customer rebates	323.0			236.0
Guarantees of vendor financing	67.4			50.2
Accrued pension and other postretirement benefits, current	6.6			12.7
Income taxes	19.6			22.2
Current liabilities of discontinued operations held for sale	79.8			88.4
Total current liabilities	$	2,015.6		$	1,910.4
Long-term debt, less current portion	1,150.9			1,153.4
Accrued pension and other postretirement benefits, long-term	227.9			238.7
Environmental liabilities, continuing and discontinued	190.9			209.9
Deferred income taxes	55.6			51.3
Noncurrent liabilities of discontinued operations held for sale	—			4.7
Other long-term liabilities	201.4			208.1
Commitments and contingent liabilities (Note 16)
Equity
Preferred stock, no par value, authorized 5,000,000 shares; no shares issued in 2015 or 2014	—			—
Common stock, $0.10 par value, authorized 260,000,000 shares; 185,983,792 issued shares at 2015 and 2014	18.6			18.6
Capital in excess of par value of common stock	407.6			401.9
Retained earnings	2,915.5			2,984.5
Accumulated other comprehensive income (loss)	(409.2		)	(375.8		)
Treasury stock, common, at cost - 2015: 52,449,627 shares, 2014: 52,666,121 shares	(1,497.6		)	(1,498.7		)
Total FMC stockholders’ equity	$	1,434.9		$	1,530.5
Noncontrolling interests	34.5			33.5
Total equity	$	1,469.4		$	1,564.0
Total liabilities and equity	$	5,311.7		$	5,340.5

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

FMC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in Millions)	Three Months Ended March 31
	2015			2014
	(unaudited)
Cash provided (required) by operating activities of continuing operations:
Net income (loss)	$	(45.5	)	$	70.4
Discontinued operations	(15.6		)	26.6
Income (loss) from continuing operations	$	(61.1	)	$	97.0
Adjustments from income from continuing operations to cash provided (required) by operating activities of continuing operations:
Depreciation and amortization	22.8			23.9
Equity in (earnings) loss of affiliates	0.1			(0.2		)
Restructuring and other charges (income)	22.3			6.7
Deferred income taxes	29.3			1.3
Pension and other postretirement benefits	10.7			8.5
Share-based compensation	4.5			3.8
Excess tax benefits from share-based compensation	(1.7		)	(3.4		)
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:
Trade receivables, net	52.5			(80.3		)
Guarantees of vendor financing	17.3			28.9
Inventories	(50.0		)	(9.5		)
Accounts payable	(35.6		)	(77.7		)
Advance payments from customers	(165.9		)	(148.4		)
Accrued customer rebates	87.6			87.4
Income taxes	(78.1		)	9.3
Pension and other postretirement benefit contributions	(27.4		)	(23.8		)
Environmental spending, continuing, net of recoveries	(3.0		)	(1.6		)
Restructuring and other spending	(3.0		)	(1.9		)
Change in other operating assets and liabilities, net (1)	(126.2		)	(26.0		)
Cash provided (required) by operating activities of continuing operations	$	(304.9	)	$	(106.0	)
Cash provided (required) by operating activities of discontinued operations:
Environmental spending, discontinued, net of recoveries	—			(3.7		)
Operating activities of discontinued operations, net of recoveries	7.7			12.9
Cash provided (required) by operating activities of discontinued operations	$	7.7		$	9.2

(1) The March 31, 2015 change is impacted by a $93.8 million reduction in the Cheminova A/S hedge liability. Total cash payments during the three months ended March 31, 2015 associated with the Cheminova A/S hedges were $273.8 million, which includes $180.1 million that were accrued and paid within the period.

The accompanying notes are an integral part of these condensed consolidated financial statements.

(continued)

6

FMC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(in Millions)	Three Months Ended March 31
	2015			2014
	(unaudited)
Cash provided (required) by investing activities of continuing operations:
Capital expenditures	$	(36.9	)	$	(63.3	)
Proceeds from disposal of property, plant and equipment	0.3			—
Other investing activities	(17.6		)	(1.1		)
Cash provided (required) by investing activities of continuing operations	$	(54.2	)	$	(64.4	)
Cash provided (required) by investing activities of discontinued operations:
Proceeds from FMC Peroxygens divestiture	—			199.1
Other discontinued investing activities	(15.6		)	(11.1		)
Cash provided (required) by investing activities of discontinued operations	$	(15.6	)	$	188.0
Cash provided (required) by financing activities of continuing operations:
Increase (decrease) in short-term debt	383.0			(39.6		)
Repayments of long-term debt	(0.4		)	(0.7		)
Distributions to non controlling interests	—			(3.0		)
Issuances of common stock, net	3.5			5.2
Excess tax benefits from share-based compensation	1.7			3.4
Dividends paid (2)	(20.1		)	(18.0		)
Other repurchases of common stock	(2.9		)	(4.0		)
Cash provided (required) by financing activities of continuing operations	$	364.8		$	(56.7	)
Effect of exchange rate changes on cash and cash equivalents	(2.1		)	(0.8		)
Increase (decrease) in cash and cash equivalents	(4.3		)	(30.7		)
Cash and cash equivalents, beginning of period	109.5			123.2
Cash and cash equivalents, end of period	$	105.2		$	92.5

(2) See Note 12 regarding quarterly cash dividend.

Supplemental disclosure of cash flow information: Cash paid for interest, net of capitalized interest was $18.0 million and $11.2 million, and income taxes paid, net of refunds were $11.1 million and $25.3 million for the three months ended March 31, 2015 and 2014, respectively. Non-cash additions to property, plant and equipment were $5.5 million and $21.4 million for March 31, 2015 and 2014.

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited)

Note 1: Financial Information and Accounting Policies

In our opinion the condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) applicable to interim period financial statements and reflect all adjustments necessary for a fair statement of results of operations and cash flows for the three months ended March 31, 2015 and 2014, and our financial position as of March 31, 2015. All such adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the Notes. The results of operations for the three months ended March 31, 2015 and 2014 are not necessarily indicative of the results of operations for the full year. The condensed consolidated balance sheets as of March 31, 2015 and December 31, 2014, and the related condensed consolidated statements of income (loss), condensed consolidated statements of comprehensive income (loss) and condensed consolidated statements of cash flows for the three months ended March 31, 2015 and 2014, have been reviewed by our independent registered public accountants. The review is described more fully in their report included herein. Our accounting policies are set forth in detail in Note 1 to the consolidated financial statements included with our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2014 (the “2014 10-K”).

FMC Alkali Chemicals Division:

In February 2015, our FMC Alkali Chemicals division ("ACD") was classified as a discontinued operation. For more information on the discontinued operations see Note 9. As a result, our FMC Minerals segment, which previously included our FMC Alkali Chemicals and FMC Lithium divisions, was renamed FMC Lithium. We have recast all the data within this filing to reflect the changes in our reportable segments to conform to the current year presentation and to present ACD as a discontinued operation retrospectively for all periods presented.

Note 2: Recently Issued and Adopted Accounting Pronouncements and Regulatory Items

New accounting guidance and regulatory items

In April 2015, the Financial Accounting Standards Board ("FASB") issued ASU 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this new standard require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this standard. We are required to adopt this standard in the first quarter of 2016. Early adoption is permitted. The amendments should be applied on a retrospective basis. ASU 2015-03 will impact our consolidated balance sheet.

In February 2015, the FASB issued ASU 2015-02, Consolidation: Amendments to the Consolidation Analysis. This new standard changes the consolidation evaluation for entities that are required to evaluate whether they should consolidate certain legal entities. We are required to adopt this standard in the first quarter of 2016. Early adoption is permitted. The standard permits the use of a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption, or a reporting entity may also apply the amendments retrospectively. We are evaluating the effect that ASU 2015-02 will have on our consolidated financial statements. We have not yet completed the assessment to determine the effect of the standard on our ongoing financial reporting.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This new guidance will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. We are required to adopt this standard on January 1, 2017; however, in April 2015 the FASB voted to propose to defer the effective date of the new revenue recognition standard by one year. If deferred, the provisions of this standard would be effective for interim and annual periods beginning after December 15, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. We are evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures. We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.

Recently adopted accounting guidance

In April 2014, the FASB issued its updated guidance on the financial reporting of discontinued operations. This new standard changes the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Additionally, expanded disclosures about discontinued operations will be required to provide financial statement users with more information about the

8

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

assets, liabilities, income, and expenses of discontinued operations. This guidance impacts disclosures within an entity's financial statements and notes to the financial statements. We have adopted this guidance prospectively this quarter.

Note 3: Acquisitions

Cheminova A/S

On September 8, 2014, we entered into a definitive Share Purchase Agreement (the "Purchase Agreement") with Auriga Industries A/S, a Denmark Aktieselskab ("Auriga") and Cheminova A/S, a Denmark Aktieselskab, a wholly owned subsidiary of Auriga ("Cheminova"). On April 21, 2015, pursuant to the terms and conditions set forth in the Purchase Agreement, we completed the acquisition of 100 percent of the outstanding equity of Cheminova from Auriga for an aggregate purchase price of $1.2 billion, excluding net debt to be assumed and hedged-related costs totaling $0.6 billion (the “Acquisition”). Beginning in the second quarter of 2015, Cheminova will be integrated into our FMC Agricultural Solutions segment and included within our results of operations. The Acquisition was funded with the October 10, 2014 term loan which was secured for the purposes of the Acquisition, see Note 8 for more information.

Cheminova is a business under the U.S. GAAP business combinations accounting guidance, and therefore we will apply acquisition accounting. Acquisition accounting requires, among other things, that assets and liabilities assumed be recognized at their fair values as of the acquisition date. The net assets of the Cheminova acquisition will be recorded at the estimated fair values using primarily Level 2 and Level 3 inputs (see Note 15 for an explanation of Level 2 and 3 inputs). In valuing acquired assets and liabilities, valuation inputs include an estimate of future cash flows and discount rates based on the internal rate of return and the weighted average rate of return.

We have not completed the detailed valuation work necessary to determine the estimates of the fair value of the acquired assets and assumed liabilities. As a result we have not determined the preliminary allocation of the purchase price. We also have not completed the detailed analysis to present the pro forma financial information for the combined companies. As such, both the preliminary allocation of the purchase price as well as the pro forma financial information will be included in our future filings.

Acquisition related costs

Pursuant to the terms and conditions set forth in the Purchase Agreement, we agreed to acquire all of the outstanding equity of Cheminova from Auriga for an aggregate purchase price of 8.5 billion Danish krone ("DKK"). At the time we entered into the Purchase Agreement, the U.S. dollar ("USD" or “$”) to DKK exchange rate was USD $1.00 to DKK 5.77, resulting in a USD purchase price of $1.47 billion, excluding assumed debt of approximately $0.3 billion. In order to minimize our exposure to adverse changes in the USD to DKK exchange rate from September 8, 2014 to April 21, 2015, (the acquisition close date) we entered into a series of foreign currency forward contracts ("FX forward contracts"). The FX forward contracts provided us the ability to fix the USD to DKK exchange rate for most of the DKK 8.5 billion purchase price, thereby limiting our exposure to foreign currency rate fluctuations. Over the period from September 2014 to March 2015 the USD strengthened against the DKK by 19 percent to an exchange rate of USD $1.00 to DKK 6.88 at March 31, 2015. The strengthening of the USD against the DKK results in a lower USD purchase price for Cheminova. Partially offsetting this was a mark-to-market loss on the FX forward contracts of $180.1 million during the three months ended March 31, 2015.

The loss on the FX forward contracts pursuant to GAAP is required to be expensed immediately. As a result, during the three months ended March 31, 2015, a $180.1 million loss associated with these FX forward contracts was recognized. The FX forward contract loss recognized in 2014 was $99.6 million. These losses are included in "Selling, general and administrative expenses" within the condensed consolidated statements of income (loss) and included them within Acquisition related charges within Note 17. In addition to the FX forward contract charges, additional legal and professional fees were incurred for the three months ended March 31, 2015 associated with this Acquisition as described in Note 17.

Note 4: Goodwill and Intangible Assets

The changes in the carrying amount of goodwill by business segment for the three months ended March 31, 2015, are presented in the table below:

(in Millions)	FMC Agricultural Solutions		FMC Health and Nutrition			FMC Lithium		Total
Balance, December 31, 2014	$	31.0	$	321.5		$	—	$	352.5
Foreign currency adjustments	—		(28.4		)	—		(28.4		)
Balance, March 31, 2015	$	31.0	$	293.1		$	—	$	324.1

9

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

Our intangible assets, other than goodwill, consist of the following:

	March 31, 2015							December 31, 2014
(in Millions)	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (finite-lived)
Customer relationships	$	147.8	$	(24.6	)	$	123.2	$	152.8	$	(22.5	)	$	130.3
Patents	1.7		(0.2		)	1.5		1.7		(0.1		)	1.6
Brands (1)	1.2		(0.7		)	0.5		1.2		(0.6		)	0.6
Purchased and licensed technologies	71.7		(25.4		)	46.3		74.3		(24.5		)	49.8
Other intangibles	3.6		(2.1		)	1.5		3.6		(2.4		)	1.2
	$	226.0	$	(53.0	)	$	173.0	$	233.6	$	(50.1	)	$	183.5

Intangible assets not subject to amortization (indefinite life)
Brands (1)	$	60.5				$	60.5	$	63.4				$	63.4
Total intangible assets	$	286.5	$	(53.0	)	$	233.5	$	297.0	$	(50.1	)	$	246.9

(1) Represents trademarks, trade names and know how.

At March 31, 2015, the finite-lived and indefinite life intangibles were allocated among our business segments as follows:

(in Millions)	Finite-lived		Indefinite Life
FMC Agricultural Solutions	$	97.4	$	35.2
FMC Health and Nutrition	74.4		25.3
FMC Lithium	1.2		—
Total	$	173.0	$	60.5

Note 5: Inventories

Inventories consisted of the following:

(in Millions)	March 31, 2015			December 31, 2014
Finished goods	$	287.8		$	281.1
Work in process	243.9			248.8
Raw materials, supplies and other	274.5			242.1
First-in, first-out inventory	$	806.2		$	772.0
Less: Excess of first-in, first-out cost over last-in, first-out cost	(165.4		)	(164.4		)
Net inventories	$	640.8		$	607.6

Note 6: Property, Plant and Equipment

Property, plant and equipment consisted of the following:

(in Millions)	March 31, 2015			December 31, 2014
Property, plant and equipment	$	1,580.9		$	1,618.7
Accumulated depreciation	(678.3		)	(688.7		)
Property, plant and equipment, net	$	902.6		$	930.0

10

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

Note 7: Restructuring and Other Charges (Income)

Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income) as noted below:

	Three Months Ended March 31
(in Millions)	2015		2014
Restructuring charges and asset disposals	$	5.4	$	5.3
Other charges (income), net	16.9		1.4
Total restructuring and other charges	$	22.3	$	6.7

Restructuring charges and asset disposals

There were no significant restructuring activities that commenced during 2015. For detail on the restructuring charges and asset disposals which commenced prior to 2015, see Note 7 to our consolidated financial statements included with our 2014 Form 10-K.

	Restructuring Charges
(in Millions)	Severance and Employee Benefits (1)		Other Charges (Income) (2)			Asset Disposal Charges (3)		Total
Health and Nutrition Restructuring	$	0.8	$	0.1		$	1.2	$	2.1
Lithium Restructuring	0.3		—			—		0.3
Other Items	3.3		(0.3		)	—		3.0
Three months ended March 31, 2015	$	4.4	$	(0.2	)	$	1.2	$	5.4
Health and Nutrition Restructuring	4.9		—			—		4.9
Lithium Restructuring	—		0.1			—		0.1
Other Items	—		0.3			—		0.3
Three months ended March 31, 2014	$	4.9	$	0.4		$	—	$	5.3

____________________ 

(1) Represents severance and employee benefit charges. Income represents adjustments to previously recorded severance and employee benefits.

(2) Primarily represents costs associated with lease payments, contract terminations, and other miscellaneous exit costs. Other Income primarily represents favorable developments on previously recorded exit costs as recoveries associated with restructuring.

(3) Primarily represents accelerated depreciation and impairment charges on long-lived assets, which were or are to be abandoned. To the extent incurred, the acceleration effect of re-estimating settlement dates and revised cost estimates associated with asset retirement obligations due to facility shutdowns are also included within the asset disposal charges.

Roll forward of restructuring reserves

The following table shows a roll forward of restructuring reserves, continuing and discontinued, that will result in cash spending. These amounts exclude asset retirement obligations.

(in Millions)	Balance at 12/31/14 (4)		Change in reserves (2)		Cash payments			Other (3)			Balance at 3/31/15 (4)
Health and Nutrition Restructuring	$	4.6	$	0.9	$	(1.8	)	$	0.2		$	3.9
Lithium Restructuring	0.2		0.3		(0.1		)	—			0.4
Other Workforce Related and Facility Shutdowns (1)	2.8		3.0		(1.1		)	0.4			5.1
Restructuring activities related to discontinued operations (5)	2.7		—		(0.1		)	(0.3		)	2.3
Total	$	10.3	$	4.2	$	(3.1	)	$	0.3		$	11.7

____________________ 

(1) Primarily severance costs related to workforce reductions and facility shutdowns noted in the “Other Items” sections above.

(2) Primarily severance, exited lease, contract termination and other miscellaneous exit costs. Any accelerated depreciation and impairment charges noted above impacted our property, plant and equipment balances and are not included in the above tables.

11

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

(3) Primarily foreign currency translation adjustments.

(4) Included in “Accrued and other liabilities” on the condensed consolidated balance sheets.

(5) Cash spending associated with restructuring activities of discontinued operations is reported within Payments of other discontinued reserves, net of recoveries on the condensed consolidated statements of cash flows.

Other charges (income), net

	Three Months Ended March 31
(in Millions)	2015		2014
Environmental charges, net	$	1.9	$	1.4
Other items, net	15.0		—
Other charges (income), net	$	16.9	$	1.4

Environmental charges, net

Environmental charges represent the net charges associated with environmental remediation at continuing operating sites. See Note 10 for additional details.

Other items, Net

Our FMC Agricultural Solutions segment enters into collaboration and license agreements with various third-party companies for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development. In most transactions the rights and technology obtained is referred to as in-process research and development and in accordance with GAAP, the amounts paid are expensed as incurred since they were acquired outside of a business combination. During the three months ended March 31, 2015, we entered into one such transaction, consisting of the acquisition of all global rights to a pre-development novel, proprietary broadleaf herbicide.

Note 8: Debt

Debt maturing within one year:

(in Millions)	March 31, 2015		December 31, 2014
Short-term foreign debt (1)	$	40.5	$	36.6
Commercial paper (2)	865.1		486.6
Total short-term debt	$	905.6	$	523.2
Current portion of long-term debt	1.7		2.0
Short-term debt and current portion of long-term debt	$	907.3	$	525.2

____________________

(1) At March 31, 2015, the average interest rate on the borrowings was 4.50%. We often provide parent-company guarantees to lending institutions that extend credit to our foreign subsidiaries.

(2) At March 31, 2015, the average interest rate on the borrowings was 0.62%.

12

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

Long-term debt:

(in Millions)	March 31, 2015
	Interest Rate Percentage		Maturity Date	3/31/2015		12/31/2014
Pollution control and industrial revenue bonds (less unamortized discounts of $0.2 and $0.2, respectively)	0.2-6.5%		2021-2035	$	141.6	$	141.5
Senior notes (less unamortized discount of $1.9 and $1.9, respectively)	3.95-5.2%		2019-2024	998.1		998.1
Credit Facility (1)	2.6	%	2019	—		—
Foreign debt	0-9.3%		2015-2024	12.9		15.8
Total long-term debt				$	1,152.6	$	1,155.4
Less: debt maturing within one year				1.7		2.0
Total long-term debt, less current portion				$	1,150.9	$	1,153.4

____________________

(1) Letters of credit outstanding under our Credit Facility totaled $100.1 million and available funds under this facility were $534.8 million at March 31, 2015 (which reflects borrowings under our commercial paper program).

Covenants

Among other restrictions, our Credit Facility contains financial covenants applicable to FMC and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our actual leverage for the four consecutive quarters ended March 31, 2015, was 3.2 which is below the maximum leverage of 3.5. Our actual interest coverage for the four consecutive quarters ended March 31, 2015, was 11.7 which is above the minimum interest coverage of 3.5. We were in compliance with all covenants at March 31, 2015. Following the acquisition of Cheminova A/S (see Note 3), the maximum leverage covenant increased to 4.5 and will step down in accordance with the provisions of the Credit Facility.

Term Loan Facility

On April 21, 2015, we borrowed $1.65 billion under our previously announced senior unsecured Term Loan Facility. The proceeds of the borrowing were used to finance the acquisition of Cheminova A/S as well as to pay costs, fees and expenses incurred in connection with the acquisition and the term loan facility.

The scheduled maturity of the Term Loan Facility is on the fifth anniversary of this closing date. The borrowings under the Term Loan Agreement will bear interest at a floating rate, which will be a base rate or a Eurocurrency rate equal to the London interbank offered rate for the relevant interest period, plus in each case an applicable margin, as determined in accordance with the provisions of the Term Loan Agreement. The base rate will be the highest of: the rate of interest announced publicly by Citibank, N.A. in New York, New York from time to time as its “base rate”; the federal funds effective rate plus1/2 of one percent; and the Eurocurrency rate for a one-month period plus one percent.

The Term Loan Agreement contains financial and other covenants, including a maximum leverage ratio of 4.5 and minimum interest coverage ratio 3.5 immediately following the acquisition. The Term Loan Agreement also contains a cross-default provision whereby a default under our other indebtedness in excess of $50.0 million, after grace periods and absent a waiver from the lenders, would be an event of default under the Term Loan Agreement and could result in a demand for payment of all amounts outstanding under this facility.

Note 9: Discontinued Operations

FMC Alkali:

On February 3, 2015, we signed a stock and asset purchase agreement ( the "Definitive Agreement") to sell our FMC Alkali Chemicals division ("ACD") to a wholly owned subsidiary of Tronox Limited ("Tronox"). The sale of ACD to Tronox was completed on April 1, 2015 resulting in approximately $1.6 billion in pre-tax proceeds ($1.2 billion after-tax).

ACD meets the criteria to be an asset held for sale and we have also presented ACD as a discontinued operation in accordance with GAAP. In addition to the definitive agreement we entered into a customary transitional services agreement with Tronox to provide for the orderly separation of the business and transition of various functions and processes. These services will be provided

13

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

by us to Tronox for up to 12 months after closing. These services include information technology services, human resource and facility services among other services, while Tronox assumes the operations of ACD.

Additionally, FMC is providing certain financial guarantees to third parties on behalf of ACD. These financial guarantees include payment guarantees to the lessors of various transportation equipment leases, subleases of certain transportation equipment leases and a self-bonding guarantee for several environmental reclamation obligations assumed by Tronox, which were previously treated as an asset retirement obligation by FMC. In accordance with the Definitive Agreement, Tronox is provided 90 days to secure FMC's release from such guarantees after which FMC is entitled to receive compensation from Tronox based on the outstanding amount of guarantees until such release is obtained.

The results of our discontinued FMC ACD operations are summarized below:

(in Millions)	Three Months Ended March 31
	2015		2014
Revenue	$	194.0	$	184.9
Costs of sales and services	149.2		149.5
Income (loss) from discontinued operations before income taxes (1)	19.0		28.2
Provision for income taxes	0.4		4.7
Total discontinued operations of FMC ACD, net of income taxes	$	18.6	$	23.5
Less: discontinued operations of FMC ACD attributable to noncontrolling interests	$	—	$	1.6
Discontinued operations of FMC ACD, net of income taxes, attributable to FMC Stockholders	$	18.6	$	21.9

____________________

(1) Amounts include approximately zero and $1.9 million attributable to noncontrolling interests, allocated interest expense of $2.2 million and $1.9 million, divestiture related charges of $11.3 million and zero and a pension curtailment charge of $5.3 million and zero for the three months ended March 31, 2015 and 2014, respectively. Interest was allocated in accordance with relevant discontinued operations accounting guidance.

The following table presents the major classes of assets and liabilities of FMC Alkali Chemicals:

(in Millions)	March 31, 2015			December 31, 2014
Assets
Current assets of discontinued operations held for sale (primarily trade receivables and inventories)	$	205.7		$	203.3
Property, plant & equipment (1)	383.2			378.6
Other non-current assets (1)	22.9			22.9
Total assets of discontinued operations held for sale (2)	$	611.8		$	604.8
Liabilities
Current liabilities of discontinued operations held for sale	(70.7		)	(88.4		)
Noncurrent liabilities of discontinued operations held for sale (1)	(9.1		)	(4.7		)
Total liabilities of discontinued operations held for sale (2)	$	(79.8	)	$	(93.1	)
Net Assets	$	532.0		$	511.7

____________________

(1)     Presented as "Noncurrent assets\liabilities of discontinued operations held for sale" on the condensed consolidated balance sheet as

of December 31, 2014.

(2)    Presented as "Current assets\liabilities of discontinued operations held for sale" on the condensed consolidated balance sheet as of

March 31, 2015.

14

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

In addition to our discontinued FMC Alkali Chemicals division our other discontinued operations include adjustments to retained liabilities. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

Our discontinued operations comprised the following:

(in Millions)	Three Months Ended March 31
	2015			2014
Adjustment for workers’ compensation, product liability, other postretirement benefits and other, net of income tax benefit (expense) of ($0.3) and zero for the three months ended March 31, 2015 and 2014, respectively	$	(2.5	)	$	(1.5	)
Provision for environmental liabilities, net of recoveries, net of income tax benefit of $1.9 and $2.7 for the three months ended March 31, 2015 and 2014, respectively (1)	(0.6		)	(4.8		)
Provision for legal reserves and expenses, net of recoveries, net of income tax benefit (expense) of ($0.1) and $2.3 for the three months ended March 31, 2015 and 2014, respectively	0.1			(3.8		)
Discontinued operations of FMC Alkali Chemicals, net of income tax benefit (expense) of ($0.4) and ($4.7) for the three months ended March 31, 2015 and 2014, respectively	18.6			21.9
Discontinued operations of FMC Peroxygens, net of income tax benefit (expense) of zero and ($29.3) for the three months ended March 31, 2015 and 2014, respectively (2)	—			(40.0		)
Discontinued operations, net of income taxes	$	15.6		$	(28.2	)

____________________

(1) See a roll forward of our environmental reserves as well as discussion on significant environmental issues that occurred during the 2015 in Note 10.

(2) On February 28, 2014, we completed the sale of our FMC Peroxygens business for $199.1 million in cash to One Equity Partners (OEP), the private investment arm of J.P. Morgan Chase & Co. The sale resulted in a further pre-tax loss of $10.1 million ($33.4 million net of tax). The net of tax loss was driven by the final allocation of the $199.1 million of proceeds.

Note 10: Environmental Obligations

We have reserves for potential environmental obligations, which management considers probable and for which management can reasonable estimate. The table below is a roll forward of our total environmental reserves, continuing and discontinued:

(in Millions)	Gross			Recoveries (3)			Net
Total environmental reserves at December 31, 2014	$	296.2		$	(11.9	)	$	284.3
Provision/(benefit)	4.4			—			4.4
(Spending)/recoveries	(7.7		)	1.0			(6.7		)
Total environmental reserves at March 31, 2015	$	292.9		$	(10.9	)	$	282.0
Environmental reserves, current (1)	96.4			(5.3		)	91.1
Environmental reserves, long-term (2)	196.5			(5.6		)	190.9
Total environmental reserves at March 31, 2015	$	292.9		$	(10.9	)	$	282.0

____________________

(1) These amounts are included within "Accrued and other liabilities" on the condensed consolidated balance sheets.

(2) These amounts are included in “Environmental liabilities, continuing and discontinued” on the condensed consolidated balance sheets.

(3) These recorded recoveries represent probable realization of claims against U.S. government agencies and are recorded as an offset to our environmental reserves in the condensed consolidated balance sheets.

The estimated reasonably possible environmental loss contingencies, net of expected recoveries, exceed amounts accrued by approximately $210 million at March 31, 2015. This reasonably possible estimate is based upon information available as of the date of the filing but the actual future losses may be higher given the uncertainties regarding the status of laws, regulations, enforcement policies, the impact of potentially responsible parties, technology and information related to individual sites. Potential environmental obligations that have not been reserved may be material to any one quarter's or year's results of operations in the future. However, we believe any such liability arising from such potential environmental obligations is not likely to have a material adverse effect on our liquidity or financial condition as it may be satisfied over many years.

15

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

The table below provides a roll forward of our environmental recoveries representing probable realization of claims against insurance carriers and other third parties. These recoveries are recorded as "Other assets" in the condensed consolidated balance sheets.

(in Millions)	12/31/2014		Increase in Recoveries	Cash Received		3/31/2015
Environmental Recoveries	$	29.9	—	(3.6	)	$	26.3

Our net environmental provisions relate to costs for the continued cleanup of both continuing and discontinued manufacturing operations from previous years. The net provisions are comprised as follows:

	Three Months Ended March 31
(in Millions)	2015		2014
Environmental provisions, net - recorded to liabilities (1)	$	4.4	$	8.9
Environmental provisions, net - recorded to assets (2)	—		—
Environmental provision, net	$	4.4	$	8.9
Continuing operations (3)	1.9		1.4
Discontinued operations (4)	2.5		7.5
Environmental provision, net	$	4.4	$	8.9

____________________

(1)     See above roll forward of our total environmental reserves as presented on the condensed consolidated balance sheets.

(2)     See above roll forward of our total environmental recoveries as presented on the condensed consolidated balance sheets.

(3)     Recorded as a component of “Restructuring and other charges (income)” on the condensed consolidated statements of income (loss). See

Note 7. Environmental obligations for continuing operations primarily represent obligations at shut down or abandoned facilities within businesses that do not meet the criteria for presentation as discontinued operations.

(4)     Recorded as a component of “Discontinued operations, net of income taxes" on the condensed consolidated statements of income

(loss). See Note 9.

A more complete description of our environmental contingencies and the nature of our potential obligations are included in Notes 1 and 10 to our consolidated financial statements in our 2014 Form 10-K. See Note 10 to our consolidated financial statements in our 2014 Form 10-K for a description of significant updates to material environmental sites.

Note 11: Earnings Per Share

Earnings per common share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during the period on a basic and diluted basis.

Our potentially dilutive securities include potential common shares related to our stock options, restricted stock and restricted stock units. Diluted earnings per share (“Diluted EPS”) considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an antidilutive effect. Diluted EPS excludes the impact of potential common shares related to our stock options in periods in which the option exercise price is greater than the average market price of our common stock for the period. For the three months ended March 31, 2015 we had a net loss attributable to FMC stockholders and as such all 1,635 thousand potential common shares were excluded from Diluted EPS. There were 312 thousand potential common shares excluded from Diluted EPS for the three months ended March 31, 2014.

Our non-vested restricted stock awards contain rights to receive non-forfeitable dividends, and thus, are participating securities requiring the two-class method of computing EPS. The two-class method determines EPS by dividing the sum of distributed earnings to common stockholders and undistributed earnings allocated to common stockholders by the weighted average number of shares of common stock outstanding for the period. In calculating the two-class method, undistributed earnings are allocated to both common shares and participating securities based on the weighted average number of shares outstanding during the period.

16

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

Earnings applicable to common stock and common stock shares used in the calculation of basic and diluted earnings per share are as follows:

(in Millions, Except Share and Per Share Data)	Three Months Ended March 31
	2015			2014
Earnings (loss) attributable to FMC stockholders:
Continuing operations, net of income taxes	$	(62.4	)	$	93.8
Discontinued operations, net of income taxes	15.6			(28.2		)
Net income (loss) attributable to FMC stockholders	$	(46.8	)	$	65.6
Less: Distributed and undistributed earnings allocable to restricted award holders	—			(0.2		)
Net income (loss) allocable to common stockholders	$	(46.8	)	$	65.4
Basic earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.47	)	$	0.70
Discontinued operations	0.12			(0.21		)
Net income (loss) attributable to FMC stockholders	$	(0.35	)	$	0.49
Diluted earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.47	)	$	0.70
Discontinued operations	0.12			(0.21		)
Net income (loss) attributable to FMC stockholders	$	(0.35	)	$	0.49
Shares (in thousands):
Weighted average number of shares of common stock outstanding - Basic	133,577			133,139
Weighted average additional shares assuming conversion of potential common shares	—			1,114
Shares – diluted basis	133,577			134,253

Note 12: Equity

Refer to the table below for a reconciliation of equity, equity attributable to the parent, and equity attributable to noncontrolling interests for the three months ended March 31, 2015:

(in Millions, Except Per Share Data)	FMC Stockholders’ Equity			Noncontrolling Interest			Total Equity
Balance at December 31, 2014	$	1,530.5		$	33.5		$	1,564.0
Net income (loss)	(46.8		)	1.3			(45.5		)
Stock compensation plans	8.1			—			8.1
Excess tax benefits from share-based compensation	1.7			—			1.7
Shares for benefit plan trust	(0.2		)	—			(0.2		)
Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax (1)	5.8			—			5.8
Net hedging gains/(losses) and other, net of income tax (1)	0.5			—			0.5
Foreign currency translation adjustments (1)	(39.7		)	(0.3		)	(40.0		)
Dividends ($0.165 per share)	(22.1		)	—			(22.1		)
Repurchases of common stock	(2.9		)	—			(2.9		)
Balance at March 31, 2015	$	1,434.9		$	34.5		$	1,469.4

____________________

(1) See condensed consolidated statements of comprehensive income (loss).

17

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

Accumulated other comprehensive income (loss)

Summarized below is the roll forward of accumulated other comprehensive income (loss), net of tax.

(in Millions)	Foreign currency adjustments			Derivative Instruments(1)			Pension and other postretirement benefits (2)			Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2014	$	(50.4	)	$	(3.9	)	$	(321.5	)	$	(375.8	)
2015 Activity
Other comprehensive income (loss) before reclassifications	(39.7		)	2.3			(5.9		)	$	(43.3	)
Amounts reclassified from accumulated other comprehensive income (loss)	—			(1.8		)	11.7			$	9.9
Accumulated other comprehensive income (loss), net of tax at March 31, 2015	$	(90.1	)	$	(3.4	)	$	(315.7	)	$	(409.2	)

(in Millions)	Foreign currency adjustments			Derivative Instruments (1)			Pension and other postretirement benefits (2)			Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2013	$	(25.3	)	$	(6.1	)	$	(170.5	)	$	(201.9	)
2014 Activity
Other comprehensive income (loss) before reclassifications	—			2.5			0.5			$	3.0
Amounts reclassified from accumulated other comprehensive income (loss)	49.6			1.1			6.0			$	56.7
Accumulated other comprehensive income (loss), net of tax at March 31, 2014	$	24.3		$	(2.5	)	$	(164.0	)	$	(142.2	)

____________________

(1)     See Note 15 for more information.

(2)    See Note 13 for more information.

18

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

Reclassifications of accumulated other comprehensive income (loss)

The table below provides details about the reclassifications from Accumulated Other Comprehensive Income and the affected line items in the condensed consolidated statements of income (loss) for each of the periods presented.

Details about Accumulated Other Comprehensive Income Components	Amounts Reclassified from Accumulated Other Comprehensive Income (1)						Affected Line Item in the Condensed Consolidated Statements of Income (Loss)
	Three Months Ended March 31
(in Millions)	2015			2014
Foreign currency translation adjustments:
Divestiture of FMC Peroxygens (3)	—			(49.6		)	Discontinued operations, net of income taxes
Derivative instruments:
Foreign currency contracts	$	8.7		$	(0.9	)	Costs of sales and services
Energy contracts	$	(1.3	)	$	1.0		Costs of sales and services
Foreign currency contracts	$	(4.4	)	$	(1.6	)	Selling, general and administrative expenses
Total before tax	$	3.0		$	(1.5	)
	$	(1.2	)	$	0.4		Provision for income taxes
Amount included in net income	$	1.8		$	(1.1	)
Pension and other postretirement benefits (2):
Amortization of prior service costs	$	(0.4	)	$	(0.4	)	Selling, general and administrative expenses
Amortization of unrecognized net actuarial and other gains (losses)	$	(12.7	)	$	(7.2	)	Selling, general and administrative expenses
Recognized loss due to settlement and curtailment	$	(5.3	)	$	(1.6	)	Selling, general and administrative expenses (4)
Total before tax	$	(18.4	)	$	(9.2	)
	$	6.7		$	3.2		Provision for income taxes
Amount included in net income	$	(11.7	)	$	(6.0	)
Total reclassifications for the period	$	(9.9	)	$	(56.7	)	Amount included in net income

____________________

(1) Amounts in parentheses indicate charges to the condensed consolidated statements of income (loss).

(2) Pension and other postretirement benefits amounts include the impact from both continuing and discontinued operations. For detail on the continuing operations components of pension and other postretirement benefits, see Note 13.

(3) The reclassification of historical cumulative translation adjustments was the result of the divestiture of our FMC Peroxygens business during the quarter ended March 31, 2014. The loss recognized from this reclassification is considered permanent for tax purposes and therefore no tax has been provided. See Note 9 for more information. In accordance with accounting guidance, this amount was previously factored into the lower of cost or fair value test associated with the 2013 Peroxygens' asset held for sale write-down charges.

(4) The $5.3 million loss due to curtailment for the three months ended March 31, 2015 related to the disposal of our FMC Alkali Chemicals division and was recorded to Discontinued operations, net of income taxes in the condensed statements of income (loss).

Dividends and Share Repurchases

For the three months ended March 31, 2015 and 2014, we paid $20.1 million and $18.0 million, respectively, in dividends declared in previous periods. On April 16, 2015, we paid dividends totaling $22.1 million to our shareholders of record as of March 31, 2015. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of March 31, 2015.

19

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

During the three months ended March 31, 2015, we did not repurchase any shares under the publicly announced repurchase program. At March 31, 2015, $250.0 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

Note 13: Pensions and Other Postretirement Benefits

The following table summarizes the components of net annual benefit cost (income) for the three months ended March 31, 2015 and 2014:

(in Millions)	Three Months Ended March 31
	Pensions						Other Benefits
	2015			2014			2015			2014
Components of net annual benefit cost (income):
Service cost	$	4.1		$	4.9		$	—		$	—
Interest cost	15.4			15.5			0.3			0.3
Expected return on plan assets	(22.2		)	(21.6		)	—			—
Amortization of prior service cost (credit)	0.3			0.4			0.1			—
Recognized net actuarial and other (gain) loss	12.9			7.8			(0.2		)	(0.4		)
Recognized loss due to curtailment (1)	4.8			—			0.5			—
Recognized loss due to settlement (2)	—			1.6			—			—
Net periodic benefit cost (3)	$	15.3		$	8.6		$	0.7		$	(0.1	)

____________________

(1) Curtailment loss is associated with the disposal of our FMC Alkali Chemicals division and was recorded to discontinued operations within the condensed consolidated statements of income (loss).

(2) Settlement charge is associated with the acceleration of previously deferred pension actuarial losses and was triggered by a lump-sum payout to certain former executives.

(3) Net periodic benefit cost represent both continuing and discontinued operations.

We made voluntary cash contributions to our U.S. defined benefit pension plan of $25.0 million and $17.0 million in the three months ended March 31, 2015 and March 31, 2014. We expect to make approximately $65 million in voluntary cash contributions to our U.S. defined benefit pension plan during 2015.

Note 14: Income Taxes

We determine our interim tax provision using an Estimated Annual Effective Tax Rate methodology (“EAETR”) in accordance with GAAP. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision.

The determination of the EAETR is based upon a number of estimates, including the estimated annual pretax ordinary income in each tax jurisdiction in which we operate. The tax effects of discrete items are recognized in the tax provision in the quarter they occur in accordance with GAAP. Depending on various factors such as the item’s significance in relation to total income and the rate of tax applicable in the jurisdiction to which it relates, discrete items in any quarter can materially impact the reported effective tax rate. As a global enterprise, our tax expense can be impacted by changes in tax rates or laws, the finalization of tax audits and reviews, as well as other factors. As such, there can be significant volatility in interim tax provisions.

20

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

The below chart provides reconciliation between our reported effective tax rates and the EAETR.

	Three Months Ended March 31
	2015								2014
(in Millions)	Before Tax			Tax			Effective Tax Rate % Impact		Before Tax		Tax		Effective Tax Rate % Impact
Continuing operations	(110.2		)	(49.1		)	44.6	%	131.6		34.6		26.3	%
Discrete items:
Acquisition related charges (1)	190.7			70.3					3.1		0.8
Currency remeasurement (2)	6.3			(2.8		)			—		—
Other discrete items	21.8			7.3					9.9		3.4
Tax only discrete items (3)	—			3.0					—		—
Total discrete items	$	218.8		$	77.8				$	13.0	$	4.2
Continuing operations, before discrete items	108.6			28.7					144.6		38.8
Estimated Annualized Effective Tax Rate (EAETR)							26.4	%					26.8	%

___________________ 

(1) Acquisition related charges for the three months ended March 31, 2015 are primarily taxed at domestic tax rates resulting in material tax benefit. Charges include a $180.1 million loss on the hedge of the acquisition purchase price of Cheminova A/S, as noted in footnote (2) below hedge gains or losses are treated discretely for tax purposes. For more information on the hedge loss refer to Note 3.

(2) Represents transactions gains or losses on currency remeasurement, offset by the associated hedge gains or losses. Transaction gains or losses are considered non-taxable permanent items and their associated hedge gain or losses are treated discretely for tax purposes.

(3) Includes the tax effect of currency remeasurement associated with our foreign statutory operations that in accordance with GAAP income tax accounting guidance shall be treated discretely for tax purposes.

Note 15: Financial Instruments, Risk Management and Fair Value Measurements

Our financial instruments include cash and cash equivalents, trade receivables, other current assets, certain receivables classified as other long-term assets, accounts payable, and amounts included in investments and accruals meeting the definition of financial instruments. The carrying value of these financial instruments approximates their fair value. Our other financial instruments include the following:

Financial Instrument	Valuation Method
Foreign exchange forward contracts	Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on current market prices for applicable currencies.
Commodity forward and option contracts	Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on quoted market prices for applicable commodities.
Debt	Our estimates and information obtained from independent third parties using market data, such as bid/ask spreads for the last business day of the reporting period.

The estimated fair value of the financial instruments in the above table have been determined using standard pricing models which take into account the present value of expected future cash flows discounted to the balance sheet date. These standard pricing models utilize inputs derived from or corroborated by observable market data such as interest rate yield curves and currency and commodity spot and forward rates. In addition, we test a subset of our valuations against valuations received from the transaction's counterparty to validate the accuracy of our standard pricing models. Accordingly, the estimates presented may not be indicative of the amounts that we would realize in a market exchange at settlement date and do not represent potential gains or losses on these agreements. The estimated fair values of foreign exchange forward contracts and commodity forward and option contracts are included in the tables within this Note. The estimated fair value of debt is $2,170.6 million and $1,773.2 million and the carrying amount is $2,058.2 million and $1,678.6 million as of March 31, 2015 and December 31, 2014, respectively.

We enter into various financial instruments with off-balance-sheet risk as part of the normal course of business. These off-balance-sheet instruments include financial guarantees and contractual commitments to extend financial guarantees under letters of credit, and other assistance to customers (Note 16). Decisions to extend financial guarantees to customers, and the amount of collateral required under these guarantees is based on our evaluation of creditworthiness on a case-by-case basis.

21

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

Use of Derivative Financial Instruments to Manage Risk

We mitigate certain financial exposures, including currency risk, commodity purchase exposures and interest rate risk, through a program of risk management that includes the use of derivative financial instruments. We enter into foreign exchange contracts, including forward and purchased options contracts, to reduce the effects of fluctuating foreign currency exchange rates. A detailed description of these risks including a discussion on the concentration of credit risk is provided in Note 17 to our consolidated financial statements on our 2014 Form 10-K.

We formally document all relationships between hedging instruments and hedged items, as well as the risk management objective and strategy for undertaking various hedge transactions. This process includes relating derivatives that are designated as fair value or cash flow hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. We also assess both, at the inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item. If we determine that a derivative is not highly effective as a hedge, or if a derivative ceases to be a highly effective hedge, we discontinue hedge accounting with respect to that derivative prospectively.

Accounting for Derivative Instruments and Hedging Activities

Cash Flow Hedges

We recognize all derivatives on the balance sheet at fair value. On the date the derivative instrument is entered into, we generally designate the derivative as a hedge of the variability of cash flows to be received or paid related to a forecasted transaction (cash flow hedge). We record in AOCI changes in the fair value of derivatives that are designated as and meet all the required criteria for a cash flow hedge. We then reclassify these amounts into earnings as the underlying hedged item affects earnings. In contrast, we immediately record in earnings changes in the fair value of derivatives that are not designated as cash flow hedges.

As of March 31, 2015, we had open foreign currency forward contracts in AOCI in a net after tax loss position of $2.9 million designated as cash flow hedges of underlying forecasted sales and purchases. Current open contracts hedge forecasted transactions until December 31, 2015. At March 31, 2015, we had open forward contracts designated as cash flow hedges with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $404.9 million.

As of March 31, 2015, we had current open commodity contracts in AOCI in a net after tax loss position of $1.8 million designated as cash flow hedges of underlying forecasted purchases, primarily related to natural gas. Current open commodity contracts hedge forecasted transactions until December 31, 2016. At March 31, 2015, we had an equivalent of 1.4 million mmBTUs (millions of British Thermal Units) in aggregate notional volume of outstanding natural gas commodity forward contracts to hedge forecasted purchases.

Of the $4.7 million of net losses after-tax, representing both open foreign currency exchange contracts and commodity contracts, approximately $4.5 million of these losses would be realized in earnings during the twelve months ending March 31, 2016 and $0.2 million of net losses will be realized subsequent to March 31, 2016, if spot rates in the future are consistent with forward rates as of March 31, 2015. The actual effect on earnings will be dependent on the actual spot rates when the forecasted transactions occur.

Derivatives Not Designated As Hedging Instruments

We hold certain forward contracts that have not been designated as cash flow hedging instruments for accounting purposes. Contracts used to hedge the exposure to foreign currency fluctuations associated with certain monetary assets and liabilities are not designated as cash flow hedging instruments, and changes in the fair value of these items are recorded in earnings. We occasionally hold call options that are effective as economic hedges of a portion of our natural gas exposure and the change in fair value of this instrument is also recorded in earnings. We periodically hold soybean barter contracts which qualify as derivatives and we have entered into offsetting commodity contracts to hedge our exposure. Both the change in fair value of the soybean barter contracts and the offsetting commodity contracts are recorded in earnings.

We had open forward contracts not designated as cash flow hedging instruments for accounting purposes with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $3.5 billion at March 31, 2015, which included approximately $2.6 billion associated with the derivative contracts to hedge the purchase of Cheminova A/S.

22

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

Fair Value of Derivative Instruments

The following tables provide the gross fair value and net balance sheet presentation of our derivative instruments as of March 31, 2015 and December 31, 2014.

	March 31, 2015
	Gross Amount of Derivatives
(in Millions)	Designated as Cash Flow Hedges			Not Designated as Hedging Instruments			Total Gross Amounts			Gross Amounts Offset in the Consolidated Balance Sheet (3)			Net Amounts
Derivatives
Foreign exchange contracts	$	22.8		$	32.4		$	55.2		$	(28.1	)	$	27.1
Total derivative assets (1)	22.8			32.4			55.2			(28.1		)	27.1
Foreign exchange contracts	(26.1		)	(6.2		)	(32.3		)	28.1			(4.2		)
Energy contracts	(2.8		)	—			(2.8		)	—			(2.8		)
Total derivative liabilities (2)	(28.9		)	(6.2		)	(35.1		)	28.1			(7.0		)
Net derivative assets/(liabilities)	$	(6.1	)	$	26.2		$	20.1		$	—		$	20.1
	December 31, 2014
	Gross Amount of Derivatives
(in Millions)	Designated as Cash Flow Hedges			Not Designated as Hedging Instruments			Total Gross Amounts			Gross Amounts Offset in the Consolidated Balance Sheet (3)			Net Amounts
Derivatives
Foreign exchange contracts	$	17.1		$	15.1		$	32.2		$	(3.6	)	$	28.6
Energy contracts	0.3			—			0.3			(0.3		)	—
Total derivative assets (1)	17.4			15.1			32.5			(3.9		)	28.6
Foreign exchange contracts	(17.4		)	(100.0		)	(117.4		)	3.6			(113.8		)
Energy contracts	(7.6		)	—			(7.6		)	0.3			(7.3		)
Total derivative liabilities (2)	(25.0		)	(100.0		)	(125.0		)	3.9			(121.1		)
Net derivative assets/(liabilities)	$	(7.6	)	$	(84.9	)	$	(92.5	)	$	—		$	(92.5	)

____________________

(1) Net balance is included in “Prepaid and other current assets” in the condensed consolidated balance sheets.

(2) Net balance is included in “Accrued and other liabilities” in the condensed consolidated balance sheets.

(3) Represents net derivatives positions subject to master netting arrangements.

23

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

The tables below summarizes the gains or losses related to our cash flow hedges and derivatives not designated as hedging instruments for the three months ended March 31, 2015 and 2014.

Derivatives in Cash Flow Hedging Relationships

	Three Months Ended March 31
	Contracts
	Foreign Exchange					Energy					Other				Total
(in Millions)	2015			2014		2015		2014			2015		2014		2015			2014
Unrealized hedging gains (losses) and other, net of tax	$	0.3		$	1.1	$	2.0	$	1.4		$	—	$	—	$	2.3		$	2.5
Reclassification of deferred hedging (gains) losses, net of tax
Effective portion (1)	(2.6		)	1.8		0.8		(0.7		)	—		—		(1.8		)	1.1
Total derivative instrument impact on comprehensive income	$	(2.3	)	$	2.9	$	2.8	$	0.7		$	—	$	—	$	0.5		$	3.6

___________________

(1) See Note 12 for classification of amounts within the condensed consolidated statements of income (loss).

Derivatives Not Designated as Hedging Instruments

	Location of Gain or (Loss) Recognized in Income on Derivatives	Amount of Pre-tax Gain or (Loss)  Recognized in Income on Derivatives (1)
		Three Months Ended March 31
(in Millions)		2015			2014
Foreign exchange contracts	Cost of sales and services	$	(4.5	)	$	4.9
	Selling, general & administrative (2)	(180.1		)	—
Total		$	(184.6	)	$	4.9

___________________

(1) Amounts in the columns represent the gain or loss on the derivative instrument offset by the gain or loss on the hedged item.

(2) Charges represent a loss on hedging the purchase price of the Cheminova A/S acquisition. See Note 3 within these condensed consolidated financial statements for more information.

Fair-Value Measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Market participants are defined as buyers or sellers in the principle or most advantageous market for the asset or liability that are independent of the reporting entity, knowledgeable and able and willing to transact for the asset or liability.

Fair-Value Hierarchy

We have categorized our assets and liabilities that are recorded at fair value, based on the priority of the inputs to the valuation technique, into a three-level fair-value hierarchy. The fair-value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the assets and liabilities fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair-value measurement of the instrument.

Recurring Fair Value Measurements

The following tables present our fair-value hierarchy for those assets and liabilities measured at fair-value on a recurring basis in the condensed consolidated balance sheets as of March 31, 2015 and December 31, 2014. During the periods presented there were no transfers between fair-value hierarchy levels.

24

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

(in Millions)	March 31, 2015		Quoted Prices in  Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Derivatives – Foreign exchange (1)	$	27.1	$	—	$	27.1	$	—
Other (2)	32.3		32.3		—		—
Total assets	$	59.4	$	32.3	$	27.1	$	—
Liabilities
Derivatives – Commodities:
Energy contracts (1)	$	2.8	$	—	$	2.8	$	—
Derivatives – Foreign exchange (1)	4.2		—		4.2		—
Other (3)	35.2		34.6		0.6		—
Total liabilities	$	42.2	$	34.6	$	7.6	$	—

____________________

(1) See the Fair Value of Derivative Instruments table within this Note for classifications on the condensed consolidated balance sheet.

(2) Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheet. Both the asset and liability are recorded at fair value. Asset amounts included in “Other assets” in the condensed consolidated balance sheets.

(3) Consists of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts due are included in “Other long-term liabilities” in the condensed consolidated balance sheets. Level 2 liabilities represent liability-based awards associated with non-employees.

(in Millions)	December 31, 2014		Quoted Prices in  Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Derivatives – Commodities:
Derivatives – Foreign exchange (1)	$	28.6	$	—	$	28.6	$	—
Other (2)	30.9		30.9		—		—
Total assets	$	59.5	$	30.9	$	28.6	$	—
Liabilities
Derivatives – Commodities:
Energy contracts (1)	$	7.3	$	—	$	7.3	$	—
Derivatives – Foreign exchange (1)	113.8		—		113.8		—
Other (3)	33.7		33.1		0.6		—
Total liabilities	$	154.8	$	33.1	$	121.7	$	—

____________________

(1) See the Fair Value of Derivative Instruments table within this Note for classification on the condensed consolidated balance sheet.

(2) Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheet. Both the asset and liability are recorded at fair value. Asset amounts included in “Other assets” in the condensed consolidated balance sheets.

(3) Consist of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts included in “Other long-term liabilities” in the condensed consolidated balance sheets.

25

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

Nonrecurring Fair Value Measurements

The following tables present our fair value hierarchy for those assets and liabilities measured at fair value on a non-recurring basis in the condensed consolidated balance sheets during the three months ended March 31, 2015 and the year ended December 31, 2014.

(in Millions)	March 31, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Gains (Losses) (Three Months Ended March 31, 2015)
Assets
Long-lived assets associated with exit activities (1)	$	—	$	—	$	—	$	—	$	(1.2	)
Total assets	$	—	$	—	$	—	$	—	$	(1.2	)

____________________

(1) We recorded charges, within our FMC Health and Nutrition segment, to write down the value of certain long-lived assets to zero related to our FMC Health and Nutrition restructuring as they have no future use. See Note 7 for more information.

(in Millions)	December 31, 2014		Quoted Prices in  Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Gains (Losses) (Year Ended December 31, 2014)
Assets
Long-lived assets associated with exit activities (1)	$	—	$	—	$	—	$	—	$	(3.1	)
Total assets	$	—	$	—	$	—	$	—	$	(3.1	)

____________________

(1) We recorded charges, within our FMC Health and Nutrition segment, to write down the value of certain long-lived assets to zero related to our FMC Health and Nutrition restructuring as they have no future use. See Note 7 for more information.

Note 16: Guarantees, Commitments, and Contingencies

We continue to monitor the conditions that are subject to guarantees and indemnifications to identify whether a liability must be recognized in our financial statements.

Guarantees and Other Commitments

The following table provides the estimated undiscounted amount of potential future payments for each major group of guarantees at March 31, 2015. These guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates. Non-performance by the guaranteed party triggers the obligation requiring us to make payments to the beneficiary of the guarantee. Based on our experience these types of guarantees have not had a material effect on our consolidated financial position or on our liquidity. Our expectation is that future payment or performance related to the non-performance of others is considered unlikely.

(in Millions)
Guarantees:
Guarantees of vendor financing (1)	$	67.4
Other debt guarantees (2)	27.7
Total	$	95.1

____________________

(1) Represents guarantees to financial institutions on behalf of certain FMC Agricultural Solutions customers for their seasonal borrowing. This amount is recorded on the condensed consolidated balance sheets as “Guarantees of vendor financing”.

(2) These guarantees represent support provided to third-party banks for credit extended to various FMC Agricultural Solutions customers and nonconsolidated affiliates. The liability for the guarantees is recorded at an amount that approximates fair-value (i.e. representing

26

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

the stand-ready obligation) based on our historical collection experience and a current assessment of credit exposure. We believe the fair-value of these guarantees is immaterial. The majority of these guarantees have an expiration date of less than one year.

Excluded from the chart above, in connection with our property and asset sales and divestitures, we have agreed to indemnify the buyer for certain liabilities, including environmental contamination and taxes that occurred prior to the date of sale or provided guarantees to third parties relating to certain contracts assumed by the buyer. Our indemnification or guarantee obligations with respect to these liabilities may be indefinite as to duration and may or may not be subject to a deductible, minimum claim amount or cap. As such, it is not possible for us to predict the likelihood that a claim will be made or to make a reasonable estimate of the maximum potential loss or range of loss. If triggered, we may be able to recover some of the indemnity payments from third parties. We have not recorded any specific liabilities for these guarantees.

Contingencies

A detailed discussion related to our outstanding contingencies can be found in Note 18 to our consolidated financial statements included within our 2014 Form 10-K. There have been no material changes related to our contingencies from the information reported in our 2014 10-K.

Note 17: Segment Information

(in Millions)	Three Months Ended March 31
	2015			2014
Revenue
FMC Agricultural Solutions	$	392.4		$	466.9
FMC Health and Nutrition	211.0			226.2
FMC Lithium	56.0			63.8
Eliminations	—			—
Total	$	659.4		$	756.9
Income from continuing operations before income taxes
FMC Agricultural Solutions	$	81.8		$	120.1
FMC Health and Nutrition	51.0			50.9
FMC Lithium	5.5			6.6
Eliminations	—			—
Segment operating profit	$	138.3		$	177.6
Corporate and other	(15.3		)	(17.4		)
Operating profit before the items listed below	$	123.0		$	160.2
Interest expense, net	(14.0		)	(11.6		)
Restructuring and other (charges) income (1)	(22.3		)	(6.7		)
Non-operating pension and postretirement (charges) income (2)	(6.2		)	(4.2		)
Business separation costs (3)	—			(3.0		)
Acquisition related charges (4)	(190.7		)	(3.1		)
Provision for income taxes	49.1			(34.6		)
Discontinued operations, net of income taxes	15.6			(26.6		)
Net income attributable to noncontrolling interests	(1.3		)	(4.8		)
Net income (loss) attributable to FMC stockholders	$	(46.8	)	$	65.6

_________________________________________

(1) See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended March 31, 2015, relate to FMC Agricultural Solutions of $18.3 million, FMC Health and Nutrition of $2.2 million, FMC Lithium of $0.3 million and Corporate of $1.5 million. Amounts for the three months ended March 31, 2014, relate to FMC Health and Nutrition of $4.9 million, FMC Lithium of $0.1 million, and Corporate of $1.7 million.

(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes

27

FMC CORPORATION

Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss). 

(3) On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three months ended March 31, 2014 represent charges associated with the planned separation activities through March 31, 2014.

(4) Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, legal and professional fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following:

	Three Months Ended
	March 31
(in Millions)	2015		2014
Acquisition related charges - Cheminova
Legal and professional fees (1)	$	10.6	$	—
Loss/(gain) on hedging purchase price (1)	180.1		—
Acquisition related charges - Epax
Inventory fair value step-up amortization (2)	—		3.1
Acquisition/divestiture related charges	$	190.7	$	3.1

____________________

(1)    On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative

expense.” For more information on the loss on purchase price hedge see Note 3.

(2)    On the condensed consolidated statements of income (loss), these charges are included in “Costs of sales and services.”

Note 18: Subsequent Events

Cheminova Acquisition:

Refer to Note 3 for more information on the completed acquisition of Cheminova A/S, which occurred on April 21, 2015 and Note 8 on the financing associated with the acquisition.

FMC Alkali Chemicals Divestiture:

Refer to Note 9 for more information on the completed divestiture of FMC Alkali Chemicals division, which occurred on April 1, 2015.

28

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, "expect", “expects”, “should”, “could”, “may”, “will continue to”, "believe", “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and

unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of

activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2014 (the “2014 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part II included in this Form 10-Q may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2014 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Critical Accounting Policies” section in our 2014 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

• Environmental obligations and related recoveries

• Impairment and valuation of long-lived assets

• Pensions and other postretirement benefits

• Income taxes

Subsequent to the acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division (see Note 3 and Note 9 to the condensed consolidated financial statements included within this Form 10-Q for more information) we have reassessed our critical accounting policies. We have concluded that in addition to the four critical accounting policies listed above that our accounting policy over "Revenue recognition and trade receivables" is now critical to our results of operations and financial condition.

Revenue recognition and trade receivables

We recognize revenue when the earnings process is complete, which is generally upon transfer of title. This transfer typically occurs either upon shipment to the customer or upon receipt by the customer. In all cases, we apply the following criteria in recognizing revenue: persuasive evidence of an arrangement exists, delivery has occurred, the selling price is fixed or determinable and collection is reasonably assured. Rebates due to customers are accrued as a reduction of revenue in the same period that the related sales are recorded based on the contract terms.

29

We periodically enter into prepayment arrangements with customers, primarily in our FMC Agricultural Solutions segment, and receive advance payments for product to be delivered in future periods. These advance payments are recorded as deferred revenue and classified as “Advance payments from customers” on the consolidated balance sheet. Revenue associated with advance payments is recognized as shipments are made and title, ownership and risk of loss pass to the customer.

We record amounts billed for shipping and handling fees as revenue. Costs incurred for shipping and handling are recorded as costs of sales and services. Amounts billed for sales and use taxes, value-added taxes, and certain excise and other specific transactional taxes imposed on revenue-producing transactions are presented on a net basis and excluded from sales in the consolidated income statements. We record a liability until remitted to the respective taxing authority.

Trade receivables consist of amounts owed to us from customer sales and are recorded when revenue is recognized. The allowance for trade receivables represents our best estimate of the probable losses associated with potential customer defaults. In developing our allowance for trade receivables, we utilize a two stage process which includes calculating a general formula to develop an allowance to appropriately address the uncertainty surrounding collection risk of our entire portfolio and specific allowances for customers where the risk of collection has been reasonably identified either due to liquidity constraints or disputes over contractual terms and conditions.

Our method of calculating the general formula consists of estimating the recoverability of trade receivables based on historical experience, current collection trends, and external business factors such as economic factors, including regional bankruptcy rates, and political factors. Our analysis of trade receivable collection risk is performed quarterly, and the allowance is adjusted accordingly.

RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to the condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

30

OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Lithium. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. The FMC Health and Nutrition segment focuses on food, pharmaceutical ingredients, nutraceuticals, personal care and similar markets. Our food ingredients are used to enhance texture, color, structure and physical stability. The pharmaceutical additives are used for binding, encapsulation and disintegrant applications. Our FMC Lithium segment produces a wide range of products based on lithium.

First Quarter 2015 Highlights

The following are the more significant developments in our businesses during the three months ended March 31, 2015:

• Revenue of $659.4 million for the three months ended March 31, 2015 decreased $97.5 million or 13 percent versus the same period last year. The decline in revenue was primarily attributable to FMC Agricultural Solutions. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in North America remained flat period over period while sales in Asia declined eight percent, sales in Latin America decreased 39 percent and sales in Europe, Middle East and Africa declined 18 percent period over period.

• Our gross margin, excluding acquisition related charges, decreased by approximately $45 million or approximately 15 percent to $250.7 million versus last year's first quarter. Gross margin percent of 38 percent declined from 39 percent. The reduction in gross margin was due to lower volumes in Brazil within FMC Agricultural Solutions. The gross margin decline percent was driven primarily by unfavorable currency movements.

• Selling, general and administrative expenses, excluding acquisition related charges and non-operating pension and postretirement charges decreased by approximately $9 million or nine percent to $101.0 million. The majority of these decreases were experienced in our FMC Agricultural Solutions segment.

• Research and Development expenses of $26.6 million increased $0.8 million or three percent.

• Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $83.8 million decreased by $21.2 million or 20 percent primarily due to lower operating results in FMC Agricultural Solutions. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".

Other Highlights

• On February 3, 2015, we signed a stock and asset purchase agreement ( the "Definitive Agreement") to sell our FMC Alkali Chemicals division ("ACD") to a wholly owned subsidiary of Tronox Limited ("Tronox"). The sale of ACD to Tronox was completed on April 1, 2015 resulting in approximately $1.2 billion in after-tax proceeds.

• On September 8, 2014, we entered into a definitive Share Purchase Agreement with Auriga Industries A/S, a Denmark Aktieselskab and Cheminova A/S, a Denmark Aktieselskab, a wholly owned subsidiary of Auriga. On April 21, 2015, pursuant to the terms and conditions set forth in the Purchase Agreement, we completed the acquisition of 100% of the outstanding equity of Cheminova from Auriga for an aggregate purchase price of 8.5 billion Danish krone or approximately $1.2 billion, excluding net debt to be assumed and hedge related-costs totaling $0.6 billion.

31

RESULTS OF OPERATIONS

Overview

The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

SEGMENT RESULTS RECONCILIATION
(in Millions)	Three Months Ended March 31
	2015			2014
Revenue
FMC Agricultural Solutions	$	392.4		$	466.9
FMC Health and Nutrition	211.0			226.2
FMC Lithium	56.0			63.8
Eliminations	—			—
Total	$	659.4		$	756.9
Income (loss) from continuing operations before income taxes
FMC Agricultural Solutions	$	81.8		$	120.1
FMC Health and Nutrition	51.0			50.9
FMC Lithium	5.5			6.6
Eliminations	—			—
Segment operating profit	$	138.3		$	177.6
Corporate and other	(15.3		)	(17.4		)
Operating profit before the items listed below	$	123.0		$	160.2
Interest expense, net	(14.0		)	(11.6		)
Corporate special (charges) income:
Restructuring and other (charges) income (1)	(22.3		)	(6.7		)
Non-operating pension and postretirement charges (2)	(6.2		)	(4.2		)
Business separation costs (3)	—			(3.0		)
Acquisition related charges (4)	(190.7		)	(3.1		)
Provision for income taxes	49.1			(34.6		)
Discontinued operations, net of income taxes	15.6			(26.6		)
Net income attributable to noncontrolling interests	(1.3		)	(4.8		)
Net income (loss) attributable to FMC stockholders	$	(46.8	)	$	65.6

____________________

(1) See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended March 31, 2015, relate to FMC Agricultural Solutions of $18.3 million, FMC Health and Nutrition of $2.2 million, FMC Lithium of $0.3 million and Corporate of $1.5 million. Amounts for the three months ended March 31, 2014, relate to FMC Health and Nutrition of $4.9 million, FMC Lithium of $0.1 million and Corporate of $1.7 million.

(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss). 

(3) On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three months ended March 31, 2014 represent charges associated with the planned separation activities through March 31, 2014.

32

(4) Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, legal and professional fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following:

	Three Months Ended
	March 31
(in Millions)	2015		2014
Acquisition related charges - Cheminova
Legal and professional fees (1)	$	10.6	$	—
Loss/(gain) on hedging purchase price (1)	180.1		—
Acquisition related charges - Epax
Inventory fair value step-up amortization (2)	—		3.1
Acquisition/divestiture related charges	$	190.7	$	3.1

____________________

(1) On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expenses.” For more information on the loss on purchase price hedge see Note 3 to the condensed consolidated financial statements included within this Form 10-Q.

(2) On the condensed consolidated statements of income (loss), these charges are included in “Costs of sales and services.”

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, certain tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

ADJUSTED EARNINGS RECONCILIATION
(in Millions)	Three Months Ended March 31
	2015			2014
Net income (loss) attributable to FMC stockholders (GAAP)	$	(46.8	)	$	65.6
Corporate special charges (income), pre-tax	219.2			17.0
Income tax expense (benefit) on Corporate special charges (income)	(80.5		)	(5.8		)
Corporate special charges (income), net of income taxes	$	138.7		$	11.2
Discontinued operations, net of income taxes	(15.6		)	28.2
Tax adjustments	7.5			—
Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)	$	83.8		$	105.0

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition related charges, and other income and expense items.

33

Information about how each of these items relates to our businesses at the segment level and results by segment is discussed in Note 17 of the condensed consolidated financial statements included within this Form 10-Q and in Note 19 of our consolidated financial statements in our 2014 Form 10-K.

34

FMC Agricultural Solutions

($ in Millions)	Three Months Ended March 31
	2015		2014
Revenue	$	392.4	$	466.9
Operating Profit	81.8		120.1

Revenue of $392.4 million decreased approximately 16 percent versus the prior year quarter due to sales declines primarily in Latin America. The decrease in revenue period over period was driven by lower volumes of 10 percent, lower average pricing of two percent and unfavorable foreign currency impacts of four percent.

Latin America sales of $79.1 million decreased 44 percent due to market conditions in Brazil and unfavorable currency impacts. North America sales of $218.2 million decreased one percent due to pricing pressure and unfavorable product mix. Europe, Middle East and Africa (EMEA) declined 17 percent to $21.1 million primarily due to high channel inventory. Revenue in Asia of $74.0 million declined eight percent reflecting unfavorable weather conditions in Thailand and Indonesia as well as unfavorable currency impacts.

FMC Agricultural Solutions' operating profit of $81.8 million decreased approximately 32 percent compared to the year-ago quarter, reflecting the sales declines described in the preceding paragraph. Unfavorable foreign currency impacted results by 12 percent as all major currencies experienced significant devaluation against the USD. Selling, general and administrative costs positively impacted results period over period and were approximately $5 million or four percent favorable versus the year ago period due to lower people related costs primarily in Brazil. 

Outlook

Global crop protection markets are expected to be down by mid-single digit percent in 2015. The macroeconomic environment remains uncertain, mainly in light of current expectations of currency movements, interest rates, agricultural commodity prices and oil prices. We expect that earnings contributions from the Cheminova acquisition, including early synergy gains, the continued spread of weed resistance in North and Latin America, and market share gains are expected to increase full-year segment earnings by high single-digit to low doubt-digit percent in 2015.

Proforma Financial Results with Cheminova A/S

Beginning in the second quarter of 2015, we will present pro forma combined results for the FMC Agricultural Solutions segment for 2015 and 2014.  We believe that reviewing our operating results by combining actual and pro forma results for the FMC Agricultural Solutions segment for 2015 and 2014 is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of this segment. Our pro forma segment information will include adjustments as if the Cheminova transaction had occurred on January 1, 2014. Our pro forma data will also be adjusted for the effects of acquisition accounting but will not include adjustments for cost related to integration activities, cost savings or synergies that might be achieved by the combined businesses. Pro forma amounts to be presented will not necessarily be indicative of what our results would have been had we operated Cheminova since January 1, 2014, nor our future results.

Certain Regulatory Issues

A detailed discussion related to regulatory issues impacting FMC Agricultural Solutions can be found in Part II, Item 7 of our 2014 Form 10-K. There have been no material changes related to regulatory issues impacting FMC Agricultural Solutions from the information reported in our 2014 10-K.

FMC Health and Nutrition

($ in Millions)	Three Months Ended March 31
	2015		2014
Revenue	$	211.0	$	226.2
Operating Profit	51.0		50.9

Revenue was $211.0 million, a decrease of approximately seven percent versus the prior-year quarter. Unfavorable foreign currency impacts, primarily a weaker Euro, decreased revenue by approximately five percent and lower volumes, principally in alginates impacted revenue by approximately two percent.

35

Segment operating profit of $51.0 million remained flat versus the year ago quarter driven by the revenue decline discussed in the preceding paragraph offset by improved product mix.

Outlook

In 2015, we expect full-year segment operating profit to increase by mid-single digit percent. Earnings growth is expected to come from continued demand for pharmaceutical excipients and benefits from ongoing operational improvement and restructuring programs.

FMC Lithium

($ in Millions)	Three Months Ended March 31
	2015		2014
Revenue	$	56.0	$	63.8
Operating Profit	5.5		6.6

Revenue of $56.0 million decreased by approximately 12 percent versus the prior-year quarter. Revenue decreases were driven by lower volumes of butyllithium, which represented approximately 13 percent of the revenue reduction. Unfavorable foreign currency impacts decreased revenue by two percent while pricing was favorable by three percent.

Segment operating profit of $5.5 million decreased approximately 17 percent versus the year ago quarter as improved operations were offset by the increasing cost environment in Argentina.

Outlook

In 2015, we expect full-year revenue to be relatively flat in spite of continuing currency headwinds. We expect segment operating profit to be within the range of $15 to $25 million.

Other Results of Operations

Corporate and other

Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on the condensed consolidated statements of income (loss).

Corporate and other expenses of $15.3 million in the first quarter of 2015 decreased by $2.1 million from $17.4 million in the same period in 2014. The decrease is partially driven by a decrease in employees' incentive accruals of approximately $2.5 million driven primarily by the outlook of our segments as noted above.

Interest expense, net

Three Months Ended March 31, 2015 vs. 2014

Interest expense, net for the first quarter of 2015 was $14.0 million as compared to the first quarter of 2014 of $11.6 million. The increase was primarily due to an increase in short-term foreign debt outstanding and an increase in interest rates for our commercial paper program for the three months ended March 31, 2015 compared to 2014.

36

Corporate special (charges) income

Three Months Ended March 31, 2015 vs. 2014

Restructuring and other charges (income)

	Three Months Ended March 31
(in Millions)	2015		2014
Restructuring charges and asset disposals	$	5.4	$	5.3
Other charges (income), net	16.9		1.4
Total restructuring and other charges	$	22.3	$	6.7

Restructuring and asset disposal charges in 2015 of $5.4 million were primarily associated with the announced Health and Nutrition restructuring. Other charges (income) net in 2015 of $16.9 million were primarily comprised of a $15.0 million payment for the acquisition of all global rights to a pre-development novel, proprietary broadleaf herbicide. This acquisition is considered as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination.

Restructuring and asset disposal charges in 2014 of $5.3 million were primarily associated with the Health and Nutrition restructuring. Other charges (income) net in 2014 of $1.4 million were primarily related to corporate environmental charges.

The liabilities associated with the restructuring charges listed above are also included within Note 7 to the condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.

Non-operating pension and postretirement charges

The charge for the three months ended March 31, 2015 was $6.2 million compared to $4.2 million for the three months ended March 31, 2014. The increase in charges was primarily the result of higher amortization impacts of actuarial losses, see Note 13 to the condensed consolidated financial statements included in this Form 10-Q for more information. These expenses are included as a component of the line item "Selling, general and administrative expenses" on the condensed consolidated statements of income (loss).

Business separation costs

On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three months ended March 31, 2014 represent charges associated with the planned separation activities through March 31, 2014.

Acquisition related charges

A detailed description of the acquisition related charges is included in Note 17 to the condensed consolidated financial statements included within this Form 10-Q. These expenses are included as a component of the line item "Selling, general and administrative expenses" on the condensed consolidated statements of income (loss).

Provision for income taxes

A significant amount of our earnings is generated by our foreign subsidiaries (e.g. Ireland and Hong Kong), which tax earnings at lower rates than the United States federal statutory rate. Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; closure of statute of limitations or settlement of tax audits; changes in valuation allowance and changes in tax law; and the potential decision to repatriate certain future foreign earnings.

Income tax benefit was $49.1 million resulting in an effective tax rate of 44.6 percent compared to a provision of $34.6 million resulting in an effective tax rate of 26.3 percent for the three months ended March 31, 2015 and 2014, respectively. Excluding discrete items, the effective rate is 26.4 percent compared to 26.8 percent for the three months ended March 31, 2015 and 2014, respectively. A more detailed description of the change and drivers to the change in the effective tax rate is included in Note 14 to the condensed consolidated financial statements included within this Form 10-Q.

37

Discontinued operations, net of income taxes

Our discontinued operations represent our discontinued FMC Alkali Chemicals and FMC Peroxygens division results as well as adjustments to retained liabilities from other previously discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

Three Months Ended March 31, 2015 vs. 2014

Discontinued operations, net of income taxes represented a gain of $15.6 million for the three months ended March 31, 2015, compared to a loss of $26.6 million for the three months ended March 31, 2014. The change was driven by the completed divestiture of our FMC Peroxygens business in the three months ended March 31, 2014 which resulted in an after tax loss of $40.0 million in 2014. For more information on our discontinued operations, net of income taxes, see Note 9 to the condensed consolidated financial statements included in this Form 10-Q.

Net income (loss) attributable to FMC stockholders

Three Months Ended March 31, 2015 vs. 2014

Net loss attributable to FMC stockholders decreased to $46.8 million from income of $65.6 million. The decrease was primarily due to acquisition related charges, primarily the purchase price hedge, associated with the Cheminova A/S acquisition recorded during the current quarter, and lower segment operating profit in FMC Agricultural Solutions.

38

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at March 31, 2015 and December 31, 2014, were $105.2 million and $109.5 million, respectively. Of the cash and cash equivalents balance at March 31, 2015, $79.9 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings.

At March 31, 2015, we had total debt of $2,058.2 million as compared to $1,678.6 million at December 31, 2014. Total debt included $1,150.9 million and $1,153.4 million of long-term debt (excluding current portions of $1.7 million and $2.0 million) at March 31, 2015 and December 31, 2014, respectively. Short-term debt, which consists primarily of borrowings under our commercial paper program, increased from $523.2 million at December 31, 2014 to $905.6 million at March 31, 2015. Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. We have used proceeds from the commercial paper program for general corporate purposes. At March 31, 2015, the average effective interest rate on these borrowings was 0.62%.

The increase in short term debt is primarily timing related to the settlement of the Cheminova A/S purchase price hedge totaling $273.8 million in the first quarter of 2015 in advance of the closing of the acquisition in April of 2015. Short-term borrowings under the commercial paper program were used to fund the settlement of these hedges. For more detail on the hedges and related accounting treatment refer to Note 3 to the condensed consolidated financial statements included within this Form 10-Q.

Statement of Cash Flows

Cash provided (required) by operating activities was $(304.9) million and $(106.0) million for the three months ended March 31, 2015 and 2014, respectively.

The table below presents the components of net cash provided (required) by operating activities.

(in Millions)	Three Months Ended March 31
	2015			2014
Income (loss) from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes	$	(96.1	)	$	142.9
Significant non-cash expenses (1)	39.2			36.2
Operating income before non-cash expenses (Non-GAAP)	$	(56.9	)	$	179.1
Change in trade receivables (2)	52.5			(80.3		)
Change in inventories (3)	(50.0		)	(9.5		)
Change in accounts payable (4)	(35.6		)	(77.7		)
Change in accrued rebates (5)	87.6			87.4
Change in advance payments from customers (6)	(165.9		)	(148.4		)
Change in all other operating assets and liabilities (7)	(72.4		)	10.6
Restructuring and other spending (8)	(3.0		)	(1.9		)
Environmental spending, continuing, net of recoveries (9)	(3.0		)	(1.6		)
Pension and other postretirement benefit contributions (10)	(27.4		)	(23.8		)
Cash basis operating income (Non-GAAP)	$	(274.1	)	$	(66.1	)
Interest payments	(18.0		)	(11.2		)
Tax payments	(11.1		)	(25.3		)
Excess tax benefits from share-based compensation	(1.7		)	(3.4		)
Cash provided (required) by operating activities	$	(304.9	)	$	(106.0	)

____________________ 

(1) Represents the sum of depreciation, amortization, non-cash asset write downs, share-based compensation, and pension charges.

(2) The decrease in trade receivables in the first quarter of 2015 was driven by reduced revenue in Agricultural Solutions primarily in Brazil. The first quarter of 2014 was primarily driven by collection timing in that period. Collection timing is more pronounced in our FMC Agricultural Solutions business where sales, particularly in Brazil, have terms significantly longer than the rest of our businesses. Additionally, timing of collection is impacted as amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks.

39

(3) Inventory levels increased in the first quarter of 2015 due to lower than expected first quarter sales as well as inventory build to satisfy expected demand in the current growing season in our FMC Agricultural Solutions segment.  Inventory levels remained fairly constant during the first quarter of 2014 as compared to that prior year end.

(4) The decrease in accounts payable balances during the first quarter of 2015 is primarily due to timing of payments. The higher use of cash in our accounts payable during the first quarter of 2014 was driven by a Q4 2013 inventory build primarily in our FMC Agricultural Solutions segment to satisfy projected 2014 demand, which was paid during the first quarter of 2014.

(5) These rebates are associated with our FMC Agricultural Solutions segment, primarily in North America and Brazil and generally settle in the fourth quarter of each year.

(6) The advance payments from customers represent advances from our FMC Agricultural Solutions segment customers. During the past two years we received substantial increases in advance payments from customers at the end of the preceding years for the subsequent years planting season.

(7) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities. The first quarter 2015 was primarily impacted by the payments of $273.8 million for the Cheminova A/S purchase price hedges.

(8) See Note 7 in the condensed consolidated financial statements included in this Form 10-Q for further details.

(9) Included in our income presented for the three months ended March 31, 2015 and March 31, 2014 are environmental charges for environmental remediation at our operating sites of $1.9 million and $1.4 million, respectively. The amounts in 2015 will be spent in periods beyond first quarter 2015. The amounts in this row represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(10) Amounts include voluntary contributions to our U.S. defined benefit plan of $25.0 million and $17.0 million, respectively.

Cash provided (required) by operating activities of discontinued operations was $7.7 million and $9.2 million for the three months ended March 31, 2015 and 2014, respectively.

The reduction of cash provided by operating activities of discontinued operations in 2015 is due primarily to a decline in the operating results of our discontinued FMC Alkali business in 2015 compared to 2014. The decline in results is driven by $11.3 million of divestiture related charges in 2015. Partially offset this reduction of cash provided by our discontinued FMC Alkali business was reduced spending on Environmental remediation in 2015 as compared to 2014.

Cash provided (required) by investing activities of continuing operations was $(54.2) million and $(64.4) million for the three months ended March 31, 2015 and 2014, respectively.

The decrease in spending during the three months ended March 31, 2015, as compared to the same period in 2014 was primarily due to lower capital expenditures in our FMC Health and Nutrition segment.

Cash provided (required) by investing activities of discontinued operations was $(15.6) million and $188.0 million for the three months ended March 31, 2015 and 2014, respectively.

Cash provided by investing activities of discontinued operations in 2014 is directly associated with the sale of our FMC Peroxygens business which was completed on February 28, 2014. For more information see Note 9 to the condensed consolidated financial statements included in this Form 10-Q.

Cash provided (required) by financing activities was $364.8 million and $(56.7) million for the three months ended March 31, 2015 and 2014, respectively.

The change period over period in financing activities is primarily due to increased borrowings primarily to fund the settlement of the purchase price hedges for the Cheminova A/S acquisition. In 2015 borrowings were approximately $383 million compared to repayments in 2014 of $40 million.

Other potential liquidity needs

Our cash needs outside of the Cheminova acquisition and related integration expenses for 2015 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At March 31, 2015, our remaining borrowing capacity under our credit facility was $534.8 million (which includes borrowings under our commercial paper program).

As discussed throughout this 10-Q, we closed on the Cheminova acquisition in April of 2015 as well as completed the sale of our FMC Alkali Chemicals division in that same month. The proceeds from the FMC Alkali Chemicals sale as well as borrowings under our term loan facility were used to finance the acquisition. Please see Note 8 to the condensed consolidated financial statements included within this Form 10-Q for more detail on the term loan.

Projected 2015 capital expenditures as well as expenditures related to contract manufacturers are expected to be lower than 2014 levels. This includes expected spending for Cheminova subsequent to the acquisition.

Projected 2015 spending includes approximately $60 million of net environmental remediation spending. This spending does not include expected spending on capital projects relating to environmental control facilities or expected spending for environmental

40

compliance costs, which we will include as a component of costs of sales and services to the condensed consolidated statements of income (loss) since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary contributions through March 31, 2015 and March 31, 2014 of $25.0 million and $17.0 million, respectively. We expect to make approximately $65 million in voluntary cash contributions to our U.S. defined benefit pension plan during 2015. These contributions are in excess of the minimum requirements. We made voluntary contributions of $50 million in 2014. We do not believe that these projected contributions will have a significant negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.

For the three months ended March 31, 2015 and 2014, we paid $20.1 million and $18.0 million, respectively, in dividends declared in previous periods. On April 16, 2015, we paid dividends totaling $22.1 million to our shareholders of record as of March 31, 2015. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of March 31, 2015.

During the three months ended March 31, 2015, we did not repurchase any shares under the publicly announced repurchase program. At March 31, 2015, $250.0 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

Commitments and Contingencies

See Note 16 to the condensed consolidated financial statements included in this Form 10-Q.

Contractual Commitments

Information related to our contractual commitments at December 31, 2014 can be found in a table included within Part II, Item 7 of our 2014 Form 10-K. There have been no significant changes to our contractual commitments during the three months ended March 31, 2015.

Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2014 Form 10-K. Our former FMC Alkali Chemicals division mined and refined trona ore into soda ash, and this activity constituted most of FMC’s greenhouse gas emissions globally. The sale of our Alkali Chemicals Division was completed on April 1, 2015 as discussed further in Note 9 to the condensed consolidated financial statements included within this Form 10-Q. As a result, we no longer have the level of greenhouse gas emissions that were previously driven by this business.

On April 21, 2015, we completed the acquisition of Cheminova A/S as discussed further in Note 3 to the condensed consolidated financial statements included within this Form 10-Q. Cheminova A/S has foreign operations with multiple plants, which may be subject to national or local energy management or climate change regulation. Therefore, we will evaluate any such regulations as these facilities and will routinely assess the consequences of potential future climate change on our operations.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Fair-Value Measurements

See Note 15 to the condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

41

DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At March 31, 2015, our financial instrument position was a net asset of $20.1 million compared to a net liability of $92.5 million at December 31, 2014. The change in the net financial instrument position was primarily due to the settlement of outstanding hedges for the purchase price of Cheminova A/S, see Note 3 to the condensed consolidated financial statement included within this Form 10-Q for more information.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

Commodity Price Risk

Energy costs are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at March 31, 2015 and December 31, 2014, with all other variables (including interest rates) held constant.

		Hedged energy exposure vs. Energy market pricing
(in Millions)	Net Asset / (Liability) Position on Consolidated Balance Sheets	10% Increase	10% Decrease
Net asset/(liability) position at March 31, 2015	$(2.8)	$(2.2)	$(3.4)
Net asset/(liability) position at December 31, 2014	$(7.3)	$(5.3)	$(9.4)

Our FMC Agricultural Solutions segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of March 31, 2015 and December 31, 2014 our net financial instrument position was immaterial.

Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at March 31, 2015 and December 31, 2014, with all other variables (including interest rates) held constant.

		Hedged Currency vs. Functional Currency
(in Millions)	Net Asset / (Liability) Position on Consolidated Balance Sheets	10% Strengthening (1)	10% Weakening (1)
Net asset/(liability) position at March 31, 2015	$22.9	$185.8	$(140.9)
Net asset/(liability) position at December 31, 2014	$(85.2)	$91.3	$(261.0)

(1) Impacted by the purchase price hedges for the Cheminova A/S acquisition. Total notional value of outstanding hedges is approximately $2.6 billion.

42

Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of March 31, 2015 and December 31, 2014, we had no interest rate swap agreements.

Our debt portfolio, at March 31, 2015, is composed of 57 percent fixed-rate debt and 43 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at March 31, 2015, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $2.2 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $1.4 million for the three months of March 31, 2015.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

ITEM 4.    CONTROLS AND PROCEDURES

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2015, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended March 31, 2015, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

43

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of March 31, 2015, the related condensed consolidated statements of income (loss) and comprehensive income (loss), for the three-month periods ended March 31, 2015 and 2014, and the related condensed consolidated statements of cash flows for the three-month periods ended March 31, 2015 and 2014. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2014, and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity for the year then ended (not presented herein); and in our report dated February 27, 2015, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2014, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

/s/ KPMG LLP

Philadelphia, Pennsylvania

May 11, 2015

44

PART II - OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

For a discussion of developments in the legal proceedings disclosed in Part I, Item 3 of our 2014 Form 10-K, see Note 16 to the condensed consolidated financial statements included within this Form 10-Q.

ITEM 1A.    RISK FACTORS

Subsequent to the acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division (see Note 3 and Note 9 to the condensed consolidated financial statements included within this Form 10-Q for more information) we have reassessed our risk factors. Below lists our risk factors updated for these events.

Among the factors that could have an impact on our ability to achieve operating results and meet our other goals are:

Industry Risks:

Pricing and volumes in our markets are sensitive to a number of industry specific and global issues and events including:

• Capacity utilization - Our businesses are sensitive to industry capacity utilization. As a result, pricing tends to fluctuate when capacity utilization changes occur within our industry.

• Competition - All of our segments face competition, which could affect our ability to maintain or raise prices, successfully enter certain markets or retain our market position. Our FMC Agricultural Solutions, competition includes not only generic suppliers of the same pesticidal active ingredient, but also alternative proprietary pesticide chemistries, crop protection technologies that are bred into or applied onto seeds, and intellectual property regarding production or use of pesticides. Increased generic presence in agricultural chemical markets has been driven by the number of significant product patents and product data protections that have expired in the last decade, and this trend is expected to continue.

• Changes in our customer base - Our customer base has the potential to change, especially when long-term supply contracts are renegotiated. Our FMC Minerals and FMC Health and Nutrition businesses are most sensitive to this risk.

• Climatic conditions - Our FMC Agricultural Solutions markets are affected by climatic conditions, which could adversely impact crop pricing and pest infestations. Adverse weather conditions can impact our ability to extract lithium efficiently from our lithium reserves in Argentina. Natural disasters can impact production at our facilities in various parts of the world. The nature of these events makes them difficult to predict.

• Changing regulatory environment - Changes in the regulatory environment, particularly in the United States, Brazil, China and the European Union, could adversely impact our ability to continue producing and/or selling certain products in our domestic and foreign markets or could increase the cost of doing so. Our FMC Agricultural Solutions business is most sensitive to this general regulatory risk given the need to obtain and maintain pesticide registrations in every country in which we sell our products. Compliance with changing laws and regulations may involve significant costs or capital expenditures or require changes in business practice that could result in reduced profitability. In the European Union, the regulatory risk specifically includes chemicals regulation known as REACH (Registration, Evaluation, and Authorization of Chemicals), which affects each of our business segments to varying degrees. The fundamental principle behind the REACH regulation is that manufacturers must verify that their chemicals can be marketed safely through a special registration system.

• Geographic concentration - Although we have operations in most regions throughout the globe, the majority of our FMC Agricultural Solutions sales outside the United States have principally been to customers in Brazil, Argentina and Mexico. With the acquisition of Cheminova, we will expand the reach of international sales to include Europe and key Asian countries. Accordingly, developments in those parts of the world generally have a more significant effect on our operations than developments in other places. Our operations outside the United States are subject to special risks and restrictions, including: fluctuations in currency values; exchange control regulations; changes in local political or economic conditions; governmental pricing directives; import and trade restrictions; import or export licensing requirements and trade policy; restrictions on the ability to repatriate funds; and other potentially detrimental domestic and foreign governmental practices or policies affecting U.S. companies doing business abroad.

• Food and pharmaceutical regulation - Some of our manufacturing processes and facilities, as well as some of our customers, are subjected to regulation by the U.S. Food and Drug Administration (FDA) or similar foreign agencies. Regulatory requirements of the FDA are complex, and any failure to comply with them including as a result of contamination due to acts of sabotage could subject us and/or our customers to fines, injunctions, civil penalties, lawsuits, recall or seizure of products, total or partial suspension of production, denial of government approvals, withdrawal of marketing approvals and criminal prosecution. Any of these actions could adversely impact our net sales, undermine goodwill established with our customers, damage commercial prospects for our products and materially adversely affect our results of operations.

45

• Climate change regulation - Changes in the regulation of greenhouse gases, depending on their nature and scope, could subject our manufacturing operations, particularly certain FMC Minerals' operations in the United States, to significant additional costs or limits on operations.

• Fluctuations in commodity prices - Our operating results could be significantly affected by the cost of commodities such as raw materials and energy, including natural gas. We may not be able to raise prices or improve productivity sufficiently to offset future increases in commodity pricing. Accordingly, increases in commodity prices may negatively affect our financial results. Where practical, we use hedging strategies to address material commodity price risks, where hedge strategies are available on reasonable terms. We also use raw material supply agreements that contain terms designed to mitigate the risk of short-term changes in commodity prices. However, we are unable to avoid the risk of medium- and long-term increases. Additionally, fluctuations in commodity prices could negatively impact our customers' ability to sell their product at previously forecasted prices resulting in reduced customer liquidity. Inadequate customer liquidity could affect our customers’ abilities to pay for our products and, therefore, affect existing and future sales or our ability to collect on customer receivables.

• Supply arrangements - Certain raw materials are critical to our production process. While we have made supply arrangements to meet planned operating requirements, an inability to obtain the critical raw materials or execute under the contract manufacturing arrangements would adversely impact our ability to produce certain products. We increasingly source critical intermediates and finished products from a number of suppliers. An inability to obtain these products or execute under the contract sourcing arrangements would adversely impact our ability to sell products. In FMC Minerals geological conditions can affect production of raw materials.

• Economic and political change - Our business could be adversely affected by economic and political changes in the markets where we compete including: inflation rates, recessions, trade restrictions, foreign ownership restrictions and economic embargoes imposed by the United States or any of the foreign countries in which we do business; changes in laws, taxation, and regulations and the interpretation and application of these laws, taxes, and regulations; restrictions imposed by foreign governments through exchange controls or taxation policy; nationalization or expropriation of property, undeveloped property rights, and legal systems or political instability; other governmental actions; and other external factors over which we have no control. Economic and political conditions within foreign jurisdictions or strained relations between countries can cause fluctuations in demand, price volatility, supply disruptions, or loss of property. In Argentina, continued inflation and tightening of foreign exchange controls along with deteriorating economic and financial conditions could adversely affect our business.

Operational Risks:

• Market access risk - Our results may be affected by changes in distribution channels, which could impact our ability to access the market. In certain FMC Agricultural Solutions segments, we access the market through joint ventures in which we do not have majority control. Where we do not have a strong product portfolio or market access relationships, we may be vulnerable to changes in the distribution model or influence of competitors with stronger product portfolios.

• Business disruptions - Although historically, we have engaged in contract manufacturing and has not owned and operated its own manufacturing facilities, Cheminova owns and operates large-scale manufacturing facilities in Denmark and India. This will present us with new material operating risks that we have not historically faced. After the Cheminova acquisition is completed, our operating results will be dependent on the continued operation of its various production facilities and the ability to manufacture products on schedule. Interruptions at these facilities may materially reduce the productivity and profitability of a particular manufacturing facility, or our business as a whole, during and after the period of such operational difficulties. Although we take precautions to enhance the safety of our operations and minimize the risk of disruptions, our operations are subject to hazards inherent in chemical manufacturing and the related storage and transportation of raw materials, products and wastes. These potential hazards include, explosions, fires, severe weather and natural disasters, mechanical failure, unscheduled downtimes, supplier disruptions, labor shortages or other labor difficulties, information technology systems outages, disruption in our supply chain or manufacturing and distribution operations, transportation interruptions, chemical spills, discharges or releases of toxic or hazardous substances or gases, shipment of incorrect or off-specification product to customers, storage tank leaks, other environmental risks, or other sudden disruption in business operations beyond our control as a result of events such as acts of sabotage, terrorism or war, civil or political unrest, natural disasters, pandemic situations and large scale power outages. Some of these hazards may cause severe damage to or destruction of property and equipment or personal injury and loss of life and may result in suspension of operations or the shutdown of affected facilities.

• Our manufacturing operations and those of our key contract manufacturers inherently entail hazards that require continuous oversight and control, such as leaks, ruptures, fire, explosions, chemical spills, discharges or releases of toxic or hazardous substances or gases, other environmental risks, mechanical failure or other hazards beyond our control such as acts of sabotage, terrorism or war, civil or political unrest, natural disasters, pandemic situations, large scale power outages or vehicle accidents. If operational risks materialize, they could result in loss of life, damage to the environment, or loss of production, all of which could negatively impact our ongoing operations, reputation, financial results, and cash flow.

46

• Information technology security risks - As with all Enterprise Information systems, our information technology systems could be penetrated by outside parties intent on extracting information, corrupting information, or disrupting business processes. Our systems have in the past been, and likely will in the future be, subject to unauthorized access attempts. Unauthorized access could disrupt our business operations and could result in failures or interruptions in our computer systems and in the loss of assets and could have a material adverse effect on our business, financial condition or results of operations. In addition, breaches of our security measures or the accidental loss, inadvertent disclosure, or unapproved dissemination of proprietary information or sensitive or confidential information about us, our employees, our vendors, or our customers, could result in litigation and potential liability for us, damage our reputation, or otherwise harm our business, financial condition, or results of operations.

• Capital-intensive business - With our impending acquisition of Cheminova, our business will be more capital intensive, than it has been historically. We rely on cash generated from operations and external financing to fund our growth and ongoing capital needs. Limitations on access to external financing could adversely affect our operating results. Moreover, interest payments, dividends and the expansion of our business or other business opportunities may require significant amounts of capital. We believe that our cash from operations and available borrowings under our revolving credit facility will be sufficient to meet these needs in the foreseeable future. However, if we need external financing, our access to credit markets and pricing of our capital will be dependent upon maintaining sufficient credit ratings from credit rating agencies and the state of the capital markets generally. There can be no assurances that we would be able to obtain equity or debt financing on terms we deem acceptable, and it is possible that the cost of any financings could increase significantly, thereby increasing our expenses and decreasing our net income. If we are unable to generate sufficient cash flow or raise adequate external financing, including as a result of significant disruptions in the global credit markets, we could be forced to restrict our operations and growth opportunities, which could adversely affect our operating results.

We may use our $1.5 billion revolving credit facility to meet our cash needs, to the extent available. As of March 31, 2015, we had unused and available credit capacity of $534.8 million. In the event of a default under our credit facility or any of our senior notes, we could be required to immediately repay all outstanding borrowings and make cash deposits as collateral for all obligations the facility supports, which we may not be able to do. Any default under any of our credit arrangements could cause a default under many of our other credit agreements and debt instruments. Without waivers from lenders party to those agreements, any such default could have a material adverse effect on our ability to continue to operate.

• Litigation and environmental risks - Current reserves relating to our ongoing litigation and environmental liabilities may ultimately prove to be inadequate.

• Hazardous materials - We manufacture and transport certain materials that are inherently hazardous due to their toxic or volatile nature. While we take precautions to handle and transport these materials in a safe manner, if they are mishandled or released into the environment, they could cause property damage or personal injury claims against us.

• Environmental Compliance - We are subject to extensive federal, state, local, and foreign environmental and safety laws. regulations, directives, rules and ordinances concerning, among other things, emissions in the air, discharges to land and water, and the generation, handling, treatment, disposal and remediation of hazardous waste and other materials. We may face liability arising out of the normal course of business, including alleged personal injury or property damage due to exposure to chemicals or other hazardous substances at our current or former facilities or chemicals that we manufacture, handle or own. We take our environmental responsibilities very seriously, but there is a risk of environmental impact inherent in its manufacturing operations and transportation of chemicals. Any substantial liability for environmental damage could have a material adverse effect on our financial condition, results of operations and cash flows.

• Inability to attract and retain key employees - The inability to recruit and retain key personnel or the unexpected loss of key personnel may adversely affect our operations. In addition, our future success depends in part on our ability to identify and develop talent to succeed senior management.

Technology Risks:

• Our ability to compete successfully depends in part upon our ability to maintain a superior technological capability and to continue to identify, develop and commercialize new and innovative, high value-added products for existing and future customers.

• Failure to continue to make process improvements to reduce costs could impede our competitive position.

Portfolio Management Risks:

• We continuously review our portfolio which includes the evaluation of potential business acquisitions that may strategically fit our business and strategic growth initiatives. If we are unable to successfully integrate and develop our acquired businesses, we could fail to achieve anticipated synergies which would include expected cost savings and revenue growth. Failure to achieve these anticipated synergies, could materially and adversely affect our financial results. In addition to strategic acquisitions we evaluate the diversity of our diverse portfolio in light of our objectives and alignment

47

with its growth strategy. As part of this evaluation we may not be successful in separating underperforming or non-strategic assets and gains or losses on the divestiture of, or lost operating income from, such assets may affect the company’s earnings. Moreover, we may incur asset impairment charges related to acquisitions or divestitures that reduce its earnings.

In particular, inability to successfully integrate and develop Cheminova as planned could result in our inability to achieve the synergies we have projected and could thereby cause our future results of operations to be materially and adversely worse than expected. Part of the synergies we expect to generate is the improvement of the cost-efficiency of Cheminova’s business operations. Another is to reduce the mix of Cheminova’s sales from generic, lower margin products to more differentiated and higher margin products. Yet another will be the favorable rationalization of the different distribution channels used by FMC and Cheminova in overlapping European markets. There can be no assurances that we will be successful in achieving these planned synergies.

Financial Risks:

• Deterioration in the global economy and worldwide credit and foreign exchange markets could adversely affect our business. A worsening of global or regional economic conditions or financial markets could adversely affect our customers' ability to meet the terms of sale or our suppliers' ability to perform all their commitments to us. A slowdown in economic growth in our international markets, particularly Latin American regions, or a deterioration of credit or foreign exchange markets could adversely affect customers, suppliers and our overall business there. Customers in weakened economies may be unable to purchase our products, or it could become more expensive for them to purchase imported products in their local currency, or sell their commodity at prevailing international prices, and we may be unable to collect receivables from such customers.

• We are an international company and face foreign exchange rate risks in the normal course of our business. We are particularly sensitive to the euro, the Brazilian real and the Chinese yuan. To a lesser extent, we are sensitive to the Mexican peso, the Argentine peso, the British pound sterling and several Asian currencies, including the Japanese yen. Our acquisition of Cheminova has significantly expanded our operations and sales in foreign countries and correspondingly increase our exposure to foreign exchange risks.

• Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; closure of statute of limitations or settlement of tax audits; changes in valuation allowance and changes in tax law; and the potential decision to repatriate certain future foreign earnings.

• We have significant investments in long-lived assets and continually review the carrying value of these assets for recoverability in light of changing market conditions and alternative product sourcing opportunities.

• Obligations related to our pension and postretirement plans reflect certain assumptions. To the extent our plans' actual experience differs from these assumptions, our costs and funding obligations could increase or decrease significantly.

48

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

ISSUER PURCHASES OF EQUITY SECURITIES

				Publicly Announced Program
Period	Total Number of Shares Purchased	Average Price Paid Per  Share		Total Number of Shares Purchased	Total Dollar Amount Purchased		Maximum Dollar Value of Shares that May Yet be Purchased
January 1-31, 2015	—	$	—	—	$	—	$	250,000,000
February 1-28, 2015	43,986	$	63.66	—	$	—	$	250,000,000
March 1-31, 2015	960	$	60.37	—	$	—	$	250,000,000
Total Q1 2015	44,946	$	63.59	—	$	—	$	250,000,000

During the three months ended March 31, 2015, we did not repurchase any shares under the publicly announced repurchase program. At March 31, 2015, $250.0 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

ITEM 4.    MINE SAFETY DISCLOSURES

Information regarding mine safety and other regulatory actions at our mine in Green River, Wyoming which is a part of our discontinued FMC Alkali Chemicals division is included in Exhibit 95 to this Form 10-Q.

ITEM 5.    OTHER INFORMATION

None.

ITEM 6.    EXHIBITS

10.1	FMC Corporation Incentive Compensation and Stock Plan as amended and restated through April 27, 2015
10.2	Performance-based restricted stock unit award agreement, dated February 27, 2015, by and between FMC Corporation and Pierre R. Brondeau
12	Statements of Computation of Ratios of Earnings to Fixed Charges
15	Awareness Letter of KPMG LLP
31.1	Chief Executive Officer Certification
31.2	Chief Financial Officer Certification
32.1	CEO Certification of Quarterly Report
32.2	CFO Certification of Quarterly Report
95	Mine Safety Disclosures
101	Interactive Data File

49

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

FMC CORPORATION (Registrant)
By:	/S/   PAUL W. GRAVES
	Paul W. Graves Executive Vice President and Chief Financial Officer

Date: May 11, 2015

50

INDEX OF EXHIBITS FILED WITH THE

FORM 10-Q OF FMC CORPORATION

FOR THE QUARTER ENDED MARCH 31, 2015

Exhibit No.	Exhibit Description
10.1	FMC Corporation Incentive Compensation and Stock Plan as amended and restated through April 27, 2015
10.2	Performance-based restricted stock unit award agreement, dated February 27, 2015, by and between FMC Corporation and Pierre R. Brondeau
12	Statements of Computation of Ratios of Earnings to Fixed Charges
15	Awareness Letter of KPMG LLP
31.1	Chief Executive Officer Certification
31.2	Chief Financial Officer Certification
32.1	CEO Certification of Quarterly Report
32.2	CFO Certification of Quarterly Report
95	Mine Safety Disclosures
101	Interactive Data File

51

EX-10.1

Exhibit 10.1

FMC CORPORATIONINCENTIVE COMPENSATION AND STOCK PLAN

(As Amended and Restated Through April 27, 2015)

SECTION 1. HISTORY AND PURPOSE

1.1.History. In 1995 the Company’s stockholders approved the adoption of the FMC 1995 Stock Option Plan and the FMC 1995 Management Incentive Plan with 3,000,000 shares of Common Stock available for issuance under the two plans combined. Effective as of February 16, 2001, the Board merged the FMC 1995 Management Incentive Plan with and into the FMC 1995 Stock Option Plan, and the FMC 1995 Stock Option Plan was restated as provided herein,and renamed the FMC Corporation Incentive Compensation and Stock Plan (“Plan”)). Also effective as of February 16, 2001, the Board approved an addition to the authorization of shares available for issuance under the Plan of 800,000 shares of Common Stock, making the total shares authorized for issuance under the Plan 3,800,000 as of that date.

In 2000, the Committee adopted the FMC Corporation Stock Appreciation Rights and Phantom Stock Plan to provide equity-based cash compensation to foreign employees in an effort to reduce the foreign income taxes that would otherwise be payable by such foreign employees if they received traditional grants under the Plan. The FMC Corporation Stock Appreciation Rights and Phantom Stock Plan was merged with and into the Plan effective as of February 16, 2001.

In June 2001, the Company distributed substantially all of the net assets relative to its machinery business into a separate company. FMC Technologies, Inc. (“Technologies”). Seventeen percent of FMC’s ownership in Technologies was sold to the public in June 2001, and the remainder was distributed to FMC shareholders on December 31, 2001 (the “Spin-off”). As a result of the Spin-off, each unit of FMC Common Stock was adjusted by a factor of 1.9064045. Therefore, effective as of December 31, 2001, the total number of shares authorized for issuance under the Plan was adjusted to 7,244,377, in accordance with Section 4.1 of the Plan (which equates to 28,977,508 after the two Common Stock Splits described below). Similarly, the Option Price per share of Common Stock under Stock Options outstanding under the Plan as of December 31, 2001 was adjusted by a factor of .5245476.

Further amendments to the plan were approved on February 23, 2006, to among other things, increase the number of shares of Common Stock, out of the total number available for issuance under the Plan, available for Management Incentive Awards, Restricted Stock, and Performance Units under Section 4.1. The Plan was restated as of February 23, 2006 to reflect the foregoing changes.

On August 17, 2007 the Board of Directors of the Company approved a two-for-one split of the Common Stock, to be effected in the form of a distribution payable on September 13, 2007 to the holders of the Common Stock of record as of the close of business on August 31,

2007, of one additional share of Common Stock for every share of Common Stock outstanding as of that date (the “Stock Split”). Therefore, effective as of September 13, 2007, the total number of shares reserved for issuance under the Plan was adjusted to 14,448,674 in accordance with Section 4.1 of the Plan, and the total number of shares subject to outstanding Awards granted under the Plan as of September 13, 2007 was doubled. Similarly, the Option Price per share of Common Stock under Stock Options outstanding under the Plan as of September 13, 2007 was adjusted by a factor of .5. The plan was restated as of September 13, 2007 to reflect the foregoing changes.

The Plan was amended and restated as of January 1, 2009 to comply with Section 409A of the Code.

The plan was further amended and restated as of October 1, 2011 to eliminate the discretionary authority of the Committee to approve certain transfers of Stock Options, as well as to formally recognize the Company’s option to deliver shares of Common Stock by registering them via book entry.

On April 24, 2012, the Board of Directors of the Company approved a further two-for-one split of the Common Stock, to be effected in the form of a distribution payable on May 24, 2012 to the holders of the Common Stock of record as of the close of business on May 11, 2012, of one additional share of Common Stock for every share of Common Stock outstanding as of that date (the “Second Stock Split”).  Therefore, effective as of May 24, 2012, the total number of shares reserved for issuance under the Plan was adjusted to 28,897,348 in accordance with Section 4.1 of the Plan, and the total number of shares subject to outstanding Awards granted under the Plan as of May 24, 2012 was doubled.  Similarly, the Option Price per share of Common Stock under Stock Options outstanding under the Plan as of May 24, 2012 was adjusted by a factor of .5. 

On February 18. 2013, the Plan was amended to eliminate the automatic acceleration of vesting of Stock Options and Stock Appreciation Rights upon a Change of Control.

On April 27, 2015, the Plan was restated to incorporate all of the foregoing changes, as well as the addition of a provision whereby immediately before the time any Stock Option is scheduled to expire, it shall be deemed automatically exercised if it meets the conditions set forth in Section 9.4A.

1.2.Purpose. The purpose of the Plan is to give the Company a competitive advantage in attracting, retaining and motivating officers, employees, directors and consultants of the Company and its Affiliates.

SECTION 2. DEFINITIONS

2.1.General. For purposes of the Plan, the following terms are defined as set forth below:

-2-

(a) “Affiliate” means a corporation or other entity controlled by, controlling or under common control with the Company, including, without limitation any corporation, partnership, joint venture or other entity during any period in which at least a fifty percent (50%) voting or profits interest is owned, directly or indirectly, by the Company or any successor to the Company.

(b) “Award” means a Management Incentive Award, Stock Option, Stock Appreciation Right, Performance Unit, Restricted Stock or other award authorized under the Plan.

(c) “Award Cycle” means a period of consecutive fiscal years or portions thereof designated by the Committee over which Awards are to be earned.

(d) “Board” means the Board of Directors of the Company.

(e) “Business Unit” means a unit of the business of the Company or its Affiliates as determined by the Committee and the CEO.

(f) “Capital Employed” means operating working capital plus net property, plant and equipment.

(g) “Cause” means (1) “Cause” as defined in any Individual Agreement to which the participant is a party, or (2) if there is no such Individual Agreement, or, if it does not define “Cause”: (A) the participant having been convicted of, or pleading guilty or nolo contendere to, a felony under federal or state law; (B) the Willful and continued failure on the part of the participant to substantially perform his or her employment duties in any material respect (other than such failure resulting from Disability), after a written demand for substantial performance is delivered to the participant that specifically identifies the manner in which the Company believes the participant has failed to perform his or her duties, and after the participant has failed to resume substantial performance of his or her duties within thirty (30) days of such demand; or (C) Willful and deliberate conduct on the part of the participant that is materially injurious to the Company or an Affiliate; or (D) prior to a Change in Control, such other events as will be determined by the Committee. The Committee will, unless otherwise provided in an Individual Agreement with the participant, determine whether “Cause” exists.

(h) “CEO” means the Company’s chief executive officer.

(i) “Change in Control” has the meanings set forth in Sections 14.2 Definition of Change in Control and 14.3 Special Definition of Change in Control .

(j) “Code” means the Internal Revenue Code of 1986, as amended from time to time, and any successor thereto.

-3-

(k) “Committee” means the Compensation and Organization Committee of the Board, or such other committee as the Board may from time to time designate.

(l) “Common Stock” means (1) the common stock of the Company, par value $.10 per share, subject to adjustment as provided in Section 4.1 Shares Available for Issuance; or (2) if there is a merger or consolidation and the Company is not the surviving corporation, the capital stock of the surviving corporation given in exchange for such common stock of the Company.

(m) “Company” means FMC Corporation, a Delaware corporation.

(n) “Covered Employee” means a participant who has received a Management Incentive Award, Restricted Stock or Performance Units, who has been designated as such by the Committee and who is or may be a “covered employee” within the meaning of Section 162(m)(3) of the Code in the year in which the Management Incentive Award, Restricted Stock or Performance Units are expected to be taxable to such participant.

(o) “Disability” means, unless otherwise provided by the Committee, (1) “Disability” as defined in any individual agreement to which the participant is a party, or (2) if there is no such individual agreement, or, if such agreement does not define “Disability,” then “Disability” shall be determined in accordance with the Company’s long-term disability plan.

(p) “Dividend Equivalent Rights” means the right to receive cash, Stock Options, Stock Appreciation Rights or Performance Units, as determined by the Committee, in an amount equal to any dividends that would have been paid on a Stock Option, Stock Appreciation Right or a Performance Unit, as applicable, with Dividend Equivalent Rights if such Stock Option, Stock Appreciation Right or Performance Unit, as applicable, was a share of Common Stock held by the participant on the dividend payment date. Unless the Committee determines that Dividend Equivalent Rights will be paid in cash as of the dividend payment date, such Dividend Equivalent Rights, once credited, will be converted into an equivalent number of Stock Options, Stock Appreciation Rights or Performance Units, as applicable; provided, however, that the number of shares subject to any Award will always be a whole number. Unless otherwise determined by the Committee as of the dividend payment date, if a dividend is paid in cash, the number of Stock Options, Stock Appreciation Rights or Performance Units into which a Dividend Equivalent Right will be converted will be calculated as of the dividend payment date, in accordance with the following formula:

(A x B)/C

-4-

in which “A” equals the number of Stock Options, Stock Appreciation Rights or Performance Units with Dividend Equivalent Rights held by the participant on the dividend payment date, “B” equals the cash dividend per share and “C” equals the Fair Market Value per share of Common Stock on the dividend payment date. Unless otherwise determined by the Committee as of the dividend payment date, if a dividend is paid in property other than cash, the number of Stock Options, Stock Appreciation Rights or Performance Units, as applicable into which a Dividend Equivalent Right will be converted will be calculated, as of the dividend payment date, in accordance with the formula set forth above, except that “B” will equal the fair market value per share of the property which the participant would have received if the Stock Option, Stock Appreciation Right or Performance Unit, as applicable, with Dividend Equivalent Rights held by the participant on the dividend payment date was a share of Common Stock. Notwithstanding any other provision in the Plan, Dividend Equivalent Rights may not be accumulated and paid on the date of exercise of the Stock Option or Stock Appreciation Right giving rise to the Dividend Equivalent Right.

(q) “Effective Date” means February 16, 2001, the date the Plan was adopted by the Board. The Board’s adoption of the increase of 800,000 shares (later adjusted to be an additional 1,525,123 shares as a result of the Spin-off, which equates to 3,700,000 shares as a result of the Stock Split and the Second Stock Split) of Common Stock reserved for issuance under the Plan is also effective as of February 16, 2001.

(r) “Eligible Individuals” means officers, employees, directors and consultants of the Company or any of its Affiliates, and prospective employees, directors and consultants who have accepted offers of employment, membership on a board or consultancy from the Company or its Affiliates, who are or will be responsible for or contribute to the management, growth or profitability of the business of the Company or its Affiliates, as determined by the Committee.

(s) “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, and any successor thereto.

(t) “Expiration Date” means the date on which an Award becomes unexercisable and/or not payable by reason of lapse of time or otherwise as provided in Section 6.2 Expiration Date.

(u) “Fair Market Value” means, except as otherwise provided by the Committee, as of any given date, the closing price for shares of Common Stock on the New York Stock Exchange for the specified date (as of 4:00 p.m. Eastern Standard Time or Eastern Daylight Savings Time, whichever is then in effect), or, if the shares were not traded on the New York Stock Exchange on

-5-

such date, then on the next preceding date on which the shares were traded, all as reported by such source as the Committee may select.

(v) “Grant Date” means the date designated by the Committee as the date of grant of an Award.

(w) “Incentive Stock Option” means any Stock Option designated as, and qualified as, an “incentive stock option” within the meaning of Section 422 of the Code.

(x) “Individual Agreement” means a severance, employment, consulting or similar agreement between a participant and the Company or one of its Affiliates.

(y) “Management Incentive Award” means an Award of cash, Common Stock, Restricted Stock or a combination of cash, Common Stock and Restricted Stock, as determined by the Committee.

(z) “Net Contribution” means for a Business Unit, its operating profit after-tax, less the product of (1) a percentage as determined by the Committee; and (2) the Business Unit’s Capital Employed.

(aa) “Nonqualified Stock Option” means any Stock Option that is not an Incentive Stock Option.

(bb) “Notice” means the written evidence of an Award granted under the Plan in such form as the Committee will from time to time determine.

(cc) “Performance Goals” means the performance goals established by the Committee in connection with the grant of Management Incentive Awards, Restricted Stock or Performance Units as set forth in the Notice. In the case of Qualified Performance-Based Awards, Performance Goals will be set by the Committee within the time period prescribed by Section 162(m) of the Code and related regulations, and will be based on Net Contribution, or such other performance criteria selected by the Committee, including, without limitation, the Fair Market Value of the Common Stock, the Company’s or a Business Unit’s market share, sales, earnings, costs, productivity, return on equity or return on Capital Employed.

(dd) “Performance Units” means an Award granted under Section 12 Performance Units.

(ee) “Plan” means the FMC Corporation Incentive Compensation and Stock Plan, as set forth herein and as hereinafter amended from time to time.

(ff) “Qualified Performance-Based Award” means a Management Incentive Award, an Award of Restricted Stock or an Award of Performance Units

-6-

designated as such by the Committee, based upon a determination that (1) the recipient is or may be a Covered Employee; and (2) the Committee wishes such Award to qualify for the Section 162(m) Exemption.

(gg) “Restricted Stock” means an Award granted under Section 11 Restricted Stock.

(hh) “Section 162(m) Exemption” means the exemption from the limitation on deductibility imposed by Section 162(m) of the Code that is set forth in Section 162(m)(4)(C) of the Code.

(ii) “Stock Appreciation Right” means an Award granted under Section 10 Stock Appreciation Rights.

(jj) “Stock Option” means an Award granted under Section 9 Stock Options.

(kk) “Termination of Employment” means the termination of the participant’s employment with, or performance of services for, the Company and any of its Affiliates. Temporary absences from employment because of illness, vacation or leave of absence and transfers among the Company and its Affiliates will not be considered Terminations of Employment.

(ll) “Vesting Date” means the date on which an Award becomes vested, and, if applicable, fully exercisable and/or payable by or to the participant as provided in Section 6.3 Vesting.

(mm) “Willful” means any action or omission by the participant that was not in good faith and without a reasonable belief that the action or omission was in the best interests of the Company or its Affiliates. Any act or omission based upon authority given pursuant to a duly adopted resolution of the Board, or, upon the instructions of the CEO or any other senior officer of the Company, or, based upon the advice of counsel for the Company will be conclusively presumed to be taken or omitted by the participant in good faith and in the best interests of the Company and/or its Affiliates.

2.2.Other Definitions. In addition, certain other terms used herein have definitions given to them in the first place in which they are used.

SECTION 3. ADMINISTRATION

3.1.Committee Administration. The Committee is the administrator of the Plan. Among other things, the Committee has the authority, subject to the terms of the Plan:

(a) To select the Eligible Individuals to whom Awards are granted;

(b) To determine whether and to what extent Awards are granted;

-7-

(c) To determine the amount of each Award;

(d) To determine the terms and conditions of any Award, including, but not limited to, the option price, any vesting condition, restriction or limitation regarding any Award and the shares of Common Stock relating thereto, based on such factors as the Committee will determine;

(e) To modify, amend or adjust the terms and conditions of any Award, at any time or from time to time; and

(f) To determine under what circumstances an Award may be settled in cash or Common Stock or a combination of cash and Common Stock.

The Committee has the authority to adopt, alter and repeal administrative rules, guidelines and practices governing the Plan, to interpret the terms and provisions of the Plan, any Award, any Notice and any other agreement relating to any Award and to take any action it deems appropriate for the administration of the Plan.

3.2.Committee Action. The Committee may act only by a majority of its members then in office unless it allocates or delegates its authority to a Committee member or other person to act on its behalf. Except to the extent prohibited by applicable law or applicable rules of a stock exchange, the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities and powers to any other person or persons. Any such allocation or delegation may be revoked by the Committee at any time.

Any determination made by the Committee or its delegate with respect to any Award will be made in the sole discretion of the Committee or such delegate. All decisions of the Committee or its delegate are final, conclusive and binding on all parties.

3.3.Board Authority. Any authority granted to the Committee may also be exercised by the full Board. To the extent that any permitted action taken by the Board conflicts with action taken by the Committee, the Board action will control.

SECTION 4. SHARES

4.1.Shares Available For Issuance. The maximum number of shares of Common Stock that may be delivered to participants and their beneficiaries under the Plan will be 28,977,508 (after giving effect to the Stock Split and the Second Stock Split). Shares subject to an Award under the Plan may be authorized and unissued shares or may be treasury shares.

The maximum number of shares of Common Stock that may be subject to Management Incentive Awards, Restricted Stock and Performance Units is 7,020,248 shares of Common Stock (after giving effect to the Stock Split and Second Stock Split). [Note that (after giving effect to the Stock Split and Second Stock Split) this number includes 1,820,248 shares subject to Management Incentive Awards, Restricted Stock and Performance Units awarded prior

-8-

to February 23, 2006, as well as 5,200,000-shares that are available for future grant as Management Incentive Awards, Restricted Stock and Performance Units awarded on or after February 23, 2006.]

No Award will be counted against the shares available for delivery under the Plan if the Award is payable to the participant only in the form of cash, or if the Award is paid to the participant in cash.

To the extent any Award is forfeited, any Stock Option (or Stock Appreciation Right) terminates, expires or lapses without being exercised or any Stock Appreciation Right is exercised for cash, the shares of Common Stock subject to such Award will again become available for delivery in connection with new Awards under the Plan. To the extent any shares of Common Stock subject to an Award are tendered back prior to April 20, 2011 (or, if later, the 10^th anniversary of the latest re-approval of this clause by the Company’s stockholders) or not delivered because such shares are (in either case) used to satisfy an applicable tax-withholding obligation, such shares will again become available for delivery in connection with new Awards under the Plan.

In the event of a stock dividend, stock split, merger, consolidation, separation or other change in capitalization, spin-off, extraordinary dividend or distribution, reorganization (whether or not such reorganization comes within the definition of such term in Section 368 of the Code), reclassification, recapitalization, partial or complete liquidation of the Company or other similar event or transaction, the Committee shall make such equitable substitutions or adjustments in the number, kind, and price of shares, or the identity of the issuer of shares, reserved for issuance under the Plan or subject to outstanding Awards granted under the Plan, and the maximum limitation upon any Awards to be granted to any participant, as the Committee determines to be necessary or appropriate to fulfill the purposes for which the Plan was adopted and the Awards were granted; provided, however, that no such substitution or adjustment will be made if such substitution or adjustment would give rise to any tax under Section 409A of the Code; and provided further, that the number of shares subject to any Award will always be a whole number. Any such adjusted price will be used to determine the amount payable in cash or shares, as applicable, by the Company upon the exercise of any Award. [Note that as a result of the Spin-off, for any Stock Options granted on or before December 31, 2001, the Option Prices for such Stock Options have been adjusted by a factor of .5245476 pursuant to this Section 4.1; that as a result of the Stock Split, for any Stock Options granted on or prior to September 13, 2007, the number of shares subject to such Stock Options has been doubled and the Option Prices for such Stock Options have been adjusted by a factor of .5 pursuant to this Section 4.1; and that as a result of the Second Stock Split, for any Stock Options granted on or prior to May 24, 2002 the number of shares subject to such Stock Options has been further doubled and the Option Prices for such Stock Options has been further adjusted by a factor of .5 pursuant to this Section 4.1 . ]

4.2.Individual Limits. No participant may be granted Stock Options and Stock Appreciation Rights covering in excess of 500,000 shares of Common Stock in any calendar year, provided, however that this prohibition shall not apply: i) to the extent Common Stock

-9-

subject to a Stock Option granted prior to December 31, 2001, when adjusted as a result of the Spin-off, exceeded 500,000 shares for an individual participant in a calendar year, (ii) to awards granted on or prior to September 13, 2007, to the extent when adjusted as a result of the Stock Split, the limits in this sentence are exceeded, or (iii), to awards granted on or prior to May 24, 2012, to the extent when adjusted as a result of the Second Stock Split, the limits in this sentence are exceeded.. The maximum aggregate amount with respect to each Management Incentive Award, Award of Performance Units or Award of Restricted Stock that may be granted, or, that may vest, as applicable, in any calendar year for any individual participant is 500,000 shares of Common Stock, or the dollar equivalent of 500,000 shares of Common Stock, provided, however that this prohibition shall not apply: (i) to awards granted prior to December 31, 2001, to the extent that when adjusted as a result of the Spin-off, the limits in this sentence are exceeded, (ii) to awards granted on or prior to September 13, 2007, to the extent when adjusted as a result of the Stock Split, the limits in this sentence are exceeded, or (iii), to awards granted on or prior to May 24, 2012, to the extent when adjusted as a result of the Second Stock Split, the limits in this sentence are exceeded.

SECTION 5. ELIGIBILITY

Awards may be granted under the Plan to Eligible Individuals. Incentive Stock Options may be granted only to employees of the Company and its subsidiaries or parent corporation (within the meaning of Section 424(f) of the Code).

SECTION 6. TERMS AND CONDITIONS OF AWARDS

6.1.General. Awards will be in the form and upon the terms and conditions as determined by the Committee, subject to the terms of the Plan. The Committee is authorized to grant Awards independent of, or in addition to other Awards granted under the Plan. The terms and conditions of each Award may vary from other Awards. Awards will be evidenced by Notices, the terms and conditions of which will be consistent with the terms of the Plan and will apply only to such Award.

6.2.Expiration Date. Unless otherwise provided in the Notice, the Expiration Date of an Award will be the earlier of the date that is ten (10) years after the Grant Date or the date of the participant’s Termination of Employment.

6.3.Vesting. Each Award vests and becomes fully payable, exercisable and/or released of any restriction on the Vesting Date. The Vesting Date of each Award, as determined by the Committee, will be set forth in the Notice.

SECTION 7. QUALIFIED PERFORMANCE-BASED AWARDS

7.1.The Committee may designate a Management Incentive Award, or an Award of Restricted Stock or an Award of Performance Units as a Qualified Performance-Based Award, in which case, the Award is contingent upon, and may not vest until, the attainment of Performance

-10-

Goals has been certified by the Committee. The amount of the Qualifying Performance-Based Award actually paid to a Participant at the discretion of the Committee may be less, but shall not be more, than the amount determined by the applicable Performance Goals.

SECTION 8. MANAGEMENT INCENTIVE AWARDS

8.1.Management Incentive Awards. The Committee is authorized to grant Management Incentive Awards, subject to the terms of the Plan. Notices for Management Incentive Awards will indicate the Award Cycle, any applicable Performance Goals, any applicable designation of the Award as a Qualified Performance-Based Award, the Vesting Date of the Award and the form of payment of the Award. Unless otherwise provided in a Notice, in order to be eligible to receive payment in respect of a Management Incentive Award, a participant must be an employee of the Company during the entire Award Cycle applicable to the Management Incentive Award.

8.2.Settlement. As soon as practicable after the Vesting Date, but no later than the 15^th day of the third calendar month following the Vesting Date of any Management Incentive Award, payment in respect of the Management Incentive Award will be made to the participant in cash, Common Stock, Restricted Stock or a combination of cash, Common Stock and Restricted Stock, as determined by the Committee. The number of shares of Common Stock payable under the stock portion of a Management Incentive Award will equal the amount of such portion of the award divided by the Fair Market Value of the Common Stock on the date of payment. The foregoing notwithstanding, Management Incentive Awards payable in cash may be deferred in accordance with the FMC Corporation Nonqualified Savings and Investment Plan, as it may be amended from time to time.

SECTION 9. STOCK OPTIONS

9.1.Stock Options. The Committee is authorized to grant Stock Options, including both Incentive Stock Options and Nonqualified Stock Options, subject to the terms of the Plan. Notices will indicate whether the Stock Option is intended to be an Incentive Stock Option or a Nonqualified Stock Option, the option price, the term and the number of shares to which it pertains. To the extent that any Stock Option is not designated as an Incentive Stock Option, or, even if so designated does not qualify as an Incentive Stock Option on or subsequent to its Grant Date, it will constitute a Nonqualified Stock Option. No Incentive Stock Option will be granted hereunder on or after the 10^th anniversary of the date of stockholder approval of the Plan (or, if the stockholders approve an amendment that increases the number of shares subject to the Plan, the 10^th anniversary of the date of such approval); provided, however, that Incentive Stock Options granted prior to such 10^th anniversary may extend beyond that date.

9.2.Option Price. The option price per share of Common Stock purchasable under a Stock Option will be determined by the Committee and will not be less than the Fair Market Value of the Common Stock subject to the Stock Option on the Grant Date.

-11-

9.3.Incentive Stock Options. The terms of the Plan addressing Incentive Stock Options and each Incentive Stock Option will be interpreted in a manner consistent with Section 422 of the Code and all valid regulations issued thereunder.

9.4.Exercise. Stock Options will be exercisable at such time or times and subject to the terms and conditions set forth in the Notice. A participant can exercise a Stock Option, in whole or in part, at any time on or after the Vesting Date and before the Expiration Date by giving written notice of exercise to the Company specifying the number of shares of Common Stock subject to the Stock Option to be purchased. Such notice will be accompanied by payment in full to the Company of the option price by certified or bank check or such other cash equivalent instrument as the Company may accept. If approved by the Committee, payment in full or in part may also be made in the form of Common Stock (by delivery of such shares or by attestation) already owned by the optionee of the same class as the Common Stock subject to the Stock Option, based on the Fair Market Value of the Common Stock on the date the Stock Option is exercised. Notwithstanding the foregoing, the right to make payment in the form of already owned shares of Common Stock applies only to shares that have been held by the optionee for at least six (6) months at the time of exercise or that were purchased on the open market.

If approved by the Committee, payment in full or in part may also be made by delivering a properly executed exercise notice to the Company, together with a copy of irrevocable instructions to a broker to deliver promptly to the Company the amount of sale or broker loan proceeds necessary to pay the option price, and, if requested, by the amount of any federal, state, local or foreign withholding taxes. To facilitate the foregoing, the Company may enter into agreements for coordinated procedures with one or more brokerage firms, but any loans by a broker in connection with an exercise shall be arranged between the broker and the employee, and not by the Company.

In addition, if approved by the Committee, a Stock Option may be exercised by a "net cashless exercise" procedure whereby all or any portion of the option price and/or any required tax withholding may be satisfied by a reduction in the number of shares issued upon exercise. In that case, the number of shares of Common Stock issued upon exercise will be equal to: (a) the product of (i) the number of shares as to which the Stock Option is then being exercised on a net cashless basis, and (ii) the excess of (A) the Fair Market Value on the date of exercise, over (B) the option price and/or any required tax withholding associated with the net cashless exercise (expressed on a per share basis), divided by (b) the Fair Market Value on the date of exercise. A number of shares of Common Stock equal to the difference between the number of shares as to which the Stock Option is then being exercised and the number of shares actually issued upon such exercise will be deemed to have been retained by the Company in satisfaction of the option price and/or any required tax withholding.

9.4A Automatic Exercise. The provisions of this Section 9.4A shall apply to any Stock Option that is unexercised, in whole or in part, on or after April 27, 2015. Immediately before the time at which any such Stock Option is scheduled to expire in accordance with the

-12-

terms and conditions of the Plan and the applicable option Award document, such Stock Option shall be deemed automatically exercised, if such Stock Option satisfies the following conditions:

(1) Such Stock Option is covered by a then current registration statement or a Notification under Regulation A under the 1933 Act.

(2) The last reported sale price of a Share on the principal exchange on which Shares are listed on the date of determination, or if such date is not a trading day, the last preceding trading day, exceeds the option price per Share by such amount as may be determined by the Committee or its delegate from time to time. Absent a contrary determination, such excess per Share shall be $0.01.

A Stock Option subject to this Section 9.4A shall be exercised via cashless exercise (as described in the last paragraph of Section 9.4), such that subject to the other terms and conditions of the Plan, following the date of exercise, the Company shall deliver to the Optionee shares of Common Stock having a value, at the time of exercise, equal to the excess, if any, of (A) the Fair Market Value of such shares over (B) the sum of (1) the aggregate option price for such shares, plus (2) the applicable tax withholding amounts for such exercise; provided that in connection with such cashless exercise that would not result in the issuance of a whole number of shares, the Company shall pay cash in lieu of any fractional share.

9.5.Settlement. As soon as practicable after the exercise of a Stock Option: a) if the shares purchased are represented by certificates, the Company will deliver to or on behalf of the optionee certificates of Common Stock for the number of shares purchased; or (b) if not represented by certificates, the shares purchased shall be registered by means of book entry. No shares of Common Stock will be issued until full payment therefor has been made. An optionee will have all of the rights of a stockholder of the Company holding Common Stock, including, but not limited to, the right to vote the shares and the right to receive dividends, when the optionee has given written notice of exercise, has paid in full for such shares and, if requested, has given the representation described in Section 18 General Provisions. The Committee may give optionees Dividend Equivalent Rights.

9.6.Nontransferability. No Stock Option will be transferable by the optionee other than by will or by the laws of descent and distribution. All Stock Options will be exercisable, subject to the terms of the Plan, only by the optionee, the guardian or legal representative of the optionee, or any person to whom such Stock Option is transferred pursuant to this paragraph, it being understood that the terms “holder” and “optionee” include such guardian, legal representative and other transferee. No Stock Option will be subject to execution, attachment or other similar process.

9.7.Cashing Out. On receipt of written notice of exercise, the Committee may elect to cash out all or part of the portion of the shares of Common Stock for which a Stock Option is being exercised by paying the optionee an amount, in cash or Common Stock, equal to the excess of the Fair Market Value of the Common Stock over the option price times the number of shares

-13-

of Common Stock for which the Stock Option is being exercised on the effective date of such cash-out.

SECTION 10.    STOCK APPRECIATION RIGHTS.

10.1.Stock Appreciation Rights. The Committee is authorized to grant Stock Appreciation Rights, subject to the terms of the Plan. Stock Appreciation Rights granted with a Nonqualified Stock Option may be granted either on or after the Grant Date. Stock Appreciation Rights granted with an Incentive Stock Option may be granted only on the Grant Date of such Stock Option. Notices of Stock Appreciation Rights granted with Stock Options may be incorporated into the Notice of the Stock Option. Notices of Stock Appreciation Rights will indicate whether the Stock Appreciation Right is independent of any Award or granted with a Stock Option, the price, the term, the method of exercise and the form of payment. The Committee may also grant Dividend Equivalent Rights in association with any Stock Appreciation Right. A Stock Appreciation Right exercise price may never be less than the Fair Market Value of the underlying Common Stock on the Grant Date of such Stock Appreciation Right.

10.2.Exercise. A participant can exercise Stock Appreciation Rights, in whole or in part, at any time after the Vesting Date and before the Expiration Date, or, with respect to Stock Appreciation Rights granted in connection with any Stock Option, at such time or times and to the extent that the Stock Options to which they relate are exercisable, by giving written notice of exercise to the Company specifying the number of Stock Appreciation Rights to be exercised. A Stock Appreciation Right granted with a Stock Option may be exercised by an optionee by surrendering any applicable portion of the related Stock Option in accordance with procedures established by the Committee. To the extent provided by the Committee, Stock Options which have been so surrendered will no longer be exercisable to the extent the related Stock Appreciation Rights have been exercised.

10.3.Settlement. As soon as practicable after the exercise of a Stock Appreciation Right, an optionee will be entitled to receive an amount in cash, shares of Common Stock or a combination of cash and shares of Common Stock, as determined by the Committee, in value equal to the excess of the Fair Market Value on the date of exercise of one share of Common Stock over the Stock Appreciation Right price per share multiplied by the number of shares in respect of which the Stock Appreciation Right is being exercised.

Upon the exercise of a Stock Appreciation Right granted with any Stock Option, the Stock Option or part thereof to which such Stock Appreciation Right is related will be deemed to have been exercised for the purpose of the limitation set forth in Section 4 Shares on the number of shares of Common Stock to be issued under the Plan, but only to the extent of the number of shares delivered upon the exercise of the Stock Appreciation Right.

10.4.Nontransferability. Stock Appreciation Rights will be transferable only to the extent they are granted with any Stock Option, and only to permitted transferees of such underlying Stock Option in accordance with the Nontransferability provisions of Section 9.

-14-

SECTION 11.RESTRICTED STOCK

11.1.Restricted Stock. The Committee is authorized to grant Restricted Stock, subject to the terms of the Plan. Notices for Restricted Stock may be in the form of a Notice and book-entry registration or issuance of one or more stock certificates. Any certificate issued in respect of shares of Restricted Stock will be registered in the name of such participant and will bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award, substantially in the following form:

“The transferability of this certificate and the shares of stock represented hereby are subject to the terms and conditions, including, but not limited to, forfeiture of the FMC Corporation Incentive Compensation and Stock Plan and a Restricted Stock Notice. Copies of such Plan and Notice are on file at the offices of FMC Corporation.”

The Committee may require that the certificates evidencing such shares be held in custody by the Company until the restrictions thereon will have lapsed and that, as a condition of any Award of Restricted Stock, the participant will have delivered a stock power, endorsed in blank, relating to the Common Stock covered by such Award. The Notice or certificates will indicate any applicable Performance Goals and any applicable designation of the Restricted Stock as a Qualified Performance-Based Award. Unless otherwise provided in a Notice, in order to be eligible to vest in an Award of Restricted Stock, a participant must be an employee of the Company during the entire Award Cycle applicable to the Restricted Stock.

11.2.Participant Rights. Subject to the terms of the Plan and the Notice or certificate of Restricted Stock, the participant will not be permitted to sell, assign, transfer, pledge or otherwise encumber shares of Restricted Stock until the Vesting Date. Notwithstanding the foregoing, if approved by the Committee, a participant may pledge Restricted Stock as security for a loan to obtain funds to pay the option price for Stock Options. Except as provided in the Plan and the Notice or certificate of the Restricted Stock, the participant will have, with respect to the shares of Restricted Stock, all of the rights of a stockholder of the Company holding Common Stock, including, but not limited to, the right to vote the shares and to receive dividends with respect to the shares; provided that, in the discretion of the Committee, cash or property payable as a dividend on Restricted Stock may be subjected to the same vesting conditions as the Restricted Stock giving rise to the payment or may be converted into a number of additional shares of Restricted Stock (again, having the same vesting conditions as the Restricted Stock giving rise to the payment) determined by dividing the amount of the cash or the fair market value of the property otherwise distributable (as determined by the Committee) by the Fair Market Value on the dividend payment date.

11.3.Settlement. As soon as practicable after the vesting date for any share of Restricted Stock; (a) if the share is represented by a legended certificate, that legended certificate will be exchanged for a new certificate that does not contain the legend described above in Section 11.1 and the new certificate will be delivered to the participant, or (b) if the share is

-15-

registered by means of book entry, the Company will direct its transfer agent to remove the stop-transfer order associated with the satisfied vesting condition(s).

SECTION 12.PERFORMANCE UNITS

12.1.Performance Units. The Committee is authorized to grant Performance Units, subject to the terms of the Plan. Notices of Performance Units will indicate any applicable Performance Goals, any applicable designation of the Award as a Qualified Performance-Based Award, the Vesting Date of the Performance Units and the form of payment. Unless otherwise provided in a Notice, in order to be eligible to receive payment in respect of a Performance Unit, a participant must be an employee of the Company during the entire Award Cycle applicable to the Performance Unit.

12.2.Settlement. As soon as practicable after the Vesting Date, but no later than the March 15^th of the year following the year in which the Vesting Date of a Performance Unit occurs, payment will be made in respect of the Performance Unit. Payment in respect of Performance Units will be made in an amount of cash equal to the Fair Market Value of one share of Common Stock multiplied by the number of Performance Units earned or, if applicable, in a number of shares of Common Stock equal to the number of Performance Units earned, each as determined by the Committee. Payment in respect of Performance Units may not be deferred (other than payment in respect of Performance Units granted to directors prior to January 1, 2009).

SECTION 13.OTHER AWARDS

The Committee is authorized to make, either alone or in conjunction with other Awards, Awards of cash or Common Stock and Awards that are valued in whole or in part by reference to, or are otherwise based upon, Common Stock, including, without limitation, convertible debentures.

SECTION 14.CHANGE IN CONTROL

14.1.Impact of Change in Control. Notwithstanding any other provision of the Plan to the contrary, in the event of a Change in Control, as of the date such Change in Control is determined to have occurred, any outstanding:

(a) Stock Options and Stock Appreciation Rights become fully exercisable and vested to the extent provided in the Notice, or if not provided in the Notice, to the extent determined by the Committee;

(b) Restricted Stock becomes free of all restrictions and becomes fully vested and transferable to the full extent of all or a portion of the maximum amount of the original grant as provided in the Notice, or, if not provided in the Notice, as determined by the Committee;

-16-

(c) Performance Units become vested to the extent provided in the Notice, or if not provided in the Notice, as determined by the Committee; and

(d) Management Incentive Awards become fully vested to the full extent of all or a portion of the maximum amount of the original grant as provided in the Notice, or, if not provided in the Notice, as determined by the Committee, and such Management Incentive Awards will be settled in cash or Common Stock, as determined by the Committee, as promptly as is practicable following the Change in Control (except for Management Incentive Awards deferred under the FMC Corporation Nonqualified Savings and Investment Plan which awards will be settled at the time specified in accordance with the FMC Corporation Nonqualified Savings and Investment Plan).

The Committee may also make additional substitutions, adjustments and/or settlements of outstanding Awards as it deems appropriate and consistent with the Plan’s purposes.

14.2.Definition of Change in Control. For purposes of the Plan other than with respect to the acceleration of Management Incentive Awards in accordance with Section 14.1, a “Change in Control” will mean the happening of any of the following events:

(a) An acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of twenty percent (20%) or more of either (1) the then outstanding shares of common stock of the Company (the “Outstanding Company Common Stock”) or (2) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); excluding, however, the following: (A) any acquisition directly from the Company, other than an acquisition by virtue of the exercise of a conversion privilege unless the security being so converted was itself acquired directly from the Company, (B) any acquisition by the Company, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any entity controlled by the Company, or (D) any acquisition pursuant to a transaction which complies with Subsections (1), (2) and (3) of Subsection (c) of this Section 14.2;

(b) A change in the composition of the Board such that the individuals who, as of the Effective Date, constitute the Board (such Board will be hereinafter referred to as the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, for purposes of this Section 14.2, that any individual who becomes a member of the Board subsequent to the Effective Date, whose election, or nomination for election by the Company’s stockholders, was approved by a vote of at least a majority of those individuals who are members of the Board and who were also members

-17-

of the Incumbent Board (or deemed to be such pursuant to this proviso) will be considered as though such individual were a member of the Incumbent Board; but, provided further, that any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board will not be so considered as a member of the Incumbent Board;

(c) Consummation of a reorganization, merger or consolidation, sale or other disposition of all or substantially all of the assets of the Company, or acquisition by the Company of the assets or stock of another entity (“Corporate Transaction”); excluding, however, such a Corporate Transaction pursuant to which (1) all or substantially all of the individuals and entities who are the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Corporate Transaction will beneficially own, directly or indirectly, more than sixty percent (60%) of, respectively, the outstanding shares of common stock, and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such Corporate Transaction (including, without limitation, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Corporate Transaction, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be, (2) no Person (other than the Company, any employee benefit plan (or related trust) of the Company or such corporation resulting from such Corporate Transaction) will beneficially own, directly or indirectly, twenty percent (20%) or more of, respectively, the outstanding shares of common stock of the corporation resulting from such Corporate Transaction or the combined voting power of the outstanding voting securities of such corporation entitled to vote generally in the election of directors except to the extent that such ownership existed prior to the Corporate Transaction, and (3) individuals who were members of the Incumbent Board will constitute at least a majority of the members of the board of directors of the corporation resulting from such Corporate Transaction; or

(d) The approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.

14.3.Special Definition of Change in Control. For purposes of the Plan, only with respect to the acceleration of Management Incentive Awards in accordance with Section 14.1, a “Change in Control” will mean the happening of any of the following events:

-18-

(a) A Person acquires (or has acquired over the 12-month period ending on the date of the most recent acquisition by such Person) stock of the Company possessing thirty percent (30%) or more of the total voting power of the then outstanding voting securities of the Company; excluding, however, the following: (A) any acquisition directly from the Company, other than an acquisition by virtue of the exercise of a conversion privilege unless the security being so converted was itself acquired directly from the Company, (B) any acquisition by the Company or (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any entity controlled by the Company;

(b) The date that a majority of the members of the Board is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board before the date of appointment or election;

(c) A Person acquires (or has acquired over the 12-month period ending on the date of the most recent acquisition by such Person) assets from the Company that have a total gross fair market value equal to more than forty percent (40%) of the total gross fair market value of all of the assets of the Company immediately before such acquisition or acquisitions.

SECTION 15.FORFEITURE OF AWARDS

Notwithstanding anything in the Plan to the contrary, the Committee may, in the event of serious misconduct by a participant (including, without limitation, any misconduct prejudicial to or in conflict with the Company or its Affiliates, or any Termination of Employment for Cause), or any activity of a participant in competition with the business of the Company or any Affiliate, (a) cancel any outstanding Award granted to such participant, in whole or in part, whether or not vested or deferred, and/or (b) if such conduct or activity occurs within one year following the exercise or payment of an Award, require such participant to repay to the Company any gain realized or payment received upon the exercise or payment of such Award (with such gain or payment valued as of the date of exercise or payment). Such cancellation or repayment obligation will be effective as of the date specified by the Committee. Any repayment obligation may be satisfied in Common Stock or cash or a combination thereof (based upon the Fair Market Value of Common Stock on the day of payment), and the Committee may provide for an offset to any future payments owed by the Company or any Affiliate to the participant if necessary to satisfy the repayment obligation. The determination of whether a participant has engaged in a serious breach of conduct or any activity in competition with the business of the Company or any Affiliate will be made by the Committee in good faith. This Section 15 will have no application following a Change in Control.

SECTION 16.AMENDMENT AND TERMINATION

The Committee may amend, alter, or discontinue the Plan or any Award, prospectively or retroactively, but no amendment, alteration or discontinuation may impair the

-19-

rights of a recipient of any Award without the recipient’s consent, except such an amendment made to comply with applicable law, stock exchange rules or accounting rules.

No amendment will be made without the approval of the Company’s stockholders to the extent such approval is required by applicable law or stock exchange rules, or to the extent such amendment increases the number of shares available for delivery under the Plan. Without the approval of the Company’s stockholders, the Committee will not reduce the option price of a Stock Option after the Grant Date or cancel an outstanding Stock Option and grant a new Stock Option with a lower exercise price in substitution therefor (other than, in either case, in accordance with the adjustment provisions in the last paragraph of Section 4.1).

SECTION 17.UNFUNDED STATUS OF PLAN

It is presently intended that the Plan constitute an “unfunded” plan for incentive and deferred compensation. The Committee may authorize the creation of trusts or other arrangements to meet the obligations created under the Plan to deliver Common Stock or make payments; provided, however, that unless the Committee otherwise determines, the existence of such trusts or other arrangements is consistent with the “unfunded” status of the Plan.

SECTION 18.GENERAL PLAN PROVISIONS

18.1.General Provisions. The Plan will be administered in accordance with the following provisions and any other rule, guideline and practice determined by the Committee:

(a) Each person purchasing or receiving shares pursuant to an Award may be required to represent to and agree with the Company in writing that he or she is acquiring the shares without a view to the distribution of the shares.

(b) The certificates for shares issued under an Award may include any legend which the Committee deems appropriate to reflect any restrictions on transfer.

(c) Notwithstanding any other provision of the Plan, any Award, any Notice or any other agreements made pursuant thereto, the Company is not required to issue or deliver any shares of Common Stock prior to fulfillment of all of the following conditions:

(i) Listing or approval for listing upon notice of issuance, of such shares on the New York Stock Exchange, or such other securities exchange as may at the time be the principal market for the Common Stock;

(ii) Any registration or other qualification of such shares of the Company under any state or federal law or regulation, or the maintaining in effect of any such registration or other qualification which the Committee deems necessary or advisable; and

-20-

(iii) Obtaining any other consent, approval, or permit from any state or federal governmental agency which the Committee deems necessary or advisable.

(d) The Company will not issue fractions of shares. Whenever, under the terms of the Plan, the aggregate number of shares required to be issued to a participant at a particular time includes a fractional share, one additional whole share will be issued to the participant in lieu of and in satisfaction for that fractional share.

(e) In the case of a grant of an Award to any Eligible Individual of an Affiliate, the Company may, if the Committee so directs, issue or transfer the shares of Common Stock, if any, covered by the Award to the Affiliate, for such lawful consideration as the Committee may specify, upon the condition or understanding that the Affiliate will transfer the shares of Common Stock to the Eligible Individual in accordance with the terms of the Award specified by the Committee pursuant to the provisions of the Plan. All shares of Common Stock underlying Awards that are forfeited or canceled revert to the Company.

18.2.Employment. The Plan will not constitute a contract of employment, and adoption of the Plan will not confer upon any employee any right to continued employment, nor will it interfere in any way with the right of the Company or an Affiliate to terminate at any time the employment of any employee or the membership of any director on a board of directors or any consulting arrangement with any Eligible Individual.

18.3.Tax Withholding Obligations. No later than the date as of which the Company reasonably believes an amount first becomes includible in the gross income of the participant for federal income tax purposes with respect to any Award under the Plan, the participant will pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, any federal, state, local or foreign taxes of any kind required by law to be withheld with respect to such amount. Unless otherwise determined by the Company, withholding obligations may be settled with Common Stock, including Common Stock that is part of the Award that gives rise to the withholding requirement; provided, that not more than the legally required minimum withholding may be settled with Common Stock. The obligations of the Company under the Plan will be conditional on such payment or arrangements, and the Company and its Affiliates will, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to the participant. The Committee may establish such procedures as it deems appropriate, including making irrevocable elections, for the settlement of withholding obligations with Common Stock.

18.4.Beneficiaries. The Committee will establish such procedures as it deems appropriate for a participant to designate a beneficiary to whom any amounts payable in the event of the participant’s death are to be paid or by whom any rights of the participant, after the participant’s death, may be exercised.

-21-

18.5.Governing Law. The Plan and all Awards made and actions taken thereunder will be governed by and construed in accordance with the laws of the State of Delaware, without reference to principles of conflict of laws. Notwithstanding anything herein to the contrary, in the event an Award is granted to an Eligible Individual who is employed or providing services outside the United States and who is not compensated from a payroll maintained in the United States, the Committee may modify the provisions of the Plan and/or any such Award as they pertain to such individual to comply with and account for the tax and accounting rules of the applicable foreign law so as to maintain the benefit intended to be provided to such participant under the Award.

18.6.Nontransferability. Awards under the Plan are not transferable except by will or by laws of descent and distribution; provided, that this section shall not restrict the transferability of unrestricted cash or shares of Common Stock that were unrestricted when issued or that by their terms have become unrestricted.

18.7.Severability. Wherever possible, each provision of the Plan and of each Award and of each Notice will be interpreted in such a manner as to be effective and valid under applicable law. If any provision of the Plan, any Award or any Notice is found to be prohibited by or invalid under applicable law, then (a) such provision will be deemed amended to and to have contained from the outset such language as will be necessary to accomplish the objectives of the provision as originally written to the fullest extent permitted by law; and (b) all other provisions of the Plan and any Award will remain in full force and effect.

18.8.Strict Construction. No rule of strict construction will be applied against the Company, the Committee or any other person in the interpretation of the terms of the Plan, any Award, any Notice, any other agreement or any rule or procedure established by the Committee.

18.9.Stockholder Rights. Except as otherwise provided herein, no participant will have dividend, voting or other stockholder rights by reason of a grant of an Award or a settlement of an Award in cash.

-22-

EX-10.2

Exhibit 10.2

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT

FMC CORPORATION

INCENTIVE COMPENSATION AND STOCK PLAN

THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”) is made by and between FMC Corporation (the “Company”) and PierreBrondeau(the “Participant”).

WHEREAS, the Company maintains the FMC Corporation Incentive Compensation and Stock Plan (the “Plan”); and

WHEREAS, the Plan authorizes the grant of Performance Units and

WHEREAS, to compensate the Participant for his past and anticipated future contributions to the Company and to further align the Participant’s personal financial interests with those of the Company’s stockholders, the Compensation and Organization Committee of the Company’s Board of Directors approved this grant of Performance Units to the Participant on the terms described below, effective February 27, 2015 (the “Grant Date”).

NOW, THEREFORE, in consideration of the mutual covenants herein contained and other good and valuable consideration, receipt of which is hereby acknowledged, the parties hereto agree as follows:

1.Grant of Restricted Stock Units.

(a)Pursuant to the Plan and as of the Grant Date, the Company hereby awards to the Participant a target number of 31,541 Performance Units on the terms and conditions set forth herein (the “Units”). The terms of the Plan are incorporated herein by this reference and made a part of this Agreement. Capitalized terms not otherwise defined herein will have the same meanings as in the Plan.

(b)Each Unit, once vested, represents an unfunded, unsecured right of the Participant to receive one share of Common Stock (each a “Share”) at a specified time. The Units will become vested, and Shares will be issued in respect of vested Units, as set forth in this Agreement.

2.Vesting.

(a)Subject to the Participant’s continued employment by the Company or any of its Affiliates through February 27, 2018 (the “Specified Date”),

1

the Units shall become vested based upon the Company’s “Total Shareholder Return” (as defined below) relative to the Total Shareholder Return of the “Peer Companies” (as defined below) from January 1, 2015 until December 31, 2017 (the “Measurement Period”) in accordance with the following table (the “Relative Total Shareholder Return”):

Level	Percentile Ranking of Company’s Total Shareholder Return Versus Peer Group Total Shareholder Return	Percentage of the Units Vested and Payable
Threshold	Below the 35th Percentile	0%
Target	50th  Percentile	100%
Maximum	80th Percentile or higher	200%

If the Company’s Relative Total Shareholder Return over the Measurement Period is between the levels set forth above, then the percentage of the Units that will become vested and payable will be ratably interpolated. If the Relative Total Shareholder Return at the end of the Measurement Period is below the 35^th percentile, then all Units shall be forfeited immediately and automatically and the Participant will have no further rights with respect thereto.

(b)In the event the Participant’s employment is terminated by reason of (i) Disability, (ii) death, or (iii) by the Company without Cause other than within two years following a Change in Control, then the Units, will be prorated based on the number of days the Participant was employed by the Company during the Measurement Period, and such prorated Units will remain outstanding and will vest and be delivered to the Participant, at the same time as delivery would have been made had the Participant not had a termination of employment based on the attainment of the applicable Relative Total Shareholder Return for the full Measurement Period.

(c)If prior to the date the Units otherwise vest and within two years following a Change in Control the Participant’s employment is terminated either by the Company without Cause or by the Participant due to a resignation with Good Reason (as defined in Section 18), any of the Participant’s then outstanding Units (including any pro-rated Units that remain outstanding pursuant to Section 2(b) above) will vest immediately prior to such event as if the Target vesting level was attained.

(d)Upon a cessation of the Participant’s employment with the Company or any of its Affiliates, any Unit that has not become vested on or prior to the effective date of such cessation or any Unit that does not specifically remain outstanding pursuant to Section 2(b) or 2(c) will then be forfeited immediately and

-2-

automatically and the Participant will have no further rights with respect thereto. The foregoing sentence shall apply notwithstanding anything to the contrary in the terms of the Letter Agreement between the Company and Participant dated October 23, 2009, as amended, concerning the impact on long-term incentive awards of the cessation of Mr. Brondeau’s service after both (i) December 31, 2015 and (ii) the Board of Director’s approval of a “definitive succession plan”.

(e)The application of Sections 2(b)(iii) and 2(c) is in each case conditioned on (i) the Participant’s execution and delivery to the Company of a general release of claims against the Company and its affiliates in a form prescribed by the Company, and (ii) such release becoming irrevocable within 60 days following the cessation of the Participant’s employment or such shorter period specified by the Company. For avoidance of doubt, if this release requirement is not timely satisfied, the Units will be forfeited as of the effective date of the cessation of the Participant’s employment and the Participant will have no further rights with respect thereto.

(f)Definitions

(i)“Total Shareholder Return” means with respect to any publicly traded company, including the Company, the positive or negative change in the market price of one share of such entity’s common stock over the Measurement Period, plus the aggregate amount of dividends paid with respect to a share of such company’s common stock over the Measurement Period, with such sum being divided by the market price of one share of such entity’s common stock at the commencement of the Measurement Period (in each case appropriately adjusted for any stock dividends, stock splits or other corporate transaction affecting shares of such company’s common stock).

(ii)The “Peer Companies” shall consist of the following entities, provided that such entities are still publicly traded as of the last day of the Measurement Period: Akzo Nobel NV, Huntsman Corporation, American Vanguard Corp, International Flavors and Fragrances, Inc., Albermarle Corporation Olin Corporation, Ashland, Inc., BASF SE, CHR.Hansen Holdings AS, Celanese Corporation RPM International, Inc., Chemtura Corporation, Dow Chemical, Scott’s Miracle-GRO Company, Cytec Industries Inc., Sigma-Aldrich Corporation, Du Pont (E I) DE Nemours, Eastman Chemical Company, Ecolab Inc., Westlake Chemical Corporation, Ferro Corp, Ingredion, Inc., Koninkluke DSM NV, Minerals Technologies Inc., Monsanto Co., Newmarket Corp., NL Industries, Novozymes A/S, Nufarm LTD, Olin Corp., Polyone Corp, Rockwood Holdings, Inc., Schulman (A.) Inc., Sesient Technologies Corp., Syngenta AG ADR, Tate & Lyle PLC, Valhi, Inc., and Grace, (W.R.) & Company. Any entity which is not publicly traded as of

-3-

the last day of the Measurement Period due to acquisition or through a going private transaction shall be removed from the Peer Companies from the beginning of the Measurement Period without replacement. Any entity which declares bankruptcy, is liquidated or is otherwise delisted during the Measurement Period shall remain in the Peer Companies and such entity’s performance shall be considered to have been at the bottom of the Peer Companies.

3.Timing of Issuance.

(a)Subject to Section 3(b), with respect to any Units for which the applicable performance goal is satisfied, Shares will be issued in respect of all vested Units upon the Specified Date (or upon the Company’s termination of this arrangement in a manner consistent with the requirements of Treas. Reg. § 1.409A-3(j)(4)(ix)).

(b)Notwithstanding anything herein to the contrary:

(i)to the extent permitted by Treas. Reg. § 1.409A-3(j)(4)(vi), the issuance of Shares in respect of a number of vested Units will be accelerated to the date that employment taxes become payable with respect to this Award. Such number of Units will be equal to the reasonably estimated amount of employment taxes then required to be withheld and remitted, divided by the then current Fair Market Value;

(ii)to the extent the requirements of Treas. Reg. § 1.409A-2(b)(7)(ii) are met, the issuance of Shares hereunder will be delayed to the extent the Company reasonably anticipates that the issuance will violate Federal securities laws or other applicable laws; and

(iii)to the extent compliance with the requirements of Treas. Reg. § 1.409A-3(i)(2) is necessary to avoid the application of an additional tax under Section 409A of the Code, Shares that are otherwise issuable upon the Grantee’s “separation from service” (as that term is defined in Treas. Reg. § 1.409A-1(h)) will be deferred (without interest) and issued to the Grantee immediately following that six month period.

(c)Fractional Shares will be rounded up to the next whole Share.

4.Non-Transferability. Neither the Units nor any right with respect thereto may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent and distribution, and any purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance will be void and unenforceable against the Company.

-4-

5.Stockholder Rights. The Participant will not have any stockholder rights or privileges, including voting or dividend rights, with respect to the Shares subject to Units until such Shares are actually issued and registered in the Participant’s name in the Company’s books and records.

6.No Limitation on Rights of the Company. The granting of Units will not in any way affect the right or power of the Company to make adjustments, reclassifications or changes in its capital or business structure or to merge, consolidate, reincorporate, dissolve, liquidate or sell or transfer all or any part of its business or assets.

7.Employment. Nothing in this Agreement or in the Plan will confer on the Participant any right to continue in service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or Affiliate employing or retaining the Participant) to terminate the Participant’s employment at any time for any reason, with or without cause.

8.Tax Treatment and Withholding.

(a)The Participant has had the opportunity to review with his or her own tax advisors the federal, state and local tax consequences of the transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents.

(b)It is a condition to the Company’s obligation to issue Shares hereunder that the Participant pay to the Company such amount as may be required to satisfy all tax withholding obligations arising in connection with this Award (or otherwise make arrangements acceptable to the Company for the satisfaction of such tax withholding obligations). If the required withholding amount required is not timely paid or satisfied, the Participant’s right to receive such Shares will be permanently forfeited. The Company, in its discretion, may withhold Shares otherwise issuable hereunder in satisfaction of the minimum amount required to be withheld in connection with this Award (based on the Fair Market Value of such Shares on the date of such withholding).

9.Notices.

(a)Any notice required to be given or delivered to the Company under the terms of this Agreement will be addressed to it in care of its Secretary, FMC Corporation, 1735 Market Street, Philadelphia, PA 19103, and any notice to the Participant (or other person entitled to receive the Units) will be addressed to such person at the Participant’s address now on file with the Company, or to such other address as either may designate to the other in writing. Except as otherwise provided below in Section 9(b), any notice will be deemed to

-5-

be duly given when enclosed in a properly sealed envelope addressed as stated above and deposited, postage paid, in a post office or branch post office regularly maintained by the United States government.

(b)The Participant hereby authorizes the Company to deliver electronically any prospectuses or other documentation related to this Award, the Plan and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such plans or arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by means of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to the Participant a paper copy of any document also delivered to the Participant electronically. The authorization described in this paragraph may be revoked by the Participant at any time by written notice to the Company.

10.Beneficiaries. In the event of the death of the Participant, the issuance of Shares, if any, under Section 3 shall be made in accordance with the Participant’s written beneficiary designation on file with the Company (if such a designation has been duly filed with the Company, in the form prescribed by the Company and in accordance with the notice provisions of Section 9(a)). In the absence of any such beneficiary designation, the delivery of Shares, if any, under Section 3 will be made to the person or persons to whom the Participant’s rights shall pass by will or by the applicable laws of intestacy.

11.Administration. By entering into this Agreement, the Participant agrees and acknowledges that (a) the Company has provided or made available to the Participant a copy of the Plan, (b) he or she has read the Plan, (c) all Units are subject to the Plan, (d) in the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern, and (e) pursuant to the Plan, the Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee with respect to questions arising under the Plan or this Agreement.

12.Entire Agreement. This Agreement, together with the Plan, represents the entire agreement between the parties with respect to the subject matter hereof and supersedes any prior agreement, written or otherwise, relating to the subject matter hereof. This Agreement may only be amended by a writing signed by each of the parties hereto.

-6-

13.Governing Law. The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of Delaware without regard to the principles of conflicts-of-laws.

14.Privacy. By signing this Agreement, the Participant hereby acknowledges and agrees to the Company’s transfer of certain personal data of such Participant to the Company for purposes of implementing, performing or administering the Plan or any related benefit. Participant expressly gives his consent to the Company to process such personal data.

15.Claims Procedure.

(a)To the extent the issuance of Shares hereunder is deferred until termination of employment, this Agreement is intended to constitute part of a “top-hat” plan described in Section 201(2) of ERISA. Therefore, to initiate a claim with respect to the settlement of Units, the Participant (or the person to whom ownership rights may have passed by will or the laws of descent and distribution) (the “Claimant”) must file a written request with the Company. Upon receipt of such claim, the Company will advise the Claimant within ninety (90) days of receipt of the claim whether the claim is denied. If special circumstances require more than ninety (90) days for processing, the Claimant will be notified in writing within ninety (90) days of filing the claims than the Company requires up to an additional ninety (90) days to reply. The notice will explain what special circumstances make an extension necessary and indicate the date a final decision is expected to be made.

(b)If the claim is denied in whole or in part, the Claimant will be provided a written opinion, in language calculated to be understood by the Claimant, setting forth (i) the specific reason(s) for the denial of the claim, or any part of it, (ii) specific reference(s) to pertinent provisions of the Plan or this Agreement upon which such denial was based, (iii) a description of any additional material or information necessary for the Claimant to perfect the claim, and an explanation of why such material or information is necessary, (iv) an explanation of the claim appeal procedure set forth in Section 15(c), below; and (v) a statement of the Claimant’s right to bring a civil action under section 502(a) of ERISA following an adverse determination upon appeal.

(c)Within sixty (60) days after receiving a notice from the Company that a claim has been denied, in whole or in part, a Claimant (or the Claimant’s duly authorized representative) may file with the Company a written request for a review of the denial of the claim. The Claimant or his duly authorized representative may, but need not, review the pertinent documents and submit issues and comments in writing for consideration by the Company. If the Claimant does not request a review of the initial determination within such sixty (60) days

-7-

period, the Claimant will be barred and estopped from challenging the determination.

(d)Within sixty (60) days after the Company’s receipt of a request for review, it will review the initial determination. After considering all materials presented by the Claimant, without regard to whether such materials were submitted or considered in the initial review, the Company will render a written opinion. The manner and content of the final decision will include the same information described above in Section 15(b) with respect to the initial determination. If special circumstances require that the sixty (60) day time period be extended, the Company will so notify the Claimant and will render the decision as soon as possible, but no later than one hundred twenty (120) days after receipt of the request for review. The notice will explain what special circumstances make an extension necessary and indicate the date a final decision is expected to be made. Any decision on appeal will be final, conclusive and binding upon all parties.

16.Section Headings. The headings of sections and paragraphs of this Agreement are inserted for convenience only and shall not in any way affect the meaning or construction of any provision of this Agreement.

17.Counterparts; Facsimile. This Agreement may be executed in multiple counterparts (including by facsimile signature), each of which will be deemed to be an original, but all of which together will constitute but one and the same instrument.

18.Good Reason. For purposes of this Agreement, “Good Reason” will have the meaning defined in the Participant’s Individual Agreement, if any. If no Individual Agreement exists, “Good Reason” will mean the occurrence of any one or more of the following:

(a)The assignment to the Participant of duties materially inconsistent with his or her authorities, duties, responsibilities or position, or a material adverse change in the Participant’s authorities, duties, responsibilities, position or reporting requirements;

(b)The Company’s relocation of the Participant’s principal worksite by more than (50) miles, excepting travel substantially consistent with the Participant’s business obligations; or

(c)A material reduction in the Participant’s base salary.

provided that any such event will constitute Good Reason only if the Participant notifies the Company in writing of such event within 90 days following the initial occurrence thereof, the Company fails to cure such event within 30 days after receipt from the

-8-

Participant of written notice thereof, and the Participant resigns his or her employment within 180 days following the initial occurrence of such event.

[Signature Page Follows.]

-9-

IN WITNESS WHEREOF, the Company’s duly authorized representative and the Participant have each executed this Agreement on the respective date below indicated.

FMC CORPORATION
By:	/s/ Kyle Matthews
Title:	Vice President, Human Resources
Date:	April 23, 2015
PARTICIPANT
Signature:	/s/ Pierre R. Brondeau
Address:
Date:	April 23, 2015

-10-

EX-12

Exhibit 12

FMC CORPORATION

STATEMENTS OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(in Millions, Except Ratios)	Three Months Ended March 31
	2015			2014
Earnings:
Income (loss) from continuing operations before income taxes	$	(110.2	)	$	131.6
Equity in (earnings) loss of affiliates	0.1			(0.3		)
Interest expense and amortization of debt discount, fees and expenses	14.0			11.6
Amortization of capitalized interest	1.1			0.7
Interest included in rental expense	1.9			1.6
Total earnings (losses)	$	(93.1	)	$	145.2
Fixed charges:
Interest expense and amortization of debt discount, fees and expenses	$	14.0		$	11.6
Interest capitalized as part of fixed assets	2.3			1.8
Interest included in rental expense	1.9			1.6
Total fixed charges	$	18.2		$	15.0
Ratio of earnings to fixed charges (1)	-			9.7

(1) In calculating this ratio, earnings consist of income (loss) from continuing operations before income taxes plus interest expense, net, amortization expense related to debt discounts, fees and expenses, amortization of capitalized interest, interest included in rental expenses (assumed to be one-third of rent) and Equity in (earnings) loss of affiliates. Fixed charges consist of interest expense, amortization of debt discounts, fees and expenses, interest capitalized as part of fixed assets and interest included in rental expenses. For the three months ended March 31, 2015, we incurred a loss from continuing operations , and as a result, our earnings were insufficient to cover fixed charges by $111.3 million.

EX-15

Exhibit 15

Letter re: Unaudited Interim Financial Information

May 11, 2015

FMC Corporation

Philadelphia, Pennsylvania

Re: Registration Statements on Form S-3 (No. 333-184736) and Form S-8 (Nos. 333-64702, 333-62683, 333-36973, 333-24039, 333-18383, 333-69805, 333-69714, 333-111456, 333-172387, and 333-172388).

With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated May 11, 2015 related to our review of interim financial information.

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/ KPMG LLP

Philadelphia, Pennsylvania

EX-31.1

Exhibit 31.1

CHIEF EXECUTIVE OFFICER CERTIFICATION

I, Pierre R. Brondeau, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of FMC Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 11, 2015

/s/ Pierre R. Brondeau

Pierre R. Brondeau

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

I, Paul W. Graves, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of FMC Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 11, 2015

/s/ Paul W. Graves

Paul W. Graves

Executive Vice President and

Chief Financial Officer

EX-32.1

Exhibit 32.1

CEO CERTIFICATION OF QUARTERLY REPORT

I, Pierre R. Brondeau, President and Chief Executive Officer of FMC Corporation (“the Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, based on my knowledge that:

(1) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2015 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 11, 2015

/s/ Pierre R. Brondeau

Pierre R. Brondeau

President and Chief Executive Officer

EX-32.2

Exhibit 32.2

CFO CERTIFICATION OF QUARTERLY REPORT

I, Paul W. Graves, Executive Vice President and Chief Financial Officer of FMC Corporation (“the Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, based on my knowledge that:

(1) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2015 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 11, 2015

/s/ Paul W. Graves

Paul W. Graves

Executive Vice President and

Chief Financial Officer

EX-95

Exhibit 95

MINE SAFETY DISCLOSURES

Section 1503 of the Dodd-Frank Act contains new reporting requirements regarding coal or other mine safety. We operate a mine in conjunction with our Green River, Wyoming facility, which is subject to regulation by the Mine Safety and Health Administration (“MSHA”) under the Federal Mine Safety and Health Act of 1977 (the “Mine Act”), and is therefore subject to these reporting requirements. Presented in the table below is information regarding certain mining safety and health citations which MSHA has issued with respect to our operation as required by the Dodd-Frank Act. In evaluating this information, consideration should be given to the fact that citations and orders can be contested and appealed, and in that process, may be reduced in severity, penalty amount or sometimes dismissed (vacated) altogether.

The letters used as column headings in the table below correspond to the explanations provided underneath the table as to the information set forth in each column with respect to the numbers of violations, orders, citations or dollar amounts, as the case may be, during the first quarter 2015 unless otherwise indicated.

(1) For each coal or other mine, of which the issuer or a subsidiary of the issuer is an operator:

	(A)	(B)	(C)	(D)	(E)	(F)	(G)	(H)
Operation Name	Section 104	Section 104(b)	Section 104(d)	Section 110(b)(2)	Section 107(a)	Proposed Assessments*	Fatalities	Pending Legal Action
Westvaco	43	—	8	—	1	*	—	2

____________________

* Assessments are generally delayed up to 60 days after the close of the inspection.     

(A) The total number of violations of mandatory health or safety standards that could significantly and substantially contribute to the cause and effect of a coal or other mine safety and health hazard under section 104 of the Mine Act for which the operator received a citation from MSHA.

(B) The total number of orders issued under section 104(b) of the Mine Act.

(C) The total number of citations and orders for unwarrantable failure of the operator to comply with mandatory health or safety standards under section 104(d) of the Mine Act.

(D) The total number of flagrant violations under section 110(b)(2) of the Mine Act.

(E) The total number of imminent danger orders issued under section 107(a) of the Mine Act.

(F) The total dollar value of proposed assessments from the MSHA under the Mine Act.

(G) The total number of mining related fatalities.

(H) Any pending legal action before the Federal Mine Safety and Health Review Commission involving such coal or other mines.

a. All cases included in the number listed were pending before the Office of Administrative Law Judges of the Federal Mine Safety and Health Review Commission on March 31, 2015.

(2) A list of such coal or other mines, of which the issuer or a subsidiary of the issuer is an operator, that received written notice from MSHA of (A) a pattern of violations of mandatory health or safety standards that are of such nature as could have significantly and substantially contributed to the cause and effect of coal or other mine health and safety hazards under section 104(e) of the Mine Act, or (B) the potential to have such a pattern.

NONE

(3) Any pending legal action before the Federal Mine Safety and Health Review Commission involving such coal or other mine.

SEE COLUMN (H) OF SECTION (1) ABOVE

XML

Financial Instrument, Risk Management and Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2015

Financial Instruments Risk Management And Fair Value Measurements [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following tables provide the gross fair value and net balance sheet presentation of our derivative instruments as of March 31, 2015 and December 31, 2014.

	March 31, 2015
	Gross Amount of Derivatives
(in Millions)	Designated as Cash Flow Hedges			Not Designated as Hedging Instruments			Total Gross Amounts			Gross Amounts Offset in the Consolidated Balance Sheet (3)			Net Amounts
Derivatives
Foreign exchange contracts	$	22.8		$	32.4		$	55.2		$	(28.1	)	$	27.1
Total derivative assets (1)	22.8			32.4			55.2			(28.1		)	27.1
Foreign exchange contracts	(26.1		)	(6.2		)	(32.3		)	28.1			(4.2		)
Energy contracts	(2.8		)	—			(2.8		)	—			(2.8		)
Total derivative liabilities (2)	(28.9		)	(6.2		)	(35.1		)	28.1			(7.0		)
Net derivative assets/(liabilities)	$	(6.1	)	$	26.2		$	20.1		$	—		$	20.1
	December 31, 2014
	Gross Amount of Derivatives
(in Millions)	Designated as Cash Flow Hedges			Not Designated as Hedging Instruments			Total Gross Amounts			Gross Amounts Offset in the Consolidated Balance Sheet (3)			Net Amounts
Derivatives
Foreign exchange contracts	$	17.1		$	15.1		$	32.2		$	(3.6	)	$	28.6
Energy contracts	0.3			—			0.3			(0.3		)	—
Total derivative assets (1)	17.4			15.1			32.5			(3.9		)	28.6
Foreign exchange contracts	(17.4		)	(100.0		)	(117.4		)	3.6			(113.8		)
Energy contracts	(7.6		)	—			(7.6		)	0.3			(7.3		)
Total derivative liabilities (2)	(25.0		)	(100.0		)	(125.0		)	3.9			(121.1		)
Net derivative assets/(liabilities)	$	(7.6	)	$	(84.9	)	$	(92.5	)	$	—		$	(92.5	)

____________________

(1) Net balance is included in “Prepaid and other current assets” in the condensed consolidated balance sheets.

(2) Net balance is included in “Accrued and other liabilities” in the condensed consolidated balance sheets.

(3) Represents net derivatives positions subject to master netting arrangements.

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

The tables below summarizes the gains or losses related to our cash flow hedges and derivatives not designated as hedging instruments for the three months ended March 31, 2015 and 2014.

Derivatives in Cash Flow Hedging Relationships

	Three Months Ended March 31
	Contracts
	Foreign Exchange					Energy					Other				Total
(in Millions)	2015			2014		2015		2014			2015		2014		2015			2014
Unrealized hedging gains (losses) and other, net of tax	$	0.3		$	1.1	$	2.0	$	1.4		$	—	$	—	$	2.3		$	2.5
Reclassification of deferred hedging (gains) losses, net of tax
Effective portion (1)	(2.6		)	1.8		0.8		(0.7		)	—		—		(1.8		)	1.1
Total derivative instrument impact on comprehensive income	$	(2.3	)	$	2.9	$	2.8	$	0.7		$	—	$	—	$	0.5		$	3.6

___________________

(1) See Note 12 for classification of amounts within the condensed consolidated statements of income (loss).

Derivatives Not Designated as Hedging Instruments

	Location of Gain or (Loss) Recognized in Income on Derivatives	Amount of Pre-tax Gain or (Loss)  Recognized in Income on Derivatives (1)
		Three Months Ended March 31
(in Millions)		2015			2014
Foreign exchange contracts	Cost of sales and services	$	(4.5	)	$	4.9
	Selling, general & administrative (2)	(180.1		)	—
Total		$	(184.6	)	$	4.9

___________________

(1) Amounts in the columns represent the gain or loss on the derivative instrument offset by the gain or loss on the hedged item.

(2) Charges represent a loss on hedging the purchase price of the Cheminova A/S acquisition. See Note 3 within these condensed consolidated financial statements for more information.

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following tables present our fair-value hierarchy for those assets and liabilities measured at fair-value on a recurring basis in the condensed consolidated balance sheets as of March 31, 2015 and December 31, 2014. During the periods presented there were no transfers between fair-value hierarchy levels.

(in Millions)	March 31, 2015		Quoted Prices in  Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Derivatives – Foreign exchange (1)	$	27.1	$	—	$	27.1	$	—
Other (2)	32.3		32.3		—		—
Total assets	$	59.4	$	32.3	$	27.1	$	—
Liabilities
Derivatives – Commodities:
Energy contracts (1)	$	2.8	$	—	$	2.8	$	—
Derivatives – Foreign exchange (1)	4.2		—		4.2		—
Other (3)	35.2		34.6		0.6		—
Total liabilities	$	42.2	$	34.6	$	7.6	$	—

____________________

(1) See the Fair Value of Derivative Instruments table within this Note for classifications on the condensed consolidated balance sheet.

(2) Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheet. Both the asset and liability are recorded at fair value. Asset amounts included in “Other assets” in the condensed consolidated balance sheets.

(3) Consists of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts due are included in “Other long-term liabilities” in the condensed consolidated balance sheets. Level 2 liabilities represent liability-based awards associated with non-employees.

(in Millions)	December 31, 2014		Quoted Prices in  Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Derivatives – Commodities:
Derivatives – Foreign exchange (1)	$	28.6	$	—	$	28.6	$	—
Other (2)	30.9		30.9		—		—
Total assets	$	59.5	$	30.9	$	28.6	$	—
Liabilities
Derivatives – Commodities:
Energy contracts (1)	$	7.3	$	—	$	7.3	$	—
Derivatives – Foreign exchange (1)	113.8		—		113.8		—
Other (3)	33.7		33.1		0.6		—
Total liabilities	$	154.8	$	33.1	$	121.7	$	—

____________________

(1) See the Fair Value of Derivative Instruments table within this Note for classification on the condensed consolidated balance sheet.

(2) Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheet. Both the asset and liability are recorded at fair value. Asset amounts included in “Other assets” in the condensed consolidated balance sheets.

(3) Consist of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts included in “Other long-term liabilities” in the condensed consolidated balance sheets.

Fair Value Measurements, Nonrecurring

The following tables present our fair value hierarchy for those assets and liabilities measured at fair value on a non-recurring basis in the condensed consolidated balance sheets during the three months ended March 31, 2015 and the year ended December 31, 2014.

(in Millions)	March 31, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Gains (Losses) (Three Months Ended March 31, 2015)
Assets
Long-lived assets associated with exit activities (1)	$	—	$	—	$	—	$	—	$	(1.2	)
Total assets	$	—	$	—	$	—	$	—	$	(1.2	)

____________________

(1) We recorded charges, within our FMC Health and Nutrition segment, to write down the value of certain long-lived assets to zero related to our FMC Health and Nutrition restructuring as they have no future use. See Note 7 for more information.

(in Millions)	December 31, 2014		Quoted Prices in  Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Gains (Losses) (Year Ended December 31, 2014)
Assets
Long-lived assets associated with exit activities (1)	$	—	$	—	$	—	$	—	$	(3.1	)
Total assets	$	—	$	—	$	—	$	—	$	(3.1	)

____________________

(1) We recorded charges, within our FMC Health and Nutrition segment, to write down the value of certain long-lived assets to zero related to our FMC Health and Nutrition restructuring as they have no future use. See Note 7 for more information.

XML

Discontinued Operations (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Dec. 31, 2014
Results of discontinued FMC ACD operations:
Total discontinued operations, net of income taxes	$ 15,600,000		$ (28,200,000)
Major classes of assets and liabilities:
Current assets of discontinued operations held for sale (primarily trade receivables and inventories)	611,800,000				203,300,000
Current liabilities of discontinued operations held for sale	(79,800,000)				(88,400,000)
Noncurrent liabilities of discontinued operations held for sale	0				(4,700,000)
Proceeds from FMC Peroxygens divestiture	0		199,100,000
Discontinued Operations, tax effect of workers' compensation, product liability and other postretirement benefits	(300,000)		0
Discontinued Operation, tax effect of provision for environmental and legal	1,900,000		2,700,000
Discontinued Operations, tax effect of provision for legal expenses	(100,000)		2,300,000
Discontinued Operation, Tax Effect of Discontinued Operation	(400,000)		(4,700,000)
Discontinued Operations, tax effect of Peroxygens Segment Operations	0		(29,300,000)
Discontinued workers' compensation, product liability and other postretirement benefits [Member]
Results of discontinued FMC ACD operations:
Total discontinued operations, net of income taxes	(2,500,000)		(1,500,000)
Discontinued Environmental Liabilities [Member]
Results of discontinued FMC ACD operations:
Total discontinued operations, net of income taxes	(600,000)	[1]	(4,800,000)	[1]
Discontinued Legal Expenses [Member]
Results of discontinued FMC ACD operations:
Total discontinued operations, net of income taxes	100,000		(3,800,000)
FMC Alkali Chemicals division [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax proceeds on sale of ACD	1,600,000,000
After-tax proceeds on sales of ACD	1,200,000,000
Results of discontinued FMC ACD operations:
Revenue	194,000,000		184,900,000
Costs of sales and services	149,200,000		149,500,000
Income (loss) from discontinued operations before income taxes	19,000,000	[2]	28,200,000	[2]
Provision for income taxes	400,000		4,700,000
Total discontinued operations, net of income taxes	18,600,000		23,500,000
Less: discontinued operations of FMC ACD attributable to noncontrolling interests	0		1,600,000
Discontinued operations of FMC ACD, net of income taxes, attributable to FMC Stockholders	18,600,000		21,900,000
Profit before tax attributable to noncontrolling interest holders	0		1,900,000
Allocated interest expense	2,200,000		1,900,000
Divestiture related costs	11,300,000		0
Pension curtailment charge	5,300,000		0
Major classes of assets and liabilities:
Current assets of discontinued operations held for sale (primarily trade receivables and inventories)	205,700,000				203,300,000
Property, plant & equipment	383,200,000	[3]			378,600,000	[3]
Other non-current assets	22,900,000	[3]			22,900,000	[3]
Total assets of discontinued operations held for sale	611,800,000	[4]			604,800,000	[4]
Current liabilities of discontinued operations held for sale	(70,700,000)				(88,400,000)
Noncurrent liabilities of discontinued operations held for sale	(9,100,000)	[3]			(4,700,000)	[3]
Total liabilities of discontinued operations held for sale	(79,800,000)	[4]			(93,100,000)	[4]
Net Assets	532,000,000				511,700,000
FMC Peroxygens [Member]
Results of discontinued FMC ACD operations:
Total discontinued operations, net of income taxes	0	[5]	(40,000,000)	[5]
Major classes of assets and liabilities:
Proceeds from FMC Peroxygens divestiture			199,100,000
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax			10,100,000
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax			$ 33,400,000

[1] See a roll forward of our environmental reserves as well as discussion on significant environmental issues that occurred during the 2015 in Note 10.

[2] allocated interest expense of $2.2 million and $1.9 million, divestiture related charges of $11.3 million and zero and a pension curtailment charge of $5.3 million and zero for the three months ended March 31, 2015 and 2014, respectively. Interest was allocated in accordance with relevant discontinued operations accounting guidance.

[3] Presented as "Noncurrent assets\liabilities of discontinued operations held for sale" on the condensed consolidated balance sheet as of December 31, 2014.

[4] Presented as "Current assets\liabilities of discontinued operations held for sale" on the condensed consolidated balance sheet as of March 31, 2015.

[5] On February 28, 2014, we completed the sale of our FMC Peroxygens business for $199.1 million in cash to One Equity Partners (OEP), the private investment arm of J.P. Morgan Chase & Co. The sale resulted in a further pre-tax loss of $10.1 million ($33.4 million net of tax). The net of tax loss was driven by the final allocation of the $199.1 million of proceeds.

XML

Property, Plant and Equipment (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Property, plant and equipment:
Property, plant and equipment	$ 1,580.9	$ 1,618.7
Accumulated depreciation	(678.3)	(688.7)
Property, plant and equipment, net	$ 902.6	$ 930.0

XML

Environmental Obligations (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Dec. 31, 2014
Accrual for Environmental Loss Contingencies [Roll Forward]
Environmental reserves, long-term continuing and discontinued, net of recoveries	$ 190.9				$ 209.9
Environmental loss contingencies, net of expected recoveries, in excess of accrual	210
Recorded Recoveries [Roll Forward]
Environmental charges, net	4.4		8.9
Continuing Operations [Member]
Recorded Recoveries [Roll Forward]
Environmental charges, net	1.9	[1]	1.4	[1]
Discontinued Operations [Member]
Recorded Recoveries [Roll Forward]
Environmental charges, net	2.5	[2]	7.5	[2]
Other Liabilities [Member]
Recorded Recoveries [Roll Forward]
Environmental charges, net	4.4	[3]	8.9	[3]
Other Assets [Member]
Recorded Recoveries [Roll Forward]
Environmental Recoveries, beginning	29.9
Increase in Recoveries	0
Cash Received	(3.6)
Environmental Recoveries, ending	26.3
Environmental charges, net	0	[4]	0	[4]
Gross [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Total environmental reserves at December 31, 2014	296.2
Provision/(benefit)	4.4
(Spending)/recoveries	(7.7)
Total environmental reserves at March 31, 2015	292.9
Environmental reserves, current, net of recoveries (1)	96.4	[5]
Environmental reserves, long-term continuing and discontinued, net of recoveries	196.5	[6]
Total environmental reserves, net of recoveries at end of period	292.9
Recoveries [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Total environmental reserves at December 31, 2014	(11.9)	[7]
Provision/(benefit)	0	[7]
(Spending)/recoveries	1.0	[7]
Total environmental reserves at March 31, 2015	(10.9)	[7]
Environmental reserves, current, net of recoveries (1)	(5.3)	[5],[7]
Environmental reserves, long-term continuing and discontinued, net of recoveries	(5.6)	[6],[7]
Total environmental reserves, net of recoveries at end of period	(10.9)	[7]
Net [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Total environmental reserves at December 31, 2014	284.3
Provision/(benefit)	4.4
(Spending)/recoveries	(6.7)
Total environmental reserves at March 31, 2015	282.0
Environmental reserves, current, net of recoveries (1)	91.1	[5]
Environmental reserves, long-term continuing and discontinued, net of recoveries	190.9	[6]
Total environmental reserves, net of recoveries at end of period	$ 282.0

[1] Recorded as a component of “Restructuring and other charges (income)” on the condensed consolidated statements of income (loss). See Note 7. Environmental obligations for continuing operations primarily represent obligations at shut down or abandoned facilities within businesses that do not meet the criteria for presentation as discontinued operations.

[2] Recorded as a component of “Discontinued operations, net of income taxes" on the condensed consolidated statements of income (loss). See Note 9.

[3] See above roll forward of our total environmental reserves as presented on the condensed consolidated balance sheets.

[4] See above roll forward of our total environmental recoveries as presented on the condensed consolidated balance sheets.

[5] These amounts are included within "Accrued and other liabilities" on the condensed consolidated balance sheets.

[6] These amounts are included in “Environmental liabilities, continuing and discontinued” on the condensed consolidated balance sheets.

[7] These recorded recoveries represent probable realization of claims against U.S. government agencies and are recorded as an offset to our environmental reserves in the condensed consolidated balance sheets.

XML

Goodwill and Intangible Assets Goodwill and Intangible Assets, by Segment (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Finite-Lived	$ 173.0	$ 183.5
Indefinite Life	60.5
FMC Agricultural Solutions [Member]
Finite-Lived	97.4
Indefinite Life	35.2
FMC Health and Nutrition [Member]
Finite-Lived	74.4
Indefinite Life	25.3
FMC Lithium [Member]
Finite-Lived	1.2
Indefinite Life	$ 0

XML

Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2015

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]

The results of our discontinued FMC ACD operations are summarized below:

(in Millions)	Three Months Ended March 31
	2015		2014
Revenue	$	194.0	$	184.9
Costs of sales and services	149.2		149.5
Income (loss) from discontinued operations before income taxes (1)	19.0		28.2
Provision for income taxes	0.4		4.7
Total discontinued operations of FMC ACD, net of income taxes	$	18.6	$	23.5
Less: discontinued operations of FMC ACD attributable to noncontrolling interests	$	—	$	1.6
Discontinued operations of FMC ACD, net of income taxes, attributable to FMC Stockholders	$	18.6	$	21.9

____________________

(1) Amounts include approximately zero and $1.9 million attributable to noncontrolling interests, allocated interest expense of $2.2 million and $1.9 million, divestiture related charges of $11.3 million and zero and a pension curtailment charge of $5.3 million and zero for the three months ended March 31, 2015 and 2014, respectively. Interest was allocated in accordance with relevant discontinued operations accounting guidance.

The following table presents the major classes of assets and liabilities of FMC Alkali Chemicals:

(in Millions)	March 31, 2015			December 31, 2014
Assets
Current assets of discontinued operations held for sale (primarily trade receivables and inventories)	$	205.7		$	203.3
Property, plant & equipment (1)	383.2			378.6
Other non-current assets (1)	22.9			22.9
Total assets of discontinued operations held for sale (2)	$	611.8		$	604.8
Liabilities
Current liabilities of discontinued operations held for sale	(70.7		)	(88.4		)
Noncurrent liabilities of discontinued operations held for sale (1)	(9.1		)	(4.7		)
Total liabilities of discontinued operations held for sale (2)	$	(79.8	)	$	(93.1	)
Net Assets	$	532.0		$	511.7

____________________

(1)     Presented as "Noncurrent assets\liabilities of discontinued operations held for sale" on the condensed consolidated balance sheet as

of December 31, 2014.

(2)    Presented as "Current assets\liabilities of discontinued operations held for sale" on the condensed consolidated balance sheet as of

March 31, 2015.

In addition to our discontinued FMC Alkali Chemicals division our other discontinued operations include adjustments to retained liabilities. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

Our discontinued operations comprised the following:

(in Millions)	Three Months Ended March 31
	2015			2014
Adjustment for workers’ compensation, product liability, other postretirement benefits and other, net of income tax benefit (expense) of ($0.3) and zero for the three months ended March 31, 2015 and 2014, respectively	$	(2.5	)	$	(1.5	)
Provision for environmental liabilities, net of recoveries, net of income tax benefit of $1.9 and $2.7 for the three months ended March 31, 2015 and 2014, respectively (1)	(0.6		)	(4.8		)
Provision for legal reserves and expenses, net of recoveries, net of income tax benefit (expense) of ($0.1) and $2.3 for the three months ended March 31, 2015 and 2014, respectively	0.1			(3.8		)
Discontinued operations of FMC Alkali Chemicals, net of income tax benefit (expense) of ($0.4) and ($4.7) for the three months ended March 31, 2015 and 2014, respectively	18.6			21.9
Discontinued operations of FMC Peroxygens, net of income tax benefit (expense) of zero and ($29.3) for the three months ended March 31, 2015 and 2014, respectively (2)	—			(40.0		)
Discontinued operations, net of income taxes	$	15.6		$	(28.2	)

____________________

(1) See a roll forward of our environmental reserves as well as discussion on significant environmental issues that occurred during the 2015 in Note 10.

(2) On February 28, 2014, we completed the sale of our FMC Peroxygens business for $199.1 million in cash to One Equity Partners (OEP), the private investment arm of J.P. Morgan Chase & Co. The sale resulted in a further pre-tax loss of $10.1 million ($33.4 million net of tax). The net of tax loss was driven by the final allocation of the $199.1 million of proceeds.

XML

Equity Rollforward of Stockholders Equity (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance at December 31, 2014	$ 1,564.0
Net income (loss)	(45.5)		70.4
Stock compensation plans	8.1
Excess tax benefits from share-based compensation	1.7
Shares for benefit plan trust	(0.2)
Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax	5.8	[1]	6.5
Net hedging gains/(losses) and other, net of income tax	0.5	[1]	3.6
Foreign currency translation adjustments	(40.0)	[1]
Dividends ($0.165 per share)	(22.1)
Repurchases of common stock	(2.9)
Balance at March 31, 2015	1,469.4
Dividends paid (in USD per share)	$ 0.165
FMC Shareholders' Equity [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance at December 31, 2014	1,530.5
Net income (loss)	(46.8)
Stock compensation plans	8.1
Excess tax benefits from share-based compensation	1.7
Shares for benefit plan trust	(0.2)
Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax	5.8	[1]
Net hedging gains/(losses) and other, net of income tax	0.5	[1]
Foreign currency translation adjustments	(39.7)	[1]
Dividends ($0.165 per share)	(22.1)
Repurchases of common stock	(2.9)
Balance at March 31, 2015	1,434.9
Noncontrolling Interest [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance at December 31, 2014	33.5
Net income (loss)	1.3
Stock compensation plans	0
Excess tax benefits from share-based compensation	0
Shares for benefit plan trust	0
Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax	0	[1]
Net hedging gains/(losses) and other, net of income tax	0	[1]
Foreign currency translation adjustments	(0.3)	[1]
Dividends ($0.165 per share)	0
Repurchases of common stock	0
Balance at March 31, 2015	$ 34.5

[1] See condensed consolidated statements of comprehensive income (loss).

XML

Segment Information

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment Information

Segment Information

(in Millions)	Three Months Ended March 31
	2015			2014
Revenue
FMC Agricultural Solutions	$	392.4		$	466.9
FMC Health and Nutrition	211.0			226.2
FMC Lithium	56.0			63.8
Eliminations	—			—
Total	$	659.4		$	756.9
Income from continuing operations before income taxes
FMC Agricultural Solutions	$	81.8		$	120.1
FMC Health and Nutrition	51.0			50.9
FMC Lithium	5.5			6.6
Eliminations	—			—
Segment operating profit	$	138.3		$	177.6
Corporate and other	(15.3		)	(17.4		)
Operating profit before the items listed below	$	123.0		$	160.2
Interest expense, net	(14.0		)	(11.6		)
Restructuring and other (charges) income (1)	(22.3		)	(6.7		)
Non-operating pension and postretirement (charges) income (2)	(6.2		)	(4.2		)
Business separation costs (3)	—			(3.0		)
Acquisition related charges (4)	(190.7		)	(3.1		)
Provision for income taxes	49.1			(34.6		)
Discontinued operations, net of income taxes	15.6			(26.6		)
Net income attributable to noncontrolling interests	(1.3		)	(4.8		)
Net income (loss) attributable to FMC stockholders	$	(46.8	)	$	65.6

_________________________________________

(1) See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended March 31, 2015, relate to FMC Agricultural Solutions of $18.3 million, FMC Health and Nutrition of $2.2 million, FMC Lithium of $0.3 million and Corporate of $1.5 million. Amounts for the three months ended March 31, 2014, relate to FMC Health and Nutrition of $4.9 million, FMC Lithium of $0.1 million, and Corporate of $1.7 million.

(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss). 

(3) On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three months ended March 31, 2014 represent charges associated with the planned separation activities through March 31, 2014.

(4) Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, legal and professional fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following:

	Three Months Ended
	March 31
(in Millions)	2015		2014
Acquisition related charges - Cheminova
Legal and professional fees (1)	$	10.6	$	—
Loss/(gain) on hedging purchase price (1)	180.1		—
Acquisition related charges - Epax
Inventory fair value step-up amortization (2)	—		3.1
Acquisition/divestiture related charges	$	190.7	$	3.1

____________________

(1)    On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative

expense.” For more information on the loss on purchase price hedge see Note 3.

(2)    On the condensed consolidated statements of income (loss), these charges are included in “Costs of sales and services.”

XML

Restructuring and Other Charges (Income) - Activity (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Restructuring Cost and Reserve [Line Items]
Severance and Employee Benefits	$ 4.4	[1]	$ 4.9	[1]
Other Charges (Income)	(0.2)	[2]	0.4	[2]
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down	1.2	[3]	0	[3]
Restructuring Charges and Asset Disposals	5.4		5.3
Environmental charges, net	4.4		8.9
Other, net	15.0		0
Other charges (income), net	16.9		1.4
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	10.3	[4]
Restructuring Charges and Asset Disposals	4.2	[5]
Restructuring Reserve, Settled with Cash	(3.1)
Restructuring Reserve, Translation Adjustment	0.3	[6]
Restructuring Reserve, Ending Balance	11.7	[4]
Continuing Operations [Member]
Restructuring Cost and Reserve [Line Items]
Environmental charges, net	1.9	[7]	1.4	[7]
Health and Nutrition Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Severance and Employee Benefits	0.8	[1]	4.9	[1]
Other Charges (Income)	0.1	[2]	0	[2]
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down	1.2	[3]	0	[3]
Restructuring Charges and Asset Disposals	2.1		4.9
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	4.6	[4]
Restructuring Charges and Asset Disposals	0.9	[5]
Restructuring Reserve, Settled with Cash	(1.8)
Restructuring Reserve, Translation Adjustment	0.2	[6]
Restructuring Reserve, Ending Balance	3.9	[4]
Lithium Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Severance and Employee Benefits	0.3	[1]	0	[1]
Other Charges (Income)	0	[2]	0.1	[2]
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down	0	[3]	0	[3]
Restructuring Charges and Asset Disposals	0.3		0.1
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	0.2	[4]
Restructuring Charges and Asset Disposals	0.3	[5]
Restructuring Reserve, Settled with Cash	(0.1)
Restructuring Reserve, Translation Adjustment	0	[6]
Restructuring Reserve, Ending Balance	0.4	[4]
Other Restructuring Activities [Member]
Restructuring Cost and Reserve [Line Items]
Severance and Employee Benefits	3.3	[1]	0	[1]
Other Charges (Income)	(0.3)	[2]	0.3	[2]
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down	0	[3]	0	[3]
Restructuring Charges and Asset Disposals	3.0		0.3
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	2.8	[4],[8]
Restructuring Charges and Asset Disposals	3.0	[5],[8]
Restructuring Reserve, Settled with Cash	(1.1)	[8]
Restructuring Reserve, Translation Adjustment	0.4	[6],[8]
Restructuring Reserve, Ending Balance	5.1	[4]
Discontinued Operations [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	2.7	[4],[9]
Restructuring Charges and Asset Disposals	0	[5],[9]
Restructuring Reserve, Settled with Cash	(0.1)	[9]
Restructuring Reserve, Translation Adjustment	(0.3)	[6],[9]
Restructuring Reserve, Ending Balance	$ 2.3	[4],[9]

[1] Represents severance and employee benefit charges. Income represents adjustments to previously recorded severance and employee benefits.

[2] Primarily represents costs associated with lease payments, contract terminations, and other miscellaneous exit costs. Other Income primarily represents favorable developments on previously recorded exit costs as recoveries associated with restructuring.

[3] Primarily represents accelerated depreciation and impairment charges on long-lived assets, which were or are to be abandoned. To the extent incurred, the acceleration effect of re-estimating settlement dates and revised cost estimates associated with asset retirement obligations due to facility shutdowns are also included within the asset disposal charges.

[4] Included in “Accrued and other liabilities” on the condensed consolidated balance sheets.

[5] Primarily severance, exited lease, contract termination and other miscellaneous exit costs. Any accelerated depreciation and impairment charges noted above impacted our property, plant and equipment balances and are not included in the above tables.

[6] Primarily foreign currency translation adjustments.

[7] Recorded as a component of “Restructuring and other charges (income)” on the condensed consolidated statements of income (loss). See Note 7. Environmental obligations for continuing operations primarily represent obligations at shut down or abandoned facilities within businesses that do not meet the criteria for presentation as discontinued operations.

[8] Primarily severance costs related to workforce reductions and facility shutdowns noted in the “Other Items” sections above.

[9] Cash spending associated with restructuring activities of discontinued operations is reported within Payments of other discontinued reserves, net of recoveries on the condensed consolidated statements of cash flows.

XML

Acquisitions (Details)		7 Months Ended			3 Months Ended	0 Months Ended		3 Months Ended								12 Months Ended
	Sep. 08, 2014 USD ($)	Mar. 31, 2015 Denmark, Kroner	Sep. 08, 2014 Denmark, Kroner	Mar. 31, 2015 United States of America, Dollars	Mar. 31, 2015 Cheminova [Member] DKK	Apr. 21, 2015 Cheminova [Member] Subsequent Event [Member] USD ($)	Apr. 21, 2015 Cheminova [Member] Subsequent Event [Member] USD ($)	Mar. 31, 2015 Not Designated as Hedging Instrument [Member] USD ($)		Mar. 31, 2014 Not Designated as Hedging Instrument [Member] USD ($)		Mar. 31, 2015 Foreign Exchange Contract [Member] Not Designated as Hedging Instrument [Member] Selling, General and Administrative Expenses [Member] USD ($)		Mar. 31, 2014 Foreign Exchange Contract [Member] Not Designated as Hedging Instrument [Member] Selling, General and Administrative Expenses [Member] USD ($)		Dec. 31, 2014 Foreign Exchange Contract [Member] Not Designated as Hedging Instrument [Member] Selling, General and Administrative Expenses [Member] USD ($)
Business Acquisition [Line Items]
Percentage of voting interests acquired (percent)							100.00%
Aggregate purchase price					8,500,000,000	$ 1,200,000,000
Hedge-related costs							600,000,000
Planned aggregate purchase price to acquire business	1,470,000,000
Planned aggregate purchase price net of debt	300,000,000
Foreign currency exchange ratio		6.88	5.77	1.00
Foreign currency exchange rate improvement for US dollar (percent)		19.00%
Gain (loss) on FX forward contracts								$ 184,600,000	[1]	$ (4,900,000)	[1]	$ 180,100,000	[1],[2]	$ 0	[1],[2]	$ 99,600,000	[1],[2]

[1] Amounts in the columns represent the gain or loss on the derivative instrument offset by the gain or loss on the hedged item.

[2] Charges represent a loss on hedging the purchase price of the Cheminova A/S acquisition. See Note 3 within these condensed consolidated financial statements for more information.

XML

Pensions and Other Postretirement Benefits (Tables)

3 Months Ended

Mar. 31, 2015

Pensions and Other Postretirement Benefits [Abstract]

Components of net annual benefit cost (income)

The following table summarizes the components of net annual benefit cost (income) for the three months ended March 31, 2015 and 2014:

(in Millions)	Three Months Ended March 31
	Pensions						Other Benefits
	2015			2014			2015			2014
Components of net annual benefit cost (income):
Service cost	$	4.1		$	4.9		$	—		$	—
Interest cost	15.4			15.5			0.3			0.3
Expected return on plan assets	(22.2		)	(21.6		)	—			—
Amortization of prior service cost (credit)	0.3			0.4			0.1			—
Recognized net actuarial and other (gain) loss	12.9			7.8			(0.2		)	(0.4		)
Recognized loss due to curtailment (1)	4.8			—			0.5			—
Recognized loss due to settlement (2)	—			1.6			—			—
Net periodic benefit cost (3)	$	15.3		$	8.6		$	0.7		$	(0.1	)

____________________

(1) Curtailment loss is associated with the disposal of our FMC Alkali Chemicals division and was recorded to discontinued operations within the condensed consolidated statements of income (loss).

(2) Settlement charge is associated with the acceleration of previously deferred pension actuarial losses and was triggered by a lump-sum payout to certain former executives.

(3) Net periodic benefit cost represent both continuing and discontinued operations.

XML

Debt, Long-term (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Dec. 31, 2014
Debt Instrument [Line Items]
Total long-term debt	$ 1,152,600,000		$ 1,155,400,000
Less: debt maturing within one year	1,700,000		2,000,000
Total long-term debt, less current portion	1,150,900,000		1,153,400,000
Pollution Control and Industrial Revenue Bonds [Member]
Debt Instrument [Line Items]
Interest rate percentage, minimum	0.20%
Interest rate percentage, maximum	6.50%
Maturity date, minimum	2021
Maturity date, maximum	2035
Total long-term debt	141,600,000		141,500,000
Unamortized discount	200,000		200,000
Senior Notes [Member]
Debt Instrument [Line Items]
Interest rate percentage, minimum	3.95%
Interest rate percentage, maximum	5.20%
Maturity date, minimum	2019
Maturity date, maximum	2024
Total long-term debt	998,100,000		998,100,000
Unamortized discount	1,900,000		1,900,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate percentage	2.60%
Debt Instrument, Maturity Year	2019
Total long-term debt	0	[1]	0	[1]
Covenant Terms, Maximum Leverage Ratio	3.5
Covenant Terms, Minimum Interest Coverage Ratio	3.5
Foreign Debt [Member]
Debt Instrument [Line Items]
Interest rate percentage, minimum	0.00%
Interest rate percentage, maximum	9.30%
Maturity date, minimum	2015
Maturity date, maximum	2024
Total long-term debt	12,900,000		15,800,000
Term Loan Facility [Member]
Debt Instrument [Line Items]
Term notes	1,650,000,000
Covenant Terms, Maximum Leverage Ratio	4.5
Covenant Terms, Minimum Interest Coverage Ratio	3.5
Term Loan, Cross-Default Provision, Amount	$ 50,000,000
Eurocurrency One-Month Rate [Member] | Term Loan Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.00%

[1] Letters of credit outstanding under our Credit Facility totaled $100.1 million and available funds under this facility were $534.8 million at March 31, 2015 (which reflects borrowings under our commercial paper program).

XML

Guarantees, Commitments, and Contingencies, Guarantees (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015
Guarantor Obligations [Line Items]
Guarantees	$ 95.1
Guarantees of Vendor Financing [Member]
Guarantor Obligations [Line Items]
Guarantees	67.4	[1]
Guarantee Type, Other [Member]
Guarantor Obligations [Line Items]
Guarantees	$ 27.7	[2]

[1] Represents guarantees to financial institutions on behalf of certain FMC Agricultural Solutions customers for their seasonal borrowing. This amount is recorded on the condensed consolidated balance sheets as “Guarantees of vendor financing”.

[2] These guarantees represent support provided to third-party banks for credit extended to various FMC Agricultural Solutions customers and nonconsolidated affiliates. The liability for the guarantees is recorded at an amount that approximates fair-value (i.e. representing the stand-ready obligation) based on our historical collection experience and a current assessment of credit exposure. We believe the fair-value of these guarantees is immaterial. The majority of these guarantees have an expiration date of less than one year.

XML

Pensions and Other Postretirement Benefits (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Pension Plan [Member]
Components of net annual benefit cost (income):
Service cost	$ 4.1		$ 4.9
Interest cost	15.4		15.5
Expected return on plan assets	(22.2)		(21.6)
Amortization of prior service cost (credit)	0.3		0.4
Recognized net actuarial and other (gain) loss	12.9		7.8
Recognized loss due to curtailment	4.8	[1]	0	[1]
Recognized loss due to settlement	0	[2]	1.6	[2]
Net periodic benefit cost	15.3	[3]	8.6	[3]
Other Postretirement Benefit Plan [Member]
Components of net annual benefit cost (income):
Service cost	0		0
Interest cost	0.3		0.3
Expected return on plan assets	0		0
Amortization of prior service cost (credit)	0.1		0
Recognized net actuarial and other (gain) loss	(0.2)		(0.4)
Recognized loss due to curtailment	0.5	[1]	0	[1]
Recognized loss due to settlement	0	[2]	0	[2]
Net periodic benefit cost	0.7	[3]	(0.1)	[3]
U.S. Defined Benefit Pension Plan [Member]
Pension and Other Postretirement Benefit Contributions [Abstract]
Voluntary cash contributions made to U.S. defined benefit pension plan	25.0		17.0
Estimated voluntary cash contributions during the year	$ 65

[1] Curtailment loss is associated with the disposal of our FMC Alkali Chemicals division and was recorded to discontinued operations within the condensed consolidated statements of income (loss).

[2] Settlement charge is associated with the acceleration of previously deferred pension actuarial losses and was triggered by a lump-sum payout to certain former executives.

[3] Net periodic benefit cost represent both continuing and discontinued operations.

XML

Inventories (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Inventories:
Finished goods	$ 287.8	$ 281.1
Work in process	243.9	248.8
Raw materials, supplies and other	274.5	242.1
First-in, first-out inventory	806.2	772.0
Less: Excess of first-in, first-out cost over last-in, first-out cost	(165.4)	(164.4)
Net inventories	$ 640.8	$ 607.6

XML

Financial Information and Accounting Policies

3 Months Ended

Mar. 31, 2015

Financial Information And Accounting Policies [Abstract]

Financial Information and Accounting Policies

Financial Information and Accounting Policies

In our opinion the condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) applicable to interim period financial statements and reflect all adjustments necessary for a fair statement of results of operations and cash flows for the three months ended March 31, 2015 and 2014, and our financial position as of March 31, 2015. All such adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the Notes. The results of operations for the three months ended March 31, 2015 and 2014 are not necessarily indicative of the results of operations for the full year. The condensed consolidated balance sheets as of March 31, 2015 and December 31, 2014, and the related condensed consolidated statements of income (loss), condensed consolidated statements of comprehensive income (loss) and condensed consolidated statements of cash flows for the three months ended March 31, 2015 and 2014, have been reviewed by our independent registered public accountants. The review is described more fully in their report included herein. Our accounting policies are set forth in detail in Note 1 to the consolidated financial statements included with our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2014 (the “2014 10-K”).

FMC Alkali Chemicals Division:

In February 2015, our FMC Alkali Chemicals division ("ACD") was classified as a discontinued operation. For more information on the discontinued operations see Note 9. As a result, our FMC Minerals segment, which previously included our FMC Alkali Chemicals and FMC Lithium divisions, was renamed FMC Lithium. We have recast all the data within this filing to reflect the changes in our reportable segments to conform to the current year presentation and to present ACD as a discontinued operation retrospectively for all periods presented.

XML

Income Taxes (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Income Tax [Line Items]
Continuing operations	$ (110.2)		$ 131.6
Income tax expense	(49.1)		34.6
Effective tax rate (percent)	44.60%		26.30%
Discrete Items, Before Tax:
Acquisition related charges	190.7	[1]	3.1	[1]
Currency remeasurement	6.3	[2]	0	[2]
Other discrete items	21.8		9.9
Tax only discrete items	0	[3]	0	[3]
Total discrete items	218.8		13.0
Continuing operations, before discrete items	108.6		144.6
Discrete Items, Tax:
Acquisition related charges	70.3	[1]	0.8	[1]
Currency remeasurement	(2.8)	[2]	0	[2]
Other discrete items	7.3		3.4
Tax only discrete items	3.0	[3]	0	[3]
Total discrete items	77.8		4.2
Continuing operations, before discrete items	28.7		38.8
Estimated Annualized Effective Tax Rate (EAETR) (percent)	26.40%		26.80%
Cheminova [Member]
Discrete Items, Tax:
Payments for cash flow hedge, accrued and paid in current period	$ 180.1	[4]	$ 0	[4]

[1] Acquisition related charges for the three months ended March 31, 2015 are primarily taxed at domestic tax rates resulting in material tax benefit. Charges include a $180.1 million loss on the hedge of the acquisition purchase price of Cheminova A/S, as noted in footnote (2) below hedge gains or losses are treated discretely for tax purposes. For more information on the hedge loss refer to Note 3.

[2] Represents transactions gains or losses on currency remeasurement, offset by the associated hedge gains or losses. Transaction gains or losses are considered non-taxable permanent items and their associated hedge gain or losses are treated discretely for tax purposes.

[3] Includes the tax effect of currency remeasurement associated with our foreign statutory operations that in accordance with GAAP income tax accounting guidance shall be treated discretely for tax purposes.

[4] On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expense.” For more information on the loss on purchase price hedge see Note 3.

XML

Goodwill and Intangible Assets, Goodwill (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015
Goodwill [Roll Forward]
Balance, December 31, 2014	$ 352.5
Foreign currency adjustments	(28.4)
Balance, March 31, 2015	324.1
FMC Agricultural Solutions [Member]
Goodwill [Roll Forward]
Balance, December 31, 2014	31.0
Foreign currency adjustments	0
Balance, March 31, 2015	31.0
FMC Health and Nutrition [Member]
Goodwill [Roll Forward]
Balance, December 31, 2014	321.5
Foreign currency adjustments	(28.4)
Balance, March 31, 2015	293.1
FMC Lithium [Member]
Goodwill [Roll Forward]
Balance, December 31, 2014	0
Foreign currency adjustments	0
Balance, March 31, 2015	$ 0

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2015

Inventory Disclosure [Abstract]

Schedule of inventories

Inventories consisted of the following:

(in Millions)	March 31, 2015			December 31, 2014
Finished goods	$	287.8		$	281.1
Work in process	243.9			248.8
Raw materials, supplies and other	274.5			242.1
First-in, first-out inventory	$	806.2		$	772.0
Less: Excess of first-in, first-out cost over last-in, first-out cost	(165.4		)	(164.4		)
Net inventories	$	640.8		$	607.6

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill by business segment

The changes in the carrying amount of goodwill by business segment for the three months ended March 31, 2015, are presented in the table below:

(in Millions)	FMC Agricultural Solutions		FMC Health and Nutrition			FMC Lithium		Total
Balance, December 31, 2014	$	31.0	$	321.5		$	—	$	352.5
Foreign currency adjustments	—		(28.4		)	—		(28.4		)
Balance, March 31, 2015	$	31.0	$	293.1		$	—	$	324.1

Schedule of Finite-Lived Intangible Assets

Our intangible assets, other than goodwill, consist of the following:

	March 31, 2015							December 31, 2014
(in Millions)	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (finite-lived)
Customer relationships	$	147.8	$	(24.6	)	$	123.2	$	152.8	$	(22.5	)	$	130.3
Patents	1.7		(0.2		)	1.5		1.7		(0.1		)	1.6
Brands (1)	1.2		(0.7		)	0.5		1.2		(0.6		)	0.6
Purchased and licensed technologies	71.7		(25.4		)	46.3		74.3		(24.5		)	49.8
Other intangibles	3.6		(2.1		)	1.5		3.6		(2.4		)	1.2
	$	226.0	$	(53.0	)	$	173.0	$	233.6	$	(50.1	)	$	183.5

Schedule of Indefinite-lived Intangible Assets

Intangible assets not subject to amortization (indefinite life)
Brands (1)	$	60.5				$	60.5	$	63.4				$	63.4
Total intangible assets	$	286.5	$	(53.0	)	$	233.5	$	297.0	$	(50.1	)	$	246.9

(1) Represents trademarks, trade names and know how.

Schedule of Intangible Assets by Segment

At March 31, 2015, the finite-lived and indefinite life intangibles were allocated among our business segments as follows:

(in Millions)	Finite-lived		Indefinite Life
FMC Agricultural Solutions	$	97.4	$	35.2
FMC Health and Nutrition	74.4		25.3
FMC Lithium	1.2		—
Total	$	173.0	$	60.5

XML

Earnings Per Share (Details) (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share [Abstract]
Antidilutive shares excluded from diluted EPS	1,635	312
Earnings attributable to FMC stockholders:
Income from continuing operations attributable to FMC stockholders	$ (62.4)	$ 93.8
Discontinued operations, net of income taxes	15.6	(28.2)
Net income (loss) attributable to FMC stockholders	(46.8)	65.6
Less: Distributed and undistributed earnings allocable to restricted award holders	0	(0.2)
Net income (loss) allocable to common stockholders	$ (46.8)	$ 65.4
Basic earnings per common share attributable to FMC stockholders:
Continuing operations (in USD per share)	$ (0.47)	$ 0.70
Discontinued operations (in USD per share)	$ 0.12	$ (0.21)
Net income (in USD per share)	$ (0.35)	$ 0.49
Diluted earnings per common share attributable to FMC stockholders:
Continuing operations (in USD per share)	$ (0.47)	$ 0.70
Discontinued operations (in USD per share)	$ 0.12	$ (0.21)
Net income (in USD per share)	$ (0.35)	$ 0.49
Shares:
Weighted average number of shares of common stock outstanding - Basic	133,577	133,139
Weighted average additional shares assuming conversion of potential common shares	0	1,114
Shares – diluted basis	133,577	134,253

XML

Goodwill and Intangible Assets, Finite-lived intangible Assets (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Gross	$ 226.0		$ 233.6
Accumulated Amortization	(53.0)		(50.1)
Net	173.0		183.5
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	147.8		152.8
Accumulated Amortization	(24.6)		(22.5)
Net	123.2		130.3
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	1.7		1.7
Accumulated Amortization	(0.2)		(0.1)
Net	1.5		1.6
Brands [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	1.2	[1]	1.2	[1]
Accumulated Amortization	(0.7)	[1]	(0.6)	[1]
Net	0.5	[1]	0.6	[1]
Purchased and Licensed Technologies [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	71.7		74.3
Accumulated Amortization	(25.4)		(24.5)
Net	46.3		49.8
Other Intangibles [Member]
Finite-Lived Intangible Assets [Line Items]
Gross	3.6		3.6
Accumulated Amortization	(2.1)		(2.4)
Net	$ 1.5		$ 1.2

[1] (1) Represents trademarks, trade names and know how.

XML

Property, Plant and Equipment (Tables)

3 Months Ended

Mar. 31, 2015

Property, Plant and Equipment [Abstract]

Schedule of property, plant and equipment

Property, plant and equipment consisted of the following:

(in Millions)	March 31, 2015			December 31, 2014
Property, plant and equipment	$	1,580.9		$	1,618.7
Accumulated depreciation	(678.3		)	(688.7		)
Property, plant and equipment, net	$	902.6		$	930.0

XML

Restructuring and Other Charges (Income) (Tables)

3 Months Ended

Mar. 31, 2015

Restructuring and Related Activities [Abstract]

Schedule of restructuring and other charges (income)

Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income) as noted below:

	Three Months Ended March 31
(in Millions)	2015		2014
Restructuring charges and asset disposals	$	5.4	$	5.3
Other charges (income), net	16.9		1.4
Total restructuring and other charges	$	22.3	$	6.7

Schedule of restructuring charges and asset disposals

	Restructuring Charges
(in Millions)	Severance and Employee Benefits (1)		Other Charges (Income) (2)			Asset Disposal Charges (3)		Total
Health and Nutrition Restructuring	$	0.8	$	0.1		$	1.2	$	2.1
Lithium Restructuring	0.3		—			—		0.3
Other Items	3.3		(0.3		)	—		3.0
Three months ended March 31, 2015	$	4.4	$	(0.2	)	$	1.2	$	5.4
Health and Nutrition Restructuring	4.9		—			—		4.9
Lithium Restructuring	—		0.1			—		0.1
Other Items	—		0.3			—		0.3
Three months ended March 31, 2014	$	4.9	$	0.4		$	—	$	5.3

____________________ 

(1) Represents severance and employee benefit charges. Income represents adjustments to previously recorded severance and employee benefits.

(2) Primarily represents costs associated with lease payments, contract terminations, and other miscellaneous exit costs. Other Income primarily represents favorable developments on previously recorded exit costs as recoveries associated with restructuring.

(3) Primarily represents accelerated depreciation and impairment charges on long-lived assets, which were or are to be abandoned. To the extent incurred, the acceleration effect of re-estimating settlement dates and revised cost estimates associated with asset retirement obligations due to facility shutdowns are also included within the asset disposal charges.

Restructuring reserve rollforward

The following table shows a roll forward of restructuring reserves, continuing and discontinued, that will result in cash spending. These amounts exclude asset retirement obligations.

(in Millions)	Balance at 12/31/14 (4)		Change in reserves (2)		Cash payments			Other (3)			Balance at 3/31/15 (4)
Health and Nutrition Restructuring	$	4.6	$	0.9	$	(1.8	)	$	0.2		$	3.9
Lithium Restructuring	0.2		0.3		(0.1		)	—			0.4
Other Workforce Related and Facility Shutdowns (1)	2.8		3.0		(1.1		)	0.4			5.1
Restructuring activities related to discontinued operations (5)	2.7		—		(0.1		)	(0.3		)	2.3
Total	$	10.3	$	4.2	$	(3.1	)	$	0.3		$	11.7

____________________ 

(1) Primarily severance costs related to workforce reductions and facility shutdowns noted in the “Other Items” sections above.

(2) Primarily severance, exited lease, contract termination and other miscellaneous exit costs. Any accelerated depreciation and impairment charges noted above impacted our property, plant and equipment balances and are not included in the above tables.

(3) Primarily foreign currency translation adjustments.

(4) Included in “Accrued and other liabilities” on the condensed consolidated balance sheets.

(5) Cash spending associated with restructuring activities of discontinued operations is reported within Payments of other discontinued reserves, net of recoveries on the condensed consolidated statements of cash flows.

Schedule of other charges (income), net

Other charges (income), net

	Three Months Ended March 31
(in Millions)	2015		2014
Environmental charges, net	$	1.9	$	1.4
Other items, net	15.0		—
Other charges (income), net	$	16.9	$	1.4

XML

Condensed Consolidated Statements of Cash Flows (Parenthetical) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Cash paid for interest, net of capitalized interest	$ 18.0		$ 11.2
Cash paid for taxes, net of refunds	11.1		25.3
Non-cash additions to property, plant and equipment	5.5		21.4
Cheminova [Member]
Change in other operating assets and liabilities, net, including cash flow hedge	93.8
Payments for cash flow hedge	273.8
Payments for cash flow hedge, accrued and paid in current period	$ 180.1	[1]	$ 0	[1]

[1] On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expense.” For more information on the loss on purchase price hedge see Note 3.

XML

Debt (Tables)

3 Months Ended

Mar. 31, 2015

Debt Disclosure [Abstract]

Debt Maturing within One Year

Debt maturing within one year:

(in Millions)	March 31, 2015		December 31, 2014
Short-term foreign debt (1)	$	40.5	$	36.6
Commercial paper (2)	865.1		486.6
Total short-term debt	$	905.6	$	523.2
Current portion of long-term debt	1.7		2.0
Short-term debt and current portion of long-term debt	$	907.3	$	525.2

____________________

(1) At March 31, 2015, the average interest rate on the borrowings was 4.50%. We often provide parent-company guarantees to lending institutions that extend credit to our foreign subsidiaries.

(2) At March 31, 2015, the average interest rate on the borrowings was 0.62%.

Schedule of long-term debt

Long-term debt:

(in Millions)	March 31, 2015
	Interest Rate Percentage		Maturity Date	3/31/2015		12/31/2014
Pollution control and industrial revenue bonds (less unamortized discounts of $0.2 and $0.2, respectively)	0.2-6.5%		2021-2035	$	141.6	$	141.5
Senior notes (less unamortized discount of $1.9 and $1.9, respectively)	3.95-5.2%		2019-2024	998.1		998.1
Credit Facility (1)	2.6	%	2019	—		—
Foreign debt	0-9.3%		2015-2024	12.9		15.8
Total long-term debt				$	1,152.6	$	1,155.4
Less: debt maturing within one year				1.7		2.0
Total long-term debt, less current portion				$	1,150.9	$	1,153.4

____________________

(1) Letters of credit outstanding under our Credit Facility totaled $100.1 million and available funds under this facility were $534.8 million at March 31, 2015 (which reflects borrowings under our commercial paper program).

XML

Guarantees, Commitments, and Contingencies (Tables)

3 Months Ended

Mar. 31, 2015

Commitments Guarantees and Contingent Liabilities [Abstract]

Schedule of estimated undiscounted potential future payments for guarantees

The following table provides the estimated undiscounted amount of potential future payments for each major group of guarantees at March 31, 2015. These guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates. Non-performance by the guaranteed party triggers the obligation requiring us to make payments to the beneficiary of the guarantee. Based on our experience these types of guarantees have not had a material effect on our consolidated financial position or on our liquidity. Our expectation is that future payment or performance related to the non-performance of others is considered unlikely.

(in Millions)
Guarantees:
Guarantees of vendor financing (1)	$	67.4
Other debt guarantees (2)	27.7
Total	$	95.1

____________________

(1) Represents guarantees to financial institutions on behalf of certain FMC Agricultural Solutions customers for their seasonal borrowing. This amount is recorded on the condensed consolidated balance sheets as “Guarantees of vendor financing”.

(2) These guarantees represent support provided to third-party banks for credit extended to various FMC Agricultural Solutions customers and nonconsolidated affiliates. The liability for the guarantees is recorded at an amount that approximates fair-value (i.e. representing the stand-ready obligation) based on our historical collection experience and a current assessment of credit exposure. We believe the fair-value of these guarantees is immaterial. The majority of these guarantees have an expiration date of less than one year.

XML

Debt, Credit Facility (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Line of Credit Facility [Line Items]
Line of Credit Facility, Covenant Compliance	Our actual leverage for the four consecutive quarters ended March 31, 2015, was 3.2 which is below the maximum leverage of 3.5. Our actual interest coverage for the four consecutive quarters ended March 31, 2015, was 11.7 which is above the minimum interest coverage of 3.5. We were in compliance with all covenants at March 31, 2015. We were in compliance with all covenants at March 31, 2015. Following the acquisition of Cheminova A/S (see Note 3), the maximum leverage covenant increased to 4.5 and will step down in accordance with the provisions of the Credit Facility.
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Letters of credit outstanding amount	100,100,000
Credit Agreement, available funds	534,800,000
Covenant compliance, actual leverage ratio	3.2
Covenant Terms, Maximum Leverage Ratio	3.5
Covenant compliance, actual interest coverage ratio	11.7
Covenant Terms, Minimum Interest Coverage Ratio	3.5
Covenant terms, maximum leverage ratio	4.5
Term Loan Facility [Member]
Line of Credit Facility [Line Items]
Covenant Terms, Maximum Leverage Ratio	4.5
Covenant Terms, Minimum Interest Coverage Ratio	3.5
Term notes	1,650,000,000
Term Loan, Cross-Default Provision, Amount	50,000,000
Term Loan Facility [Member] | Federal Funds Rate [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Term Loan Facility [Member] | Eurocurrency One-Month Rate [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.00%

XML

Condensed Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Income Statement [Abstract]
Revenue	$ 659.4		$ 756.9
Costs and Expenses
Costs of sales and services	408.7		463.9
Gross margin	250.7		293.0
Selling, general and administrative expenses	297.9		114.6
Research and development expenses	26.6		25.8
Restructuring and other charges (income)	22.3	[1]	6.7	[1]
Business separation costs	0	[2]	3.0	[2]
Total costs and expenses	755.5		614.0
Income from continuing operations before equity in (earnings) loss of affiliates, interest expense, net and income taxes	(96.1)		142.9
Equity in (earnings) loss of affiliates	0.1		(0.3)
Interest expense, net	14.0		11.6
Income (loss) from continuing operations before income taxes	(110.2)		131.6
Provision for income taxes	(49.1)		34.6
Income (loss) from continuing operations	(61.1)		97.0
Discontinued operations, net of income taxes	15.6		(26.6)
Net income (loss)	(45.5)		70.4
Less: Net income attributable to noncontrolling interests	1.3		4.8
Net income (loss) attributable to FMC stockholders	(46.8)		65.6
Amounts attributable to FMC stockholders:
Continuing operations, net of income taxes (benefit)	(62.4)		93.8
Discontinued operations, net of income taxes	15.6		(28.2)
Net income (loss) attributable to FMC stockholders	$ (46.8)		$ 65.6
Basic earnings (loss) per common share attributable to FMC stockholders:
Continuing operations (in USD per share)	$ (0.47)		$ 0.70
Discontinued operations (in USD per share)	$ 0.12		$ (0.21)
Net income (loss) attributable to FMC stockholders (in USD per share)	$ (0.35)		$ 0.49
Diluted earnings (loss) per common share attributable to FMC stockholders:
Continuing operations (in USD per share)	$ (0.47)		$ 0.70
Discontinued operations (in USD per share)	$ 0.12		$ (0.21)
Net income (loss) attributable to FMC stockholders (in USD per share)	$ (0.35)		$ 0.49

[1] See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended March 31, 2015, relate to FMC Agricultural Solutions of $18.3 million, FMC Health and Nutrition of $2.2 million, FMC Lithium of $0.3 million and Corporate of $1.5 million. Amounts for the three months ended March 31, 2014, relate to FMC Health and Nutrition of $4.9 million, FMC Lithium of $0.1 million, and Corporate of $1.7 million.

[2] On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three months ended March 31, 2014 represent charges associated with the planned separation activities through March 31, 2014.

XML

Goodwill and Intangible Assets, Indefinite Life Intangible Assets (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Indefinite-lived Intangible Assets by Segment [Line Items]
Gross	$ 60.5
Total intangible assets	286.5		297.0
Accumulated Amortization	(53.0)		(50.1)
Net intangible assets	233.5		246.9
Brands [Member]
Indefinite-lived Intangible Assets by Segment [Line Items]
Gross	$ 60.5	[1]	$ 63.4	[1]

[1] (1) Represents trademarks, trade names and know how.

XML

Condensed Consolidated Balance Sheets (Parentheticals) (USD $) In Millions, except Share data, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Allowance for Trade receivables	$ 34.9	$ 37.2
Preferred stock, par value (in USP per share)	$ 0	$ 0
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Common stock, par value (in USD per share)	$ 0.1	$ 0.10
Common stock, shares authorized	260,000,000	260,000,000
Common stock, shares issued	185,983,792	185,983,792
Treasury Stock, shares	52,449,627	52,666,121

XML

Equity Reclassification Out of Accumulated Other Comprehensive Income (Details) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Discontinued operations, net of income taxes	$ 15.6		$ (28.2)
Costs of sales and services	408.7		463.9
Selling, general and administrative expenses	297.9		114.6
Income from continuing operations before income taxes	(110.2)		131.6
Provision for income taxes	49.1		(34.6)
Amount included in net income	(45.5)		70.4
Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount included in net income	(9.9)	[1]	(56.7)	[1]
Foreign currency translation adjustments [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Discontinued operations, net of income taxes	0	[1],[2]	(49.6)	[1],[2]
Derivative Instruments [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income from continuing operations before income taxes	3.0	[1]	(1.5)	[1]
Provision for income taxes	(1.2)	[1]	0.4	[1]
Amount included in net income	1.8	[1]	(1.1)	[1]
Amortization of prior service costs [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Selling, general and administrative expenses	(0.4)	[1],[3]	(0.4)	[1],[3]
Amortization of unrecognized net actuarial and other gains (losses) [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Selling, general and administrative expenses	(12.7)	[1],[3]	(7.2)	[1],[3]
Recognized loss due to settlement and curtailment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Selling, general and administrative expenses	(5.3)	[1],[3],[4]	(1.6)	[1],[3]
Pension and other postretirement benefits [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income from continuing operations before income taxes	(18.4)	[1]	(9.2)	[1]
Provision for income taxes	6.7	[1]	3.2	[1]
Amount included in net income	(11.7)	[1]	(6.0)	[1]
Foreign currency contracts [Member] | Derivative Instruments [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Costs of sales and services	8.7	[1]	(0.9)	[1]
Selling, general and administrative expenses	(4.4)	[1]	(1.6)	[1]
Energy contracts [Member] | Derivative Instruments [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Costs of sales and services	(1.3)	[1]	1.0	[1]
FMC Alkali Chemicals division [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Discontinued operations, net of income taxes	18.6		23.5
FMC Alkali Chemicals division [Member] | Recognized loss due to settlement and curtailment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Selling, general and administrative expenses	$ (5.3)	[1],[3],[4]

[1] Amounts in parentheses indicate charges to the condensed consolidated statements of income (loss).

[2] The reclassification of historical cumulative translation adjustments was the result of the divestiture of our FMC Peroxygens business during the quarter ended March 31, 2014. The loss recognized from this reclassification is considered permanent for tax purposes and therefore no tax has been provided. See Note 9 for more information. In accordance with accounting guidance, this amount was previously factored into the lower of cost or fair value test associated with the 2013 Peroxygens' asset held for sale write-down charges.

[3] Pension and other postretirement benefits amounts include the impact from both continuing and discontinued operations. For detail on the continuing operations components of pension and other postretirement benefits, see Note 13.

[4] The $5.3 million loss due to curtailment for the three months ended March 31, 2015 related to the disposal of our FMC Alkali Chemicals division and was recorded to Discontinued operations, net of income taxes in the condensed statements of income (loss).

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Calculation of basic and diluted earnings per share

Earnings applicable to common stock and common stock shares used in the calculation of basic and diluted earnings per share are as follows:

(in Millions, Except Share and Per Share Data)	Three Months Ended March 31
	2015			2014
Earnings (loss) attributable to FMC stockholders:
Continuing operations, net of income taxes	$	(62.4	)	$	93.8
Discontinued operations, net of income taxes	15.6			(28.2		)
Net income (loss) attributable to FMC stockholders	$	(46.8	)	$	65.6
Less: Distributed and undistributed earnings allocable to restricted award holders	—			(0.2		)
Net income (loss) allocable to common stockholders	$	(46.8	)	$	65.4
Basic earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.47	)	$	0.70
Discontinued operations	0.12			(0.21		)
Net income (loss) attributable to FMC stockholders	$	(0.35	)	$	0.49
Diluted earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.47	)	$	0.70
Discontinued operations	0.12			(0.21		)
Net income (loss) attributable to FMC stockholders	$	(0.35	)	$	0.49
Shares (in thousands):
Weighted average number of shares of common stock outstanding - Basic	133,577			133,139
Weighted average additional shares assuming conversion of potential common shares	—			1,114
Shares – diluted basis	133,577			134,253

XML

Financial Instrument, Risk Management and Fair Value Measurements, Derivatives Gain (Loss) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				12 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Dec. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized hedging gains (losses) and other, net of tax	$ 2.3		$ 2.5
Effective portion	(1.8)	[1]	1.1	[1]
Total derivative instrument impact on comprehensive income	0.5	[2]	3.6
Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total derivative instrument impact on comprehensive income	(2.3)		2.9
Energy Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total derivative instrument impact on comprehensive income	2.8		0.7
Other Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total derivative instrument impact on comprehensive income	0		0
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized hedging gains (losses) and other, net of tax	0.3		1.1
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Foreign Exchange Contract [Member] | Cost of Sales and Services [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Effective portion	(2.6)	[1]	1.8	[1]
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Energy Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized hedging gains (losses) and other, net of tax	2.0		1.4
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Energy Contracts [Member] | Cost of Sales and Services [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Effective portion	0.8	[1]	(0.7)	[1]
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Other Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized hedging gains (losses) and other, net of tax	0		0
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Other Contract [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Effective portion	0	[1]	0	[1]
Derivatives Not Designated as Hedging Instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Pre-tax Gain or (Loss) Recognized in Income on Derivatives	(184.6)	[3]	4.9	[3]
Derivatives Not Designated as Hedging Instruments [Member] | Foreign Exchange Contract [Member] | Cost of Sales and Services [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Pre-tax Gain or (Loss) Recognized in Income on Derivatives	(4.5)	[3]	4.9	[3]
Derivatives Not Designated as Hedging Instruments [Member] | Foreign Exchange Contract [Member] | Selling, General and Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Pre-tax Gain or (Loss) Recognized in Income on Derivatives	$ (180.1)	[3],[4]	$ 0	[3],[4]	$ (99.6)	[3],[4]

[1] See Note 12 for classification of amounts within the condensed consolidated statements of income (loss).

[2] See condensed consolidated statements of comprehensive income (loss).

[3] Amounts in the columns represent the gain or loss on the derivative instrument offset by the gain or loss on the hedged item.

[4] Charges represent a loss on hedging the purchase price of the Cheminova A/S acquisition. See Note 3 within these condensed consolidated financial statements for more information.

XML

Income Taxes

3 Months Ended

Mar. 31, 2015

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

We determine our interim tax provision using an Estimated Annual Effective Tax Rate methodology (“EAETR”) in accordance with GAAP. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision.

The determination of the EAETR is based upon a number of estimates, including the estimated annual pretax ordinary income in each tax jurisdiction in which we operate. The tax effects of discrete items are recognized in the tax provision in the quarter they occur in accordance with GAAP. Depending on various factors such as the item’s significance in relation to total income and the rate of tax applicable in the jurisdiction to which it relates, discrete items in any quarter can materially impact the reported effective tax rate. As a global enterprise, our tax expense can be impacted by changes in tax rates or laws, the finalization of tax audits and reviews, as well as other factors. As such, there can be significant volatility in interim tax provisions.

The below chart provides reconciliation between our reported effective tax rates and the EAETR.

	Three Months Ended March 31
	2015								2014
(in Millions)	Before Tax			Tax			Effective Tax Rate % Impact		Before Tax		Tax		Effective Tax Rate % Impact
Continuing operations	(110.2		)	(49.1		)	44.6	%	131.6		34.6		26.3	%
Discrete items:
Acquisition related charges (1)	190.7			70.3					3.1		0.8
Currency remeasurement (2)	6.3			(2.8		)			—		—
Other discrete items	21.8			7.3					9.9		3.4
Tax only discrete items (3)	—			3.0					—		—
Total discrete items	$	218.8		$	77.8				$	13.0	$	4.2
Continuing operations, before discrete items	108.6			28.7					144.6		38.8
Estimated Annualized Effective Tax Rate (EAETR)							26.4	%					26.8	%

___________________ 

(1) Acquisition related charges for the three months ended March 31, 2015 are primarily taxed at domestic tax rates resulting in material tax benefit. Charges include a $180.1 million loss on the hedge of the acquisition purchase price of Cheminova A/S, as noted in footnote (2) below hedge gains or losses are treated discretely for tax purposes. For more information on the hedge loss refer to Note 3.

(2) Represents transactions gains or losses on currency remeasurement, offset by the associated hedge gains or losses. Transaction gains or losses are considered non-taxable permanent items and their associated hedge gain or losses are treated discretely for tax purposes.

(3) Includes the tax effect of currency remeasurement associated with our foreign statutory operations that in accordance with GAAP income tax accounting guidance shall be treated discretely for tax purposes.

XML

Equity (Tables)

3 Months Ended

Mar. 31, 2015

Equity [Abstract]

Schedule of Stockholders Equity

Refer to the table below for a reconciliation of equity, equity attributable to the parent, and equity attributable to noncontrolling interests for the three months ended March 31, 2015:

(in Millions, Except Per Share Data)	FMC Stockholders’ Equity			Noncontrolling Interest			Total Equity
Balance at December 31, 2014	$	1,530.5		$	33.5		$	1,564.0
Net income (loss)	(46.8		)	1.3			(45.5		)
Stock compensation plans	8.1			—			8.1
Excess tax benefits from share-based compensation	1.7			—			1.7
Shares for benefit plan trust	(0.2		)	—			(0.2		)
Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax (1)	5.8			—			5.8
Net hedging gains/(losses) and other, net of income tax (1)	0.5			—			0.5
Foreign currency translation adjustments (1)	(39.7		)	(0.3		)	(40.0		)
Dividends ($0.165 per share)	(22.1		)	—			(22.1		)
Repurchases of common stock	(2.9		)	—			(2.9		)
Balance at March 31, 2015	$	1,434.9		$	34.5		$	1,469.4

____________________

(1) See condensed consolidated statements of comprehensive income (loss).

Schedule of Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss)

Summarized below is the roll forward of accumulated other comprehensive income (loss), net of tax.

(in Millions)	Foreign currency adjustments			Derivative Instruments(1)			Pension and other postretirement benefits (2)			Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2014	$	(50.4	)	$	(3.9	)	$	(321.5	)	$	(375.8	)
2015 Activity
Other comprehensive income (loss) before reclassifications	(39.7		)	2.3			(5.9		)	$	(43.3	)
Amounts reclassified from accumulated other comprehensive income (loss)	—			(1.8		)	11.7			$	9.9
Accumulated other comprehensive income (loss), net of tax at March 31, 2015	$	(90.1	)	$	(3.4	)	$	(315.7	)	$	(409.2	)

(in Millions)	Foreign currency adjustments			Derivative Instruments (1)			Pension and other postretirement benefits (2)			Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2013	$	(25.3	)	$	(6.1	)	$	(170.5	)	$	(201.9	)
2014 Activity
Other comprehensive income (loss) before reclassifications	—			2.5			0.5			$	3.0
Amounts reclassified from accumulated other comprehensive income (loss)	49.6			1.1			6.0			$	56.7
Accumulated other comprehensive income (loss), net of tax at March 31, 2014	$	24.3		$	(2.5	)	$	(164.0	)	$	(142.2	)

____________________

(1)     See Note 15 for more information.

(2)    See Note 13 for more information.

Reclassification out of Accumulated Other Comprehensive Income

The table below provides details about the reclassifications from Accumulated Other Comprehensive Income and the affected line items in the condensed consolidated statements of income (loss) for each of the periods presented.

Details about Accumulated Other Comprehensive Income Components	Amounts Reclassified from Accumulated Other Comprehensive Income (1)						Affected Line Item in the Condensed Consolidated Statements of Income (Loss)
	Three Months Ended March 31
(in Millions)	2015			2014
Foreign currency translation adjustments:
Divestiture of FMC Peroxygens (3)	—			(49.6		)	Discontinued operations, net of income taxes
Derivative instruments:
Foreign currency contracts	$	8.7		$	(0.9	)	Costs of sales and services
Energy contracts	$	(1.3	)	$	1.0		Costs of sales and services
Foreign currency contracts	$	(4.4	)	$	(1.6	)	Selling, general and administrative expenses
Total before tax	$	3.0		$	(1.5	)
	$	(1.2	)	$	0.4		Provision for income taxes
Amount included in net income	$	1.8		$	(1.1	)
Pension and other postretirement benefits (2):
Amortization of prior service costs	$	(0.4	)	$	(0.4	)	Selling, general and administrative expenses
Amortization of unrecognized net actuarial and other gains (losses)	$	(12.7	)	$	(7.2	)	Selling, general and administrative expenses
Recognized loss due to settlement and curtailment	$	(5.3	)	$	(1.6	)	Selling, general and administrative expenses (4)
Total before tax	$	(18.4	)	$	(9.2	)
	$	6.7		$	3.2		Provision for income taxes
Amount included in net income	$	(11.7	)	$	(6.0	)
Total reclassifications for the period	$	(9.9	)	$	(56.7	)	Amount included in net income

____________________

(1) Amounts in parentheses indicate charges to the condensed consolidated statements of income (loss).

(2) Pension and other postretirement benefits amounts include the impact from both continuing and discontinued operations. For detail on the continuing operations components of pension and other postretirement benefits, see Note 13.

(3) The reclassification of historical cumulative translation adjustments was the result of the divestiture of our FMC Peroxygens business during the quarter ended March 31, 2014. The loss recognized from this reclassification is considered permanent for tax purposes and therefore no tax has been provided. See Note 9 for more information. In accordance with accounting guidance, this amount was previously factored into the lower of cost or fair value test associated with the 2013 Peroxygens' asset held for sale write-down charges.

(4) The $5.3 million loss due to curtailment for the three months ended March 31, 2015 related to the disposal of our FMC Alkali Chemicals division and was recorded to Discontinued operations, net of income taxes in the condensed statements of income (loss).

XML

Guarantees, Commitments, and Contingencies

3 Months Ended

Mar. 31, 2015

Commitments Guarantees and Contingent Liabilities [Abstract]

Guarantees, Commitments, and Contingencies

Guarantees, Commitments, and Contingencies

We continue to monitor the conditions that are subject to guarantees and indemnifications to identify whether a liability must be recognized in our financial statements.

Guarantees and Other Commitments

The following table provides the estimated undiscounted amount of potential future payments for each major group of guarantees at March 31, 2015. These guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates. Non-performance by the guaranteed party triggers the obligation requiring us to make payments to the beneficiary of the guarantee. Based on our experience these types of guarantees have not had a material effect on our consolidated financial position or on our liquidity. Our expectation is that future payment or performance related to the non-performance of others is considered unlikely.

(in Millions)
Guarantees:
Guarantees of vendor financing (1)	$	67.4
Other debt guarantees (2)	27.7
Total	$	95.1

____________________

(1) Represents guarantees to financial institutions on behalf of certain FMC Agricultural Solutions customers for their seasonal borrowing. This amount is recorded on the condensed consolidated balance sheets as “Guarantees of vendor financing”.

(2) These guarantees represent support provided to third-party banks for credit extended to various FMC Agricultural Solutions customers and nonconsolidated affiliates. The liability for the guarantees is recorded at an amount that approximates fair-value (i.e. representing the stand-ready obligation) based on our historical collection experience and a current assessment of credit exposure. We believe the fair-value of these guarantees is immaterial. The majority of these guarantees have an expiration date of less than one year.

Excluded from the chart above, in connection with our property and asset sales and divestitures, we have agreed to indemnify the buyer for certain liabilities, including environmental contamination and taxes that occurred prior to the date of sale or provided guarantees to third parties relating to certain contracts assumed by the buyer. Our indemnification or guarantee obligations with respect to these liabilities may be indefinite as to duration and may or may not be subject to a deductible, minimum claim amount or cap. As such, it is not possible for us to predict the likelihood that a claim will be made or to make a reasonable estimate of the maximum potential loss or range of loss. If triggered, we may be able to recover some of the indemnity payments from third parties. We have not recorded any specific liabilities for these guarantees.

Contingencies

A detailed discussion related to our outstanding contingencies can be found in Note 18 to our consolidated financial statements included within our 2014 Form 10-K. There have been no material changes related to our contingencies from the information reported in our 2014 10-K.

XML

Segment Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenue	$ 659.4		$ 756.9
Operating profit before the items listed below	123.0		160.2
Interest expense, net	(14.0)		(11.6)
Restructuring and other (charges) income	(22.3)	[1]	(6.7)	[1]
Non-operating pension and postretirement (charges) income	(6.2)	[2]	(4.2)	[2]
Business separation costs	0	[3]	(3.0)	[3]
Acquisition related charges	(190.7)	[4]	(3.1)	[4]
Provision for income taxes	49.1		(34.6)
Discontinued operations, net of income taxes	15.6		(26.6)
Net income attributable to noncontrolling interests	(1.3)		(4.8)
Net income (loss) attributable to FMC stockholders	(46.8)		65.6
Acquisition & Divestiture related costs	190.7		3.1
Operating Segments [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Operating profit	138.3		177.6
FMC Agricultural Solutions [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenue	392.4		466.9
Operating profit	81.8		120.1
Restructuring and other (charges) income	(18.3)
FMC Health and Nutrition [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenue	211.0		226.2
Operating profit	51.0		50.9
Restructuring and other (charges) income	(2.2)		(4.9)
FMC Lithium [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenue	56.0		63.8
Operating profit	5.5		6.6
Restructuring and other (charges) income	(0.3)		(0.1)
Eliminations [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenue	0		0
Operating profit	0		0
Corporate [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Operating profit	(15.3)		(17.4)
Restructuring and other (charges) income	(1.5)		(1.7)
Cheminova [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Legal and professional fees	10.6	[5]	0	[5]
Payments for cash flow hedge, accrued and paid in current period	180.1	[5]	0	[5]
EPAX [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Inventory fair value step-up amortization	$ 0	[6]	$ 3.1	[6]

[1] See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended March 31, 2015, relate to FMC Agricultural Solutions of $18.3 million, FMC Health and Nutrition of $2.2 million, FMC Lithium of $0.3 million and Corporate of $1.5 million. Amounts for the three months ended March 31, 2014, relate to FMC Health and Nutrition of $4.9 million, FMC Lithium of $0.1 million, and Corporate of $1.7 million.

[2] Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss).

[3] On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three months ended March 31, 2014 represent charges associated with the planned separation activities through March 31, 2014.

[4] Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, legal and professional fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following: Three Months Ended March 31(in Millions)2015 2014Acquisition related charges - Cheminova Legal and professional fees (1)$10.6 $—Loss/(gain) on hedging purchase price (1)180.1 —Acquisition related charges - Epax Inventory fair value step-up amortization (2)— 3.1Acquisition/divestiture related charges$190.7 $3.1____________________(1) On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expense.” For more information on the loss on purchase price hedge see Note 3.(2) On the condensed consolidated statements of income (loss), these charges are included in “Costs of sales and services.”

[5] On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expense.” For more information on the loss on purchase price hedge see Note 3.

[6] On the condensed consolidated statements of income (loss), these charges are included in “Costs of sales and services.”

XML

Condensed Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Cash provided (required) by operating activities of continuing operations:
Net income (loss)	$ (45.5)		$ 70.4
Discontinued operations	(15.6)		26.6
Income (loss) from continuing operations	(61.1)		97.0
Adjustments from income from continuing operations to cash provided (required) by operating activities of continuing operations:
Depreciation and amortization	22.8		23.9
Equity in (earnings) loss of affiliates	0.1		(0.2)
Restructuring and other charges (income)	22.3		6.7
Deferred income taxes	29.3		1.3
Pension and other postretirement benefits	10.7		8.5
Share-based Compensation	4.5		3.8
Excess tax benefits from share-based compensation	(1.7)		(3.4)
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:
Trade receivables, net	52.5		(80.3)
Guarantees of vendor financing	17.3		28.9
Inventories	(50.0)		(9.5)
Accounts payable	(35.6)		(77.7)
Advance payments from customers	(165.9)		(148.4)
Accrued customer rebates	87.6		87.4
Income taxes	(78.1)		9.3
Pension and other postretirement benefit contributions	(27.4)		(23.8)
Environmental spending, continuing, net of recoveries	(3.0)		(1.6)
Restructuring and other spending	(3.0)		(1.9)
Change in other operating assets and liabilities, net	(126.2)	[1]	(26.0)
Cash provided (required) by operating activities of continuing operations	(304.9)		(106.0)
Cash provided (required) by operating activities of discontinued operations:
Environmental spending, discontinued, net of recoveries	0		(3.7)
Operating activities of discontinued operations, net of recoveries	7.7		12.9
Cash provided (required) by operating activities of discontinued operations	7.7		9.2
Cash provided (required) by investing activities of continuing operations:
Capital expenditures	(36.9)		(63.3)
Proceeds from disposal of property, plant and equipment	0.3		0
Other investing activities	(17.6)		(1.1)
Cash provided (required) by investing activities of continuing operations	(54.2)		(64.4)
Cash provided (required) by investing activities of discontinued operations:
Proceeds from FMC Peroxygens divestiture	0		199.1
Other discontinued investing activities	(15.6)		(11.1)
Cash provided (required) by investing activities of discontinued operations	(15.6)		188.0
Cash provided (required) by financing activities of continuing operations:
Increase (decrease) in short-term debt	383.0		(39.6)
Repayments of long-term debt	(0.4)		(0.7)
Distributions to non controlling interests	0		(3.0)
Issuances of common stock, net	3.5		5.2
Excess tax benefits from share-based compensation	1.7		3.4
Dividends paid	(20.1)	[2]	(18.0)	[2]
Other repurchases of common stock	(2.9)		(4.0)
Cash provided (required) by financing activities of continuing operations	364.8		(56.7)
Effect of exchange rate changes on cash and cash equivalents	(2.1)		(0.8)
Increase (decrease) in cash and cash equivalents	(4.3)		(30.7)
Cash and cash equivalents, beginning of period	109.5		123.2
Cash and cash equivalents, end of period	$ 105.2		$ 92.5

[1] (1)The March 31, 2015 change is impacted by a $93.8 million reduction in the Cheminova A/S hedge liability. Total cash payments during the three months ended March 31, 2015 associated with the Cheminova A/S hedges were $273.8 million, which includes $180.1 million that were accrued and paid within the period

[2] See Note 12 regarding quarterly cash dividend.

XML

Condensed Consolidated Statements of Comprehensive Income (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (45.5)		$ 70.4
Foreign currency adjustments:
Foreign currency translation gain (loss) arising during the period	(39.7)		0.3
Reclassification of foreign currency translation losses	0		49.6
Total foreign currency translation adjustments	(39.7)	[1]	49.9	[1]
Derivative instruments:
Unrealized hedging gains (losses) and other, net of tax of $0.4 and $1.3 for the three months ended March 31, 2015 and 2014, respectively	2.3		2.5
Reclassification of deferred hedging (gains) losses and other, included in net income, net of tax of ($1.2) and $0.4 for the three months ended March 31, 2015 and 2014, respectively	(1.8)	[2]	1.1	[2]
Total derivative instruments, net of tax of ($0.8) and $1.7 for the three months ended March 31, 2015 and 2014, respectively	0.5	[3]	3.6
Pension and other postretirement benefits:
Unrealized actuarial gains (losses) and prior service (costs) credits, net of tax of ($4.7) and zero for the three months ended March 31, 2015 and 2014, respectively	(5.9)	[4]	0.5	[4]
Reclassification of net actuarial and other (gain) loss and amortization of prior service costs, included in net income, net of tax of $6.7 and $3.2 for the three months ended March 31, 2015 and 2014, respectively	11.7	[2]	6.0	[2]
Total pension and other postretirement benefits, net of tax of $2.0 and $3.2 for the three months ended March 31, 2015 and 2014, respectively	5.8	[3]	6.5
Other comprehensive income (loss), net of tax	(33.4)		60.0
Comprehensive income (loss)	(78.9)		130.4
Less: Comprehensive income attributable to the noncontrolling interest	1.3		5.1
Comprehensive income (loss) attributable to FMC stockholders	$ (80.2)		$ 125.3

[1] Income taxes are not provided on the equity in undistributed earnings of our foreign subsidiaries or affiliates since it is our intention that such earnings will remain invested in those affiliates permanently. The amount for 2014 includes reclassification to net income due to the divestiture of our FMC Peroxygens business, see Note 12 for more information. In accordance with accounting guidance, this amount was previously factored into the lower of cost or fair value test associated with the 2013 Peroxygens' asset held for sale write-down charges.

[2] For more detail on the components of these reclassifications and the affected line item in the condensed consolidated statements of income (loss) see Note 12.

[3] See condensed consolidated statements of comprehensive income (loss).

[4] At December 31st of each year, we remeasure our pension and postretirement plan obligations at which time we record any actuarial gains (losses) and prior service (costs) credits to other comprehensive income. The interim adjustments noted above typically reflect the foreign currency translation impacts from the unrealized actuarial gains (losses) and prior service (costs) credits related to our foreign pension and postretirement plans. During the three months ended March 31, 2015, due to the disposal of our FMC Alkali Chemicals division, we triggered a curtailment of our U.S. pension plans. As a result we revalued our pension plans which resulted in adjustments to comprehensive income. See Note 13 for more information.

XML

Discontinued Operations

3 Months Ended

Mar. 31, 2015

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued Operations

FMC Alkali:

On February 3, 2015, we signed a stock and asset purchase agreement ( the "Definitive Agreement") to sell our FMC Alkali Chemicals division ("ACD") to a wholly owned subsidiary of Tronox Limited ("Tronox"). The sale of ACD to Tronox was completed on April 1, 2015 resulting in approximately $1.6 billion in pre-tax proceeds ($1.2 billion after-tax).

ACD meets the criteria to be an asset held for sale and we have also presented ACD as a discontinued operation in accordance with GAAP. In addition to the definitive agreement we entered into a customary transitional services agreement with Tronox to provide for the orderly separation of the business and transition of various functions and processes. These services will be provided by us to Tronox for up to 12 months after closing. These services include information technology services, human resource and facility services among other services, while Tronox assumes the operations of ACD.

Additionally, FMC is providing certain financial guarantees to third parties on behalf of ACD. These financial guarantees include payment guarantees to the lessors of various transportation equipment leases, subleases of certain transportation equipment leases and a self-bonding guarantee for several environmental reclamation obligations assumed by Tronox, which were previously treated as an asset retirement obligation by FMC. In accordance with the Definitive Agreement, Tronox is provided 90 days to secure FMC's release from such guarantees after which FMC is entitled to receive compensation from Tronox based on the outstanding amount of guarantees until such release is obtained.

The results of our discontinued FMC ACD operations are summarized below:

(in Millions)	Three Months Ended March 31
	2015		2014
Revenue	$	194.0	$	184.9
Costs of sales and services	149.2		149.5
Income (loss) from discontinued operations before income taxes (1)	19.0		28.2
Provision for income taxes	0.4		4.7
Total discontinued operations of FMC ACD, net of income taxes	$	18.6	$	23.5
Less: discontinued operations of FMC ACD attributable to noncontrolling interests	$	—	$	1.6
Discontinued operations of FMC ACD, net of income taxes, attributable to FMC Stockholders	$	18.6	$	21.9

____________________

(1) Amounts include approximately zero and $1.9 million attributable to noncontrolling interests, allocated interest expense of $2.2 million and $1.9 million, divestiture related charges of $11.3 million and zero and a pension curtailment charge of $5.3 million and zero for the three months ended March 31, 2015 and 2014, respectively. Interest was allocated in accordance with relevant discontinued operations accounting guidance.

The following table presents the major classes of assets and liabilities of FMC Alkali Chemicals:

(in Millions)	March 31, 2015			December 31, 2014
Assets
Current assets of discontinued operations held for sale (primarily trade receivables and inventories)	$	205.7		$	203.3
Property, plant & equipment (1)	383.2			378.6
Other non-current assets (1)	22.9			22.9
Total assets of discontinued operations held for sale (2)	$	611.8		$	604.8
Liabilities
Current liabilities of discontinued operations held for sale	(70.7		)	(88.4		)
Noncurrent liabilities of discontinued operations held for sale (1)	(9.1		)	(4.7		)
Total liabilities of discontinued operations held for sale (2)	$	(79.8	)	$	(93.1	)
Net Assets	$	532.0		$	511.7

____________________

(1)     Presented as "Noncurrent assets\liabilities of discontinued operations held for sale" on the condensed consolidated balance sheet as

of December 31, 2014.

(2)    Presented as "Current assets\liabilities of discontinued operations held for sale" on the condensed consolidated balance sheet as of

March 31, 2015.

In addition to our discontinued FMC Alkali Chemicals division our other discontinued operations include adjustments to retained liabilities. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

Our discontinued operations comprised the following:

(in Millions)	Three Months Ended March 31
	2015			2014
Adjustment for workers’ compensation, product liability, other postretirement benefits and other, net of income tax benefit (expense) of ($0.3) and zero for the three months ended March 31, 2015 and 2014, respectively	$	(2.5	)	$	(1.5	)
Provision for environmental liabilities, net of recoveries, net of income tax benefit of $1.9 and $2.7 for the three months ended March 31, 2015 and 2014, respectively (1)	(0.6		)	(4.8		)
Provision for legal reserves and expenses, net of recoveries, net of income tax benefit (expense) of ($0.1) and $2.3 for the three months ended March 31, 2015 and 2014, respectively	0.1			(3.8		)
Discontinued operations of FMC Alkali Chemicals, net of income tax benefit (expense) of ($0.4) and ($4.7) for the three months ended March 31, 2015 and 2014, respectively	18.6			21.9
Discontinued operations of FMC Peroxygens, net of income tax benefit (expense) of zero and ($29.3) for the three months ended March 31, 2015 and 2014, respectively (2)	—			(40.0		)
Discontinued operations, net of income taxes	$	15.6		$	(28.2	)

____________________

(1) See a roll forward of our environmental reserves as well as discussion on significant environmental issues that occurred during the 2015 in Note 10.

(2) On February 28, 2014, we completed the sale of our FMC Peroxygens business for $199.1 million in cash to One Equity Partners (OEP), the private investment arm of J.P. Morgan Chase & Co. The sale resulted in a further pre-tax loss of $10.1 million ($33.4 million net of tax). The net of tax loss was driven by the final allocation of the $199.1 million of proceeds.

XML

Document and Entity Information Document	3 Months Ended
	Mar. 31, 2015
Document Information [Line Items]
Entity Registrant Name	FMC CORPORATION
Entity Central Index Key	0000037785
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding	133,534,165

XML

Environmental Obligations

3 Months Ended

Mar. 31, 2015

Environmental Remediation Obligations [Abstract]

Environmental Obligations

Environmental Obligations

We have reserves for potential environmental obligations, which management considers probable and for which management can reasonable estimate. The table below is a roll forward of our total environmental reserves, continuing and discontinued:

(in Millions)	Gross			Recoveries (3)			Net
Total environmental reserves at December 31, 2014	$	296.2		$	(11.9	)	$	284.3
Provision/(benefit)	4.4			—			4.4
(Spending)/recoveries	(7.7		)	1.0			(6.7		)
Total environmental reserves at March 31, 2015	$	292.9		$	(10.9	)	$	282.0
Environmental reserves, current (1)	96.4			(5.3		)	91.1
Environmental reserves, long-term (2)	196.5			(5.6		)	190.9
Total environmental reserves at March 31, 2015	$	292.9		$	(10.9	)	$	282.0

____________________

(1) These amounts are included within "Accrued and other liabilities" on the condensed consolidated balance sheets.

(2) These amounts are included in “Environmental liabilities, continuing and discontinued” on the condensed consolidated balance sheets.

(3) These recorded recoveries represent probable realization of claims against U.S. government agencies and are recorded as an offset to our environmental reserves in the condensed consolidated balance sheets.

The estimated reasonably possible environmental loss contingencies, net of expected recoveries, exceed amounts accrued by approximately $210 million at March 31, 2015. This reasonably possible estimate is based upon information available as of the date of the filing but the actual future losses may be higher given the uncertainties regarding the status of laws, regulations, enforcement policies, the impact of potentially responsible parties, technology and information related to individual sites. Potential environmental obligations that have not been reserved may be material to any one quarter's or year's results of operations in the future. However, we believe any such liability arising from such potential environmental obligations is not likely to have a material adverse effect on our liquidity or financial condition as it may be satisfied over many years.

The table below provides a roll forward of our environmental recoveries representing probable realization of claims against insurance carriers and other third parties. These recoveries are recorded as "Other assets" in the condensed consolidated balance sheets.

(in Millions)	12/31/2014		Increase in Recoveries	Cash Received		3/31/2015
Environmental Recoveries	$	29.9	—	(3.6	)	$	26.3

Our net environmental provisions relate to costs for the continued cleanup of both continuing and discontinued manufacturing operations from previous years. The net provisions are comprised as follows:

	Three Months Ended March 31
(in Millions)	2015		2014
Environmental provisions, net - recorded to liabilities (1)	$	4.4	$	8.9
Environmental provisions, net - recorded to assets (2)	—		—
Environmental provision, net	$	4.4	$	8.9
Continuing operations (3)	1.9		1.4
Discontinued operations (4)	2.5		7.5
Environmental provision, net	$	4.4	$	8.9

____________________

(1)     See above roll forward of our total environmental reserves as presented on the condensed consolidated balance sheets.

(2)     See above roll forward of our total environmental recoveries as presented on the condensed consolidated balance sheets.

(3)     Recorded as a component of “Restructuring and other charges (income)” on the condensed consolidated statements of income (loss). See

Note 7. Environmental obligations for continuing operations primarily represent obligations at shut down or abandoned facilities within businesses that do not meet the criteria for presentation as discontinued operations.

(4)     Recorded as a component of “Discontinued operations, net of income taxes" on the condensed consolidated statements of income

(loss). See Note 9.

A more complete description of our environmental contingencies and the nature of our potential obligations are included in Notes 1 and 10 to our consolidated financial statements in our 2014 Form 10-K. See Note 10 to our consolidated financial statements in our 2014 Form 10-K for a description of significant updates to material environmental sites.

XML

Condensed Consolidated Statements of Comprehensive Income (Parentheticals) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Unrealized hedging gains (losses) and other, tax	$ 0.4	$ 1.3
Reclassification of deferred hedging gains (losses) and other, included in net income, tax	(1.2)	0.4
Total derivative instruments, tax	(0.8)	1.7
Unrealized actuarial gains (losses) and prior service (costs) credits, tax	(4.7)	0
Reclassification of net actuarial and other (gain) loss and amortization of prior service costs, included in net income, tax	6.7	3.2
Total pension and other postretirement benefits, tax	$ 2.0	$ 3.2

XML

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

The changes in the carrying amount of goodwill by business segment for the three months ended March 31, 2015, are presented in the table below:

(in Millions)	FMC Agricultural Solutions		FMC Health and Nutrition			FMC Lithium		Total
Balance, December 31, 2014	$	31.0	$	321.5		$	—	$	352.5
Foreign currency adjustments	—		(28.4		)	—		(28.4		)
Balance, March 31, 2015	$	31.0	$	293.1		$	—	$	324.1

Our intangible assets, other than goodwill, consist of the following:

	March 31, 2015							December 31, 2014
(in Millions)	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (finite-lived)
Customer relationships	$	147.8	$	(24.6	)	$	123.2	$	152.8	$	(22.5	)	$	130.3
Patents	1.7		(0.2		)	1.5		1.7		(0.1		)	1.6
Brands (1)	1.2		(0.7		)	0.5		1.2		(0.6		)	0.6
Purchased and licensed technologies	71.7		(25.4		)	46.3		74.3		(24.5		)	49.8
Other intangibles	3.6		(2.1		)	1.5		3.6		(2.4		)	1.2
	$	226.0	$	(53.0	)	$	173.0	$	233.6	$	(50.1	)	$	183.5

Intangible assets not subject to amortization (indefinite life)
Brands (1)	$	60.5				$	60.5	$	63.4				$	63.4
Total intangible assets	$	286.5	$	(53.0	)	$	233.5	$	297.0	$	(50.1	)	$	246.9

(1) Represents trademarks, trade names and know how.

At March 31, 2015, the finite-lived and indefinite life intangibles were allocated among our business segments as follows:

(in Millions)	Finite-lived		Indefinite Life
FMC Agricultural Solutions	$	97.4	$	35.2
FMC Health and Nutrition	74.4		25.3
FMC Lithium	1.2		—
Total	$	173.0	$	60.5

XML

Acquisitions

3 Months Ended

Mar. 31, 2015

Business Combinations [Abstract]

Acquisitions

Acquisitions

Cheminova A/S

On September 8, 2014, we entered into a definitive Share Purchase Agreement (the "Purchase Agreement") with Auriga Industries A/S, a Denmark Aktieselskab ("Auriga") and Cheminova A/S, a Denmark Aktieselskab, a wholly owned subsidiary of Auriga ("Cheminova"). On April 21, 2015, pursuant to the terms and conditions set forth in the Purchase Agreement, we completed the acquisition of 100 percent of the outstanding equity of Cheminova from Auriga for an aggregate purchase price of $1.2 billion, excluding net debt to be assumed and hedged-related costs totaling $0.6 billion (the “Acquisition”). Beginning in the second quarter of 2015, Cheminova will be integrated into our FMC Agricultural Solutions segment and included within our results of operations. The Acquisition was funded with the October 10, 2014 term loan which was secured for the purposes of the Acquisition, see Note 8 for more information.

Cheminova is a business under the U.S. GAAP business combinations accounting guidance, and therefore we will apply acquisition accounting. Acquisition accounting requires, among other things, that assets and liabilities assumed be recognized at their fair values as of the acquisition date. The net assets of the Cheminova acquisition will be recorded at the estimated fair values using primarily Level 2 and Level 3 inputs (see Note 15 for an explanation of Level 2 and 3 inputs). In valuing acquired assets and liabilities, valuation inputs include an estimate of future cash flows and discount rates based on the internal rate of return and the weighted average rate of return.

We have not completed the detailed valuation work necessary to determine the estimates of the fair value of the acquired assets and assumed liabilities. As a result we have not determined the preliminary allocation of the purchase price. We also have not completed the detailed analysis to present the pro forma financial information for the combined companies. As such, both the preliminary allocation of the purchase price as well as the pro forma financial information will be included in our future filings.

Acquisition related costs

Pursuant to the terms and conditions set forth in the Purchase Agreement, we agreed to acquire all of the outstanding equity of Cheminova from Auriga for an aggregate purchase price of 8.5 billion Danish krone ("DKK"). At the time we entered into the Purchase Agreement, the U.S. dollar ("USD" or “$”) to DKK exchange rate was USD $1.00 to DKK 5.77, resulting in a USD purchase price of $1.47 billion, excluding assumed debt of approximately $0.3 billion. In order to minimize our exposure to adverse changes in the USD to DKK exchange rate from September 8, 2014 to April 21, 2015, (the acquisition close date) we entered into a series of foreign currency forward contracts ("FX forward contracts"). The FX forward contracts provided us the ability to fix the USD to DKK exchange rate for most of the DKK 8.5 billion purchase price, thereby limiting our exposure to foreign currency rate fluctuations. Over the period from September 2014 to March 2015 the USD strengthened against the DKK by 19 percent to an exchange rate of USD $1.00 to DKK 6.88 at March 31, 2015. The strengthening of the USD against the DKK results in a lower USD purchase price for Cheminova. Partially offsetting this was a mark-to-market loss on the FX forward contracts of $180.1 million during the three months ended March 31, 2015.

The loss on the FX forward contracts pursuant to GAAP is required to be expensed immediately. As a result, during the three months ended March 31, 2015, a $180.1 million loss associated with these FX forward contracts was recognized. The FX forward contract loss recognized in 2014 was $99.6 million. These losses are included in "Selling, general and administrative expenses" within the condensed consolidated statements of income (loss) and included them within Acquisition related charges within Note 17. In addition to the FX forward contract charges, additional legal and professional fees were incurred for the three months ended March 31, 2015 associated with this Acquisition as described in Note 17.

XML

Financial Instrument, Risk Management and Fair Value Measurements

3 Months Ended

Mar. 31, 2015

Financial Instruments Risk Management And Fair Value Measurements [Abstract]

Financial Instrument Risk Management and Fair Value Measurements

Financial Instruments, Risk Management and Fair Value Measurements

Our financial instruments include cash and cash equivalents, trade receivables, other current assets, certain receivables classified as other long-term assets, accounts payable, and amounts included in investments and accruals meeting the definition of financial instruments. The carrying value of these financial instruments approximates their fair value. Our other financial instruments include the following:

Financial Instrument	Valuation Method
Foreign exchange forward contracts	Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on current market prices for applicable currencies.
Commodity forward and option contracts	Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on quoted market prices for applicable commodities.
Debt	Our estimates and information obtained from independent third parties using market data, such as bid/ask spreads for the last business day of the reporting period.

The estimated fair value of the financial instruments in the above table have been determined using standard pricing models which take into account the present value of expected future cash flows discounted to the balance sheet date. These standard pricing models utilize inputs derived from or corroborated by observable market data such as interest rate yield curves and currency and commodity spot and forward rates. In addition, we test a subset of our valuations against valuations received from the transaction's counterparty to validate the accuracy of our standard pricing models. Accordingly, the estimates presented may not be indicative of the amounts that we would realize in a market exchange at settlement date and do not represent potential gains or losses on these agreements. The estimated fair values of foreign exchange forward contracts and commodity forward and option contracts are included in the tables within this Note. The estimated fair value of debt is $2,170.6 million and $1,773.2 million and the carrying amount is $2,058.2 million and $1,678.6 million as of March 31, 2015 and December 31, 2014, respectively.

We enter into various financial instruments with off-balance-sheet risk as part of the normal course of business. These off-balance-sheet instruments include financial guarantees and contractual commitments to extend financial guarantees under letters of credit, and other assistance to customers (Note 16). Decisions to extend financial guarantees to customers, and the amount of collateral required under these guarantees is based on our evaluation of creditworthiness on a case-by-case basis.

Use of Derivative Financial Instruments to Manage Risk

We mitigate certain financial exposures, including currency risk, commodity purchase exposures and interest rate risk, through a program of risk management that includes the use of derivative financial instruments. We enter into foreign exchange contracts, including forward and purchased options contracts, to reduce the effects of fluctuating foreign currency exchange rates. A detailed description of these risks including a discussion on the concentration of credit risk is provided in Note 17 to our consolidated financial statements on our 2014 Form 10-K.

We formally document all relationships between hedging instruments and hedged items, as well as the risk management objective and strategy for undertaking various hedge transactions. This process includes relating derivatives that are designated as fair value or cash flow hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. We also assess both, at the inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item. If we determine that a derivative is not highly effective as a hedge, or if a derivative ceases to be a highly effective hedge, we discontinue hedge accounting with respect to that derivative prospectively.

Accounting for Derivative Instruments and Hedging Activities

Cash Flow Hedges

We recognize all derivatives on the balance sheet at fair value. On the date the derivative instrument is entered into, we generally designate the derivative as a hedge of the variability of cash flows to be received or paid related to a forecasted transaction (cash flow hedge). We record in AOCI changes in the fair value of derivatives that are designated as and meet all the required criteria for a cash flow hedge. We then reclassify these amounts into earnings as the underlying hedged item affects earnings. In contrast, we immediately record in earnings changes in the fair value of derivatives that are not designated as cash flow hedges.

As of March 31, 2015, we had open foreign currency forward contracts in AOCI in a net after tax loss position of $2.9 million designated as cash flow hedges of underlying forecasted sales and purchases. Current open contracts hedge forecasted transactions until December 31, 2015. At March 31, 2015, we had open forward contracts designated as cash flow hedges with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $404.9 million.

As of March 31, 2015, we had current open commodity contracts in AOCI in a net after tax loss position of $1.8 million designated as cash flow hedges of underlying forecasted purchases, primarily related to natural gas. Current open commodity contracts hedge forecasted transactions until December 31, 2016. At March 31, 2015, we had an equivalent of 1.4 million mmBTUs (millions of British Thermal Units) in aggregate notional volume of outstanding natural gas commodity forward contracts to hedge forecasted purchases.

Of the $4.7 million of net losses after-tax, representing both open foreign currency exchange contracts and commodity contracts, approximately $4.5 million of these losses would be realized in earnings during the twelve months ending March 31, 2016 and $0.2 million of net losses will be realized subsequent to March 31, 2016, if spot rates in the future are consistent with forward rates as of March 31, 2015. The actual effect on earnings will be dependent on the actual spot rates when the forecasted transactions occur.

Derivatives Not Designated As Hedging Instruments

We hold certain forward contracts that have not been designated as cash flow hedging instruments for accounting purposes. Contracts used to hedge the exposure to foreign currency fluctuations associated with certain monetary assets and liabilities are not designated as cash flow hedging instruments, and changes in the fair value of these items are recorded in earnings. We occasionally hold call options that are effective as economic hedges of a portion of our natural gas exposure and the change in fair value of this instrument is also recorded in earnings. We periodically hold soybean barter contracts which qualify as derivatives and we have entered into offsetting commodity contracts to hedge our exposure. Both the change in fair value of the soybean barter contracts and the offsetting commodity contracts are recorded in earnings.

We had open forward contracts not designated as cash flow hedging instruments for accounting purposes with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $3.5 billion at March 31, 2015, which included approximately $2.6 billion associated with the derivative contracts to hedge the purchase of Cheminova A/S.

Fair Value of Derivative Instruments

The following tables provide the gross fair value and net balance sheet presentation of our derivative instruments as of March 31, 2015 and December 31, 2014.

	March 31, 2015
	Gross Amount of Derivatives
(in Millions)	Designated as Cash Flow Hedges			Not Designated as Hedging Instruments			Total Gross Amounts			Gross Amounts Offset in the Consolidated Balance Sheet (3)			Net Amounts
Derivatives
Foreign exchange contracts	$	22.8		$	32.4		$	55.2		$	(28.1	)	$	27.1
Total derivative assets (1)	22.8			32.4			55.2			(28.1		)	27.1
Foreign exchange contracts	(26.1		)	(6.2		)	(32.3		)	28.1			(4.2		)
Energy contracts	(2.8		)	—			(2.8		)	—			(2.8		)
Total derivative liabilities (2)	(28.9		)	(6.2		)	(35.1		)	28.1			(7.0		)
Net derivative assets/(liabilities)	$	(6.1	)	$	26.2		$	20.1		$	—		$	20.1
	December 31, 2014
	Gross Amount of Derivatives
(in Millions)	Designated as Cash Flow Hedges			Not Designated as Hedging Instruments			Total Gross Amounts			Gross Amounts Offset in the Consolidated Balance Sheet (3)			Net Amounts
Derivatives
Foreign exchange contracts	$	17.1		$	15.1		$	32.2		$	(3.6	)	$	28.6
Energy contracts	0.3			—			0.3			(0.3		)	—
Total derivative assets (1)	17.4			15.1			32.5			(3.9		)	28.6
Foreign exchange contracts	(17.4		)	(100.0		)	(117.4		)	3.6			(113.8		)
Energy contracts	(7.6		)	—			(7.6		)	0.3			(7.3		)
Total derivative liabilities (2)	(25.0		)	(100.0		)	(125.0		)	3.9			(121.1		)
Net derivative assets/(liabilities)	$	(7.6	)	$	(84.9	)	$	(92.5	)	$	—		$	(92.5	)

____________________

(1) Net balance is included in “Prepaid and other current assets” in the condensed consolidated balance sheets.

(2) Net balance is included in “Accrued and other liabilities” in the condensed consolidated balance sheets.

(3) Represents net derivatives positions subject to master netting arrangements.

The tables below summarizes the gains or losses related to our cash flow hedges and derivatives not designated as hedging instruments for the three months ended March 31, 2015 and 2014.

Derivatives in Cash Flow Hedging Relationships

	Three Months Ended March 31
	Contracts
	Foreign Exchange					Energy					Other				Total
(in Millions)	2015			2014		2015		2014			2015		2014		2015			2014
Unrealized hedging gains (losses) and other, net of tax	$	0.3		$	1.1	$	2.0	$	1.4		$	—	$	—	$	2.3		$	2.5
Reclassification of deferred hedging (gains) losses, net of tax
Effective portion (1)	(2.6		)	1.8		0.8		(0.7		)	—		—		(1.8		)	1.1
Total derivative instrument impact on comprehensive income	$	(2.3	)	$	2.9	$	2.8	$	0.7		$	—	$	—	$	0.5		$	3.6

___________________

(1) See Note 12 for classification of amounts within the condensed consolidated statements of income (loss).

Derivatives Not Designated as Hedging Instruments

	Location of Gain or (Loss) Recognized in Income on Derivatives	Amount of Pre-tax Gain or (Loss)  Recognized in Income on Derivatives (1)
		Three Months Ended March 31
(in Millions)		2015			2014
Foreign exchange contracts	Cost of sales and services	$	(4.5	)	$	4.9
	Selling, general & administrative (2)	(180.1		)	—
Total		$	(184.6	)	$	4.9

___________________

(1) Amounts in the columns represent the gain or loss on the derivative instrument offset by the gain or loss on the hedged item.

(2) Charges represent a loss on hedging the purchase price of the Cheminova A/S acquisition. See Note 3 within these condensed consolidated financial statements for more information.

Fair-Value Measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Market participants are defined as buyers or sellers in the principle or most advantageous market for the asset or liability that are independent of the reporting entity, knowledgeable and able and willing to transact for the asset or liability.

Fair-Value Hierarchy

We have categorized our assets and liabilities that are recorded at fair value, based on the priority of the inputs to the valuation technique, into a three-level fair-value hierarchy. The fair-value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the assets and liabilities fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair-value measurement of the instrument.

Recurring Fair Value Measurements

The following tables present our fair-value hierarchy for those assets and liabilities measured at fair-value on a recurring basis in the condensed consolidated balance sheets as of March 31, 2015 and December 31, 2014. During the periods presented there were no transfers between fair-value hierarchy levels.

(in Millions)	March 31, 2015		Quoted Prices in  Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Derivatives – Foreign exchange (1)	$	27.1	$	—	$	27.1	$	—
Other (2)	32.3		32.3		—		—
Total assets	$	59.4	$	32.3	$	27.1	$	—
Liabilities
Derivatives – Commodities:
Energy contracts (1)	$	2.8	$	—	$	2.8	$	—
Derivatives – Foreign exchange (1)	4.2		—		4.2		—
Other (3)	35.2		34.6		0.6		—
Total liabilities	$	42.2	$	34.6	$	7.6	$	—

____________________

(1) See the Fair Value of Derivative Instruments table within this Note for classifications on the condensed consolidated balance sheet.

(2) Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheet. Both the asset and liability are recorded at fair value. Asset amounts included in “Other assets” in the condensed consolidated balance sheets.

(3) Consists of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts due are included in “Other long-term liabilities” in the condensed consolidated balance sheets. Level 2 liabilities represent liability-based awards associated with non-employees.

(in Millions)	December 31, 2014		Quoted Prices in  Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Derivatives – Commodities:
Derivatives – Foreign exchange (1)	$	28.6	$	—	$	28.6	$	—
Other (2)	30.9		30.9		—		—
Total assets	$	59.5	$	30.9	$	28.6	$	—
Liabilities
Derivatives – Commodities:
Energy contracts (1)	$	7.3	$	—	$	7.3	$	—
Derivatives – Foreign exchange (1)	113.8		—		113.8		—
Other (3)	33.7		33.1		0.6		—
Total liabilities	$	154.8	$	33.1	$	121.7	$	—

____________________

(1) See the Fair Value of Derivative Instruments table within this Note for classification on the condensed consolidated balance sheet.

(2) Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheet. Both the asset and liability are recorded at fair value. Asset amounts included in “Other assets” in the condensed consolidated balance sheets.

(3) Consist of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts included in “Other long-term liabilities” in the condensed consolidated balance sheets.

Nonrecurring Fair Value Measurements

The following tables present our fair value hierarchy for those assets and liabilities measured at fair value on a non-recurring basis in the condensed consolidated balance sheets during the three months ended March 31, 2015 and the year ended December 31, 2014.

(in Millions)	March 31, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Gains (Losses) (Three Months Ended March 31, 2015)
Assets
Long-lived assets associated with exit activities (1)	$	—	$	—	$	—	$	—	$	(1.2	)
Total assets	$	—	$	—	$	—	$	—	$	(1.2	)

____________________

(1) We recorded charges, within our FMC Health and Nutrition segment, to write down the value of certain long-lived assets to zero related to our FMC Health and Nutrition restructuring as they have no future use. See Note 7 for more information.

(in Millions)	December 31, 2014		Quoted Prices in  Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Gains (Losses) (Year Ended December 31, 2014)
Assets
Long-lived assets associated with exit activities (1)	$	—	$	—	$	—	$	—	$	(3.1	)
Total assets	$	—	$	—	$	—	$	—	$	(3.1	)

____________________

(1) We recorded charges, within our FMC Health and Nutrition segment, to write down the value of certain long-lived assets to zero related to our FMC Health and Nutrition restructuring as they have no future use. See Note 7 for more information.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

Earnings per common share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during the period on a basic and diluted basis.

Our potentially dilutive securities include potential common shares related to our stock options, restricted stock and restricted stock units. Diluted earnings per share (“Diluted EPS”) considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an antidilutive effect. Diluted EPS excludes the impact of potential common shares related to our stock options in periods in which the option exercise price is greater than the average market price of our common stock for the period. For the three months ended March 31, 2015 we had a net loss attributable to FMC stockholders and as such all 1,635 thousand potential common shares were excluded from Diluted EPS. There were 312 thousand potential common shares excluded from Diluted EPS for the three months ended March 31, 2014.

Our non-vested restricted stock awards contain rights to receive non-forfeitable dividends, and thus, are participating securities requiring the two-class method of computing EPS. The two-class method determines EPS by dividing the sum of distributed earnings to common stockholders and undistributed earnings allocated to common stockholders by the weighted average number of shares of common stock outstanding for the period. In calculating the two-class method, undistributed earnings are allocated to both common shares and participating securities based on the weighted average number of shares outstanding during the period.

Earnings applicable to common stock and common stock shares used in the calculation of basic and diluted earnings per share are as follows:

(in Millions, Except Share and Per Share Data)	Three Months Ended March 31
	2015			2014
Earnings (loss) attributable to FMC stockholders:
Continuing operations, net of income taxes	$	(62.4	)	$	93.8
Discontinued operations, net of income taxes	15.6			(28.2		)
Net income (loss) attributable to FMC stockholders	$	(46.8	)	$	65.6
Less: Distributed and undistributed earnings allocable to restricted award holders	—			(0.2		)
Net income (loss) allocable to common stockholders	$	(46.8	)	$	65.4
Basic earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.47	)	$	0.70
Discontinued operations	0.12			(0.21		)
Net income (loss) attributable to FMC stockholders	$	(0.35	)	$	0.49
Diluted earnings (loss) per common share attributable to FMC stockholders:
Continuing operations	$	(0.47	)	$	0.70
Discontinued operations	0.12			(0.21		)
Net income (loss) attributable to FMC stockholders	$	(0.35	)	$	0.49
Shares (in thousands):
Weighted average number of shares of common stock outstanding - Basic	133,577			133,139
Weighted average additional shares assuming conversion of potential common shares	—			1,114
Shares – diluted basis	133,577			134,253

XML

Restructuring and Other Charges (Income)

3 Months Ended

Mar. 31, 2015

Restructuring and Related Activities [Abstract]

Restructuring and Other Charges (Income)

Restructuring and Other Charges (Income)

Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income) as noted below:

	Three Months Ended March 31
(in Millions)	2015		2014
Restructuring charges and asset disposals	$	5.4	$	5.3
Other charges (income), net	16.9		1.4
Total restructuring and other charges	$	22.3	$	6.7

Restructuring charges and asset disposals

There were no significant restructuring activities that commenced during 2015. For detail on the restructuring charges and asset disposals which commenced prior to 2015, see Note 7 to our consolidated financial statements included with our 2014 Form 10-K.

	Restructuring Charges
(in Millions)	Severance and Employee Benefits (1)		Other Charges (Income) (2)			Asset Disposal Charges (3)		Total
Health and Nutrition Restructuring	$	0.8	$	0.1		$	1.2	$	2.1
Lithium Restructuring	0.3		—			—		0.3
Other Items	3.3		(0.3		)	—		3.0
Three months ended March 31, 2015	$	4.4	$	(0.2	)	$	1.2	$	5.4
Health and Nutrition Restructuring	4.9		—			—		4.9
Lithium Restructuring	—		0.1			—		0.1
Other Items	—		0.3			—		0.3
Three months ended March 31, 2014	$	4.9	$	0.4		$	—	$	5.3

____________________ 

(1) Represents severance and employee benefit charges. Income represents adjustments to previously recorded severance and employee benefits.

(2) Primarily represents costs associated with lease payments, contract terminations, and other miscellaneous exit costs. Other Income primarily represents favorable developments on previously recorded exit costs as recoveries associated with restructuring.

(3) Primarily represents accelerated depreciation and impairment charges on long-lived assets, which were or are to be abandoned. To the extent incurred, the acceleration effect of re-estimating settlement dates and revised cost estimates associated with asset retirement obligations due to facility shutdowns are also included within the asset disposal charges.

Roll forward of restructuring reserves

The following table shows a roll forward of restructuring reserves, continuing and discontinued, that will result in cash spending. These amounts exclude asset retirement obligations.

(in Millions)	Balance at 12/31/14 (4)		Change in reserves (2)		Cash payments			Other (3)			Balance at 3/31/15 (4)
Health and Nutrition Restructuring	$	4.6	$	0.9	$	(1.8	)	$	0.2		$	3.9
Lithium Restructuring	0.2		0.3		(0.1		)	—			0.4
Other Workforce Related and Facility Shutdowns (1)	2.8		3.0		(1.1		)	0.4			5.1
Restructuring activities related to discontinued operations (5)	2.7		—		(0.1		)	(0.3		)	2.3
Total	$	10.3	$	4.2	$	(3.1	)	$	0.3		$	11.7

____________________ 

(1) Primarily severance costs related to workforce reductions and facility shutdowns noted in the “Other Items” sections above.

(2) Primarily severance, exited lease, contract termination and other miscellaneous exit costs. Any accelerated depreciation and impairment charges noted above impacted our property, plant and equipment balances and are not included in the above tables.

(3) Primarily foreign currency translation adjustments.

(4) Included in “Accrued and other liabilities” on the condensed consolidated balance sheets.

(5) Cash spending associated with restructuring activities of discontinued operations is reported within Payments of other discontinued reserves, net of recoveries on the condensed consolidated statements of cash flows.

Other charges (income), net

	Three Months Ended March 31
(in Millions)	2015		2014
Environmental charges, net	$	1.9	$	1.4
Other items, net	15.0		—
Other charges (income), net	$	16.9	$	1.4

Environmental charges, net

Environmental charges represent the net charges associated with environmental remediation at continuing operating sites. See Note 10 for additional details.

Other items, Net

Our FMC Agricultural Solutions segment enters into collaboration and license agreements with various third-party companies for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development. In most transactions the rights and technology obtained is referred to as in-process research and development and in accordance with GAAP, the amounts paid are expensed as incurred since they were acquired outside of a business combination. During the three months ended March 31, 2015, we entered into one such transaction, consisting of the acquisition of all global rights to a pre-development novel, proprietary broadleaf herbicide.

XML

Equity Additional Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				0 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Apr. 16, 2015
Subsequent Event [Line Items]
Dividend paid	$ 20.1	[1]	$ 18.0	[1]
Stock repurchase program, remaining authorized repurchase amount	250.0
Subsequent Event [Member]
Subsequent Event [Line Items]
Dividend paid					$ 22.1
Dividends payable, date to be paid					Apr. 16, 2015

[1] See Note 12 regarding quarterly cash dividend.

XML

Inventories

3 Months Ended

Mar. 31, 2015

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories consisted of the following:

(in Millions)	March 31, 2015			December 31, 2014
Finished goods	$	287.8		$	281.1
Work in process	243.9			248.8
Raw materials, supplies and other	274.5			242.1
First-in, first-out inventory	$	806.2		$	772.0
Less: Excess of first-in, first-out cost over last-in, first-out cost	(165.4		)	(164.4		)
Net inventories	$	640.8		$	607.6

XML

Property, Plant and Equipment

3 Months Ended

Mar. 31, 2015

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment consisted of the following:

(in Millions)	March 31, 2015			December 31, 2014
Property, plant and equipment	$	1,580.9		$	1,618.7
Accumulated depreciation	(678.3		)	(688.7		)
Property, plant and equipment, net	$	902.6		$	930.0

XML

Debt

3 Months Ended

Mar. 31, 2015

Debt Disclosure [Abstract]

Debt

Debt

Debt maturing within one year:

(in Millions)	March 31, 2015		December 31, 2014
Short-term foreign debt (1)	$	40.5	$	36.6
Commercial paper (2)	865.1		486.6
Total short-term debt	$	905.6	$	523.2
Current portion of long-term debt	1.7		2.0
Short-term debt and current portion of long-term debt	$	907.3	$	525.2

____________________

(1) At March 31, 2015, the average interest rate on the borrowings was 4.50%. We often provide parent-company guarantees to lending institutions that extend credit to our foreign subsidiaries.

(2) At March 31, 2015, the average interest rate on the borrowings was 0.62%.

Long-term debt:

(in Millions)	March 31, 2015
	Interest Rate Percentage		Maturity Date	3/31/2015		12/31/2014
Pollution control and industrial revenue bonds (less unamortized discounts of $0.2 and $0.2, respectively)	0.2-6.5%		2021-2035	$	141.6	$	141.5
Senior notes (less unamortized discount of $1.9 and $1.9, respectively)	3.95-5.2%		2019-2024	998.1		998.1
Credit Facility (1)	2.6	%	2019	—		—
Foreign debt	0-9.3%		2015-2024	12.9		15.8
Total long-term debt				$	1,152.6	$	1,155.4
Less: debt maturing within one year				1.7		2.0
Total long-term debt, less current portion				$	1,150.9	$	1,153.4

____________________

(1) Letters of credit outstanding under our Credit Facility totaled $100.1 million and available funds under this facility were $534.8 million at March 31, 2015 (which reflects borrowings under our commercial paper program).

Covenants

Among other restrictions, our Credit Facility contains financial covenants applicable to FMC and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our actual leverage for the four consecutive quarters ended March 31, 2015, was 3.2 which is below the maximum leverage of 3.5. Our actual interest coverage for the four consecutive quarters ended March 31, 2015, was 11.7 which is above the minimum interest coverage of 3.5. We were in compliance with all covenants at March 31, 2015. Following the acquisition of Cheminova A/S (see Note 3), the maximum leverage covenant increased to 4.5 and will step down in accordance with the provisions of the Credit Facility.

Term Loan Facility

On April 21, 2015, we borrowed $1.65 billion under our previously announced senior unsecured Term Loan Facility. The proceeds of the borrowing were used to finance the acquisition of Cheminova A/S as well as to pay costs, fees and expenses incurred in connection with the acquisition and the term loan facility.

The scheduled maturity of the Term Loan Facility is on the fifth anniversary of this closing date. The borrowings under the Term Loan Agreement will bear interest at a floating rate, which will be a base rate or a Eurocurrency rate equal to the London interbank offered rate for the relevant interest period, plus in each case an applicable margin, as determined in accordance with the provisions of the Term Loan Agreement. The base rate will be the highest of: the rate of interest announced publicly by Citibank, N.A. in New York, New York from time to time as its “base rate”; the federal funds effective rate plus1/2 of one percent; and the Eurocurrency rate for a one-month period plus one percent.

The Term Loan Agreement contains financial and other covenants, including a maximum leverage ratio of 4.5 and minimum interest coverage ratio 3.5 immediately following the acquisition. The Term Loan Agreement also contains a cross-default provision whereby a default under our other indebtedness in excess of $50.0 million, after grace periods and absent a waiver from the lenders, would be an event of default under the Term Loan Agreement and could result in a demand for payment of all amounts outstanding under this facility.

XML

Financial Instrument, Risk Management and Fair Value Measurements, Derivatives Fair Value Balance Sheet Presentation (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Assets	$ 55.2	[1]	$ 32.5	[1]
Gross Amounts Offset in the Consolidated Balance Sheet	0	[2]	0	[2]
Net Amounts, Assets	27.1	[1]	28.6	[1]
Gross Amount of Derivatives, Liabilities	(35.1)	[3]	(125.0)	[3]
Net Amounts, Liabilities	(7.0)	[3]	(121.1)	[3]
Net derivative assets/(liabilities)	20.1		(92.5)
Fair Value by Asset Class [Domain]
Derivatives, Fair Value [Line Items]
Gross Amounts Offset in the Consolidated Balance Sheet	(28.1)	[1],[2]	(3.9)	[1],[2]
Derivative Financial Instruments, Liabilities [Member]
Derivatives, Fair Value [Line Items]
Gross Amounts Offset in the Consolidated Balance Sheet	28.1	[2],[3]	3.9	[2],[3]
Foreign Exchange Contract [Member] | Prepaid and Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Assets	55.2		32.2
Gross Amounts Offset in the Consolidated Balance Sheet	(28.1)	[2]	(3.6)	[2]
Net Amounts, Assets	27.1		28.6
Foreign Exchange Contract [Member] | Accured and Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Gross Amounts Offset in the Consolidated Balance Sheet	28.1	[2]	3.6	[2]
Gross Amount of Derivatives, Liabilities	(32.3)		(117.4)
Net Amounts, Liabilities	(4.2)		(113.8)
Energy Contracts [Member] | Prepaid and Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Assets			0.3
Gross Amounts Offset in the Consolidated Balance Sheet			(0.3)	[2]
Net Amounts, Assets			0
Energy Contracts [Member] | Accured and Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Gross Amounts Offset in the Consolidated Balance Sheet	0	[2]	0.3	[2]
Gross Amount of Derivatives, Liabilities	(2.8)		(7.6)
Net Amounts, Liabilities	(2.8)		(7.3)
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Assets	22.8	[1]	17.4	[1]
Gross Amount of Derivatives, Liabilities	(28.9)	[3]	(25.0)	[3]
Net derivative assets/(liabilities)	(6.1)		(7.6)
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Foreign Exchange Contract [Member] | Prepaid and Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Assets	22.8		17.1
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Foreign Exchange Contract [Member] | Accured and Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Liabilities	(26.1)		(17.4)
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Energy Contracts [Member] | Prepaid and Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Assets			0.3
Derivatives Designated as Hedging Instruments [Member] | Cash Flow Hedging [Member] | Energy Contracts [Member] | Accured and Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Liabilities	(2.8)		(7.6)
Derivatives Not Designated as Hedging Instruments [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Assets	32.4	[1]	15.1	[1]
Gross Amount of Derivatives, Liabilities	(6.2)	[3]	(100.0)	[3]
Net derivative assets/(liabilities)	26.2		(84.9)
Derivatives Not Designated as Hedging Instruments [Member] | Foreign Exchange Contract [Member] | Prepaid and Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Assets	32.4		15.1
Derivatives Not Designated as Hedging Instruments [Member] | Foreign Exchange Contract [Member] | Accured and Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Liabilities	(6.2)		(100.0)
Derivatives Not Designated as Hedging Instruments [Member] | Energy Contracts [Member] | Prepaid and Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Assets			0
Derivatives Not Designated as Hedging Instruments [Member] | Energy Contracts [Member] | Accured and Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Gross Amount of Derivatives, Liabilities	$ 0		$ 0

[1] Net balance is included in “Prepaid and other current assets” in the condensed consolidated balance sheets.

[2] Represents net derivatives positions subject to master netting arrangements.

[3] Net balance is included in “Accrued and other liabilities” in the condensed consolidated balance sheets.

XML

Financial Instrument, Risk Management and Fair Value Measurements, Fair Value (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended			12 Months Ended
	Mar. 31, 2015		Mar. 31, 2014	Dec. 31, 2014
Assets
Derivatives – Foreign exchange	$ 55.2	[1]		$ 32.5	[1]
Total Gains (Losses) for the Period	(5.4)		(5.3)
Liabilities
Derivative Liabilities	35.1	[2]		125.0	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Assets
Other	32.3	[3]		30.9	[3]
Total assets	32.3			30.9
Liabilities
Other	34.6	[4]		33.1	[5]
Total liabilities	34.6			33.1
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Foreign Exchange Contract [Member]
Assets
Derivatives – Foreign exchange	0	[6]		0	[7]
Liabilities
Derivative Liabilities	0	[6]		0	[7]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Energy Contracts [Member]
Liabilities
Derivative Liabilities	0	[6]		0	[7]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Assets
Other	0	[3]		0	[3]
Total assets	27.1			28.6
Liabilities
Other	0.6	[4]		0.6	[5]
Total liabilities	7.6			121.7
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Contract [Member]
Assets
Derivatives – Foreign exchange	27.1	[6]		28.6	[7]
Liabilities
Derivative Liabilities	4.2	[6]		113.8	[7]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Energy Contracts [Member]
Liabilities
Derivative Liabilities	2.8	[6]		7.3	[7]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Assets
Other	0	[3]		0	[3]
Total assets	0			0
Liabilities
Other	0	[4]		0	[5]
Total liabilities	0			0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Foreign Exchange Contract [Member]
Assets
Derivatives – Foreign exchange	0	[6]		0	[7]
Liabilities
Derivative Liabilities	0	[6]		0	[7]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Energy Contracts [Member]
Liabilities
Derivative Liabilities	0	[6]		0	[7]
Fair Value, Measurements, Nonrecurring [Member]
Assets
Total Gains (Losses) for the Period	(1.2)			(3.1)
Total Gains (Losses) for the Period	(1.2)	[8]		(3.1)	[9]
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 1 [Member]
Assets
Total assets	0			0
Long-lived assets associated with exit activities	0	[8]		0	[9]
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 2 [Member]
Assets
Total assets	0			0
Long-lived assets associated with exit activities	0	[8]		0	[9]
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 3 [Member]
Assets
Total assets	0			0
Long-lived assets associated with exit activities	0	[8]		0	[9]
Estimate of Fair Value Measurement [Member] | Fair Value, Measurements, Recurring [Member]
Assets
Other	32.3	[3]		30.9	[3]
Total assets	59.4			59.5
Liabilities
Other	35.2	[4]		33.7	[5]
Total liabilities	42.2			154.8
Estimate of Fair Value Measurement [Member] | Fair Value, Measurements, Recurring [Member] | Foreign Exchange Contract [Member]
Assets
Derivatives – Foreign exchange	27.1	[6]		28.6	[7]
Liabilities
Derivative Liabilities	4.2	[6]		113.8	[7]
Estimate of Fair Value Measurement [Member] | Fair Value, Measurements, Recurring [Member] | Energy Contracts [Member]
Liabilities
Derivative Liabilities	2.8	[6]		7.3	[7]
Estimate of Fair Value Measurement [Member] | Fair Value, Measurements, Nonrecurring [Member]
Assets
Total assets	0			0
Long-lived assets associated with exit activities	$ 0	[8]		$ 0	[9]

[1] Net balance is included in “Prepaid and other current assets” in the condensed consolidated balance sheets.

[2] Net balance is included in “Accrued and other liabilities” in the condensed consolidated balance sheets.

[3] Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheet. Both the asset and liability are recorded at fair value. Asset amounts included in “Other assets” in the condensed consolidated balance sheets.

[4] Consists of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts due are included in “Other long-term liabilities” in the condensed consolidated balance sheets. Level 2 liabilities represent liability-based awards associated with non-employees.

[5] Consist of a deferred compensation arrangement recognized on our balance sheet. Both the asset and liability are recorded at fair value. Liability amounts included in “Other long-term liabilities” in the condensed consolidated balance sheets.

[6] See the Fair Value of Derivative Instruments table within this Note for classifications on the condensed consolidated balance sheet.

[7] See the Fair Value of Derivative Instruments table within this Note for classification on the condensed consolidated balance sheet.

[8] (1)We recorded charges, within our FMC Health and Nutrition segment, to write down the value of certain long-lived assets to zero related to our FMC Health and Nutrition restructuring as they have no future use. See Note 7 for more information.

[9] We recorded charges, within our FMC Health and Nutrition segment, to write down the value of certain long-lived assets to zero related to our FMC Health and Nutrition restructuring as they have no future use. See Note 7 for more information.

XML

Financial Instrument, Risk Management and Fair Value Measurements Narrative (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Derivative [Line Items]
Estimated fair value of debt	$ 2,170.6	$ 1,773.2
Carrying value of debt	2,058.2	1,678.6
Designated as Hedging Instrument [Member]
Derivative [Line Items]
Cash flow hedge gain (loss) to be reclassified within 12 months	(4.5)
Cash flow hedge gain (loss) to be reclassified after 12 months	(0.2)
Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative [Line Items]
Derivative notional amount	404.9
Designated as Hedging Instrument [Member] | Energy contracts [Member]
Derivative [Line Items]
Nonmonetary notional amount of price risk cash flow hedge	1,400,000
Designated as Hedging Instrument [Member] | Foreign Currency and Energy Contracts [Member]
Derivative [Line Items]
Cumulative changes in net gain (loss) from cash flow hedges	(4.7)
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative [Line Items]
Derivative notional amount	3,500.0
Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative [Line Items]
Cumulative changes in net gain (loss) from cash flow hedges	(2.9)
Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Energy contracts [Member]
Derivative [Line Items]
Cumulative changes in net gain (loss) from cash flow hedges	(1.8)
Cheminova [Member] | Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative [Line Items]
Derivative notional amount	$ 2,600.0

XML

Environmental Obligations (Tables)

3 Months Ended

Mar. 31, 2015

Environmental Remediation Obligations [Abstract]

Environmental reserves rollforward, continuing and discontinued

The table below is a roll forward of our total environmental reserves, continuing and discontinued:

(in Millions)	Gross			Recoveries (3)			Net
Total environmental reserves at December 31, 2014	$	296.2		$	(11.9	)	$	284.3
Provision/(benefit)	4.4			—			4.4
(Spending)/recoveries	(7.7		)	1.0			(6.7		)
Total environmental reserves at March 31, 2015	$	292.9		$	(10.9	)	$	282.0
Environmental reserves, current (1)	96.4			(5.3		)	91.1
Environmental reserves, long-term (2)	196.5			(5.6		)	190.9
Total environmental reserves at March 31, 2015	$	292.9		$	(10.9	)	$	282.0

____________________

(1) These amounts are included within "Accrued and other liabilities" on the condensed consolidated balance sheets.

(2) These amounts are included in “Environmental liabilities, continuing and discontinued” on the condensed consolidated balance sheets.

(3) These recorded recoveries represent probable realization of claims against U.S. government agencies and are recorded as an offset to our environmental reserves in the condensed consolidated balance sheets.

Schedule of environmental recoveries

The table below provides a roll forward of our environmental recoveries representing probable realization of claims against insurance carriers and other third parties. These recoveries are recorded as "Other assets" in the condensed consolidated balance sheets.

(in Millions)	12/31/2014		Increase in Recoveries	Cash Received		3/31/2015
Environmental Recoveries	$	29.9	—	(3.6	)	$	26.3

Schedule of net environmental provision by operating and discontinued sites

Our net environmental provisions relate to costs for the continued cleanup of both continuing and discontinued manufacturing operations from previous years. The net provisions are comprised as follows:

	Three Months Ended March 31
(in Millions)	2015		2014
Environmental provisions, net - recorded to liabilities (1)	$	4.4	$	8.9
Environmental provisions, net - recorded to assets (2)	—		—
Environmental provision, net	$	4.4	$	8.9
Continuing operations (3)	1.9		1.4
Discontinued operations (4)	2.5		7.5
Environmental provision, net	$	4.4	$	8.9

____________________

(1)     See above roll forward of our total environmental reserves as presented on the condensed consolidated balance sheets.

(2)     See above roll forward of our total environmental recoveries as presented on the condensed consolidated balance sheets.

(3)     Recorded as a component of “Restructuring and other charges (income)” on the condensed consolidated statements of income (loss). See

Note 7. Environmental obligations for continuing operations primarily represent obligations at shut down or abandoned facilities within businesses that do not meet the criteria for presentation as discontinued operations.

(4)     Recorded as a component of “Discontinued operations, net of income taxes" on the condensed consolidated statements of income

(loss). See Note 9.

XML

Debt, Maturing within One Year (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Short-term Debt [Line Items]
Short-term foreign debt	$ 40.5	[1]	$ 36.6	[1]
Commercial paper	865.1	[2]	486.6	[2]
Total Short-term debt	905.6		523.2
Current portion of long-term debt	1.7		2.0
Short-term debt and current portion of long-term debt	$ 907.3		$ 525.2
Short-term Debt [Member]
Short-term Debt [Line Items]
Interest rate percentage	4.50%
Commercial Paper [Member]
Short-term Debt [Line Items]
Interest rate percentage	0.62%

[1] At March 31, 2015, the average interest rate on the borrowings was 4.50%. We often provide parent-company guarantees to lending institutions that extend credit to our foreign subsidiaries.

[2] At March 31, 2015, the average interest rate on the borrowings was 0.62%.

XML

Pensions and Other Postretirement Benefits

3 Months Ended

Mar. 31, 2015

Pensions and Other Postretirement Benefits [Abstract]

Pension and Other Postretirement Benefits

Pensions and Other Postretirement Benefits

The following table summarizes the components of net annual benefit cost (income) for the three months ended March 31, 2015 and 2014:

(in Millions)	Three Months Ended March 31
	Pensions						Other Benefits
	2015			2014			2015			2014
Components of net annual benefit cost (income):
Service cost	$	4.1		$	4.9		$	—		$	—
Interest cost	15.4			15.5			0.3			0.3
Expected return on plan assets	(22.2		)	(21.6		)	—			—
Amortization of prior service cost (credit)	0.3			0.4			0.1			—
Recognized net actuarial and other (gain) loss	12.9			7.8			(0.2		)	(0.4		)
Recognized loss due to curtailment (1)	4.8			—			0.5			—
Recognized loss due to settlement (2)	—			1.6			—			—
Net periodic benefit cost (3)	$	15.3		$	8.6		$	0.7		$	(0.1	)

____________________

(1) Curtailment loss is associated with the disposal of our FMC Alkali Chemicals division and was recorded to discontinued operations within the condensed consolidated statements of income (loss).

(2) Settlement charge is associated with the acceleration of previously deferred pension actuarial losses and was triggered by a lump-sum payout to certain former executives.

(3) Net periodic benefit cost represent both continuing and discontinued operations.

We made voluntary cash contributions to our U.S. defined benefit pension plan of $25.0 million and $17.0 million in the three months ended March 31, 2015 and March 31, 2014. We expect to make approximately $65 million in voluntary cash contributions to our U.S. defined benefit pension plan during 2015.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2015

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Cheminova Acquisition:

Refer to Note 3 for more information on the completed acquisition of Cheminova A/S, which occurred on April 21, 2015 and Note 8 on the financing associated with the acquisition.

FMC Alkali Chemicals Divestiture:

Refer to Note 9 for more information on the completed divestiture of FMC Alkali Chemicals division, which occurred on April 1, 2015.

XML

Restructuring and Other Charges (Income) Restructuring and Other Charges (Income) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Restructuring and Related Activities [Abstract]
Restructuring charges and asset disposals	$ 5.4		$ 5.3
Other charges (income), net	16.9		1.4
Total restructuring and other charges	$ 22.3	[1]	$ 6.7	[1]

[1] See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended March 31, 2015, relate to FMC Agricultural Solutions of $18.3 million, FMC Health and Nutrition of $2.2 million, FMC Lithium of $0.3 million and Corporate of $1.5 million. Amounts for the three months ended March 31, 2014, relate to FMC Health and Nutrition of $4.9 million, FMC Lithium of $0.1 million, and Corporate of $1.7 million.

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment reporting information by segment

(in Millions)	Three Months Ended March 31
	2015			2014
Revenue
FMC Agricultural Solutions	$	392.4		$	466.9
FMC Health and Nutrition	211.0			226.2
FMC Lithium	56.0			63.8
Eliminations	—			—
Total	$	659.4		$	756.9
Income from continuing operations before income taxes
FMC Agricultural Solutions	$	81.8		$	120.1
FMC Health and Nutrition	51.0			50.9
FMC Lithium	5.5			6.6
Eliminations	—			—
Segment operating profit	$	138.3		$	177.6
Corporate and other	(15.3		)	(17.4		)
Operating profit before the items listed below	$	123.0		$	160.2
Interest expense, net	(14.0		)	(11.6		)
Restructuring and other (charges) income (1)	(22.3		)	(6.7		)
Non-operating pension and postretirement (charges) income (2)	(6.2		)	(4.2		)
Business separation costs (3)	—			(3.0		)
Acquisition related charges (4)	(190.7		)	(3.1		)
Provision for income taxes	49.1			(34.6		)
Discontinued operations, net of income taxes	15.6			(26.6		)
Net income attributable to noncontrolling interests	(1.3		)	(4.8		)
Net income (loss) attributable to FMC stockholders	$	(46.8	)	$	65.6

_________________________________________

(1) See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended March 31, 2015, relate to FMC Agricultural Solutions of $18.3 million, FMC Health and Nutrition of $2.2 million, FMC Lithium of $0.3 million and Corporate of $1.5 million. Amounts for the three months ended March 31, 2014, relate to FMC Health and Nutrition of $4.9 million, FMC Lithium of $0.1 million, and Corporate of $1.7 million.

(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss). 

(3) On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three months ended March 31, 2014 represent charges associated with the planned separation activities through March 31, 2014.

(4) Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, legal and professional fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following:

	Three Months Ended
	March 31
(in Millions)	2015		2014
Acquisition related charges - Cheminova
Legal and professional fees (1)	$	10.6	$	—
Loss/(gain) on hedging purchase price (1)	180.1		—
Acquisition related charges - Epax
Inventory fair value step-up amortization (2)	—		3.1
Acquisition/divestiture related charges	$	190.7	$	3.1

____________________

(1)    On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative

expense.” For more information on the loss on purchase price hedge see Note 3.

(2)    On the condensed consolidated statements of income (loss), these charges are included in “Costs of sales and services.”

XML

Condensed Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Assets, Current [Abstract]
Cash and cash equivalents	$ 105.2	$ 109.5
Trade receivables, net of allowance - 2015: $34.9; 2014: $37.2	1,537.4	1,602.5
Inventories	640.8	607.6
Prepaid and other current assets	287.3	188.8
Deferred income taxes	147.1	222.7
Current assets of discontinued operations held for sale	611.8	203.3
Total current assets	3,329.6	2,934.4
Investments	4.7	5.5
Property, plant and equipment, net	902.6	930.0
Goodwill	324.1	352.5
Other intangibles, net	233.5	246.9
Other assets	281.5	269.6
Deferred income taxes	235.7	200.1
Noncurrent assets of discontinued operations held for sale	0	401.5
Total assets	5,311.7	5,340.5
Current liabilities
Short-term debt and current portion of long-term debt	907.3	525.2
Accounts payable, trade and other	316.5	378.3
Advance payments from customers	24.2	190.2
Accrued and other liabilities	271.2	407.2
Accrued customer rebates	323.0	236.0
Guarantees of vendor financing	67.4	50.2
Accrued pension and other postretirement benefits, current	6.6	12.7
Income taxes	19.6	22.2
Current liabilities of discontinued operations held for sale	79.8	88.4
Total current liabilities	2,015.6	1,910.4
Long-term debt, less current portion	1,150.9	1,153.4
Accrued pension and other postretirement benefits, long-term	227.9	238.7
Environmental liabilities, continuing and discontinued	190.9	209.9
Deferred income taxes	55.6	51.3
Noncurrent liabilities of discontinued operations held for sale	0	4.7
Other long-term liabilities	201.4	208.1
Commitments and contingent liabilities (Note 16)
Equity
Preferred stock, no par value, authorized 5,000,000 shares; no shares issued in 2015 or 2014	0	0
Common stock, $0.10 par value, authorized 260,000,000 shares; 185,983,792 issued shares at 2015 and 2014	18.6	18.6
Capital in excess of par value of common stock	407.6	401.9
Retained earnings	2,915.5	2,984.5
Accumulated other comprehensive income (loss)	(409.2)	(375.8)
Treasury stock, common, at cost - 2015: 52,449,627 shares, 2014: 52,666,121 shares	(1,497.6)	(1,498.7)
Total FMC stockholders’ equity	1,434.9	1,530.5
Noncontrolling interests	34.5	33.5
Total equity	1,469.4	1,564.0
Total liabilities and equity	$ 5,311.7	$ 5,340.5

XML

Recently Issued and Adopted Accounting Pronouncements and Regulatory Items

3 Months Ended

Mar. 31, 2015

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Recently Issued and Adopted Accounting Pronoucements and Regulatory Items

Recently Issued and Adopted Accounting Pronouncements and Regulatory Items

New accounting guidance and regulatory items

In April 2015, the Financial Accounting Standards Board ("FASB") issued ASU 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this new standard require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this standard. We are required to adopt this standard in the first quarter of 2016. Early adoption is permitted. The amendments should be applied on a retrospective basis. ASU 2015-03 will impact our consolidated balance sheet.

In February 2015, the FASB issued ASU 2015-02, Consolidation: Amendments to the Consolidation Analysis. This new standard changes the consolidation evaluation for entities that are required to evaluate whether they should consolidate certain legal entities. We are required to adopt this standard in the first quarter of 2016. Early adoption is permitted. The standard permits the use of a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption, or a reporting entity may also apply the amendments retrospectively. We are evaluating the effect that ASU 2015-02 will have on our consolidated financial statements. We have not yet completed the assessment to determine the effect of the standard on our ongoing financial reporting.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This new guidance will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. We are required to adopt this standard on January 1, 2017; however, in April 2015 the FASB voted to propose to defer the effective date of the new revenue recognition standard by one year. If deferred, the provisions of this standard would be effective for interim and annual periods beginning after December 15, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. We are evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures. We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.

Recently adopted accounting guidance

In April 2014, the FASB issued its updated guidance on the financial reporting of discontinued operations. This new standard changes the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Additionally, expanded disclosures about discontinued operations will be required to provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. This guidance impacts disclosures within an entity's financial statements and notes to the financial statements. We have adopted this guidance prospectively this quarter.

XML

Schedule of Accumulated Other Comprehensive Loss (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), net of tax, beginning	$ (375.8)		$ (201.9)
Other comprehensive income (loss) before reclassifications	(43.3)		3.0
Amounts reclassified from accumulated other comprehensive income (loss)	9.9		56.7
Accumulated other comprehensive income (loss), net of tax, ending	(409.2)		(142.2)
Foreign currency adjustments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), net of tax, beginning	(50.4)		(25.3)
Other comprehensive income (loss) before reclassifications	(39.7)		0
Amounts reclassified from accumulated other comprehensive income (loss)	0		49.6
Accumulated other comprehensive income (loss), net of tax, ending	(90.1)		24.3
Derivative Instruments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), net of tax, beginning	(3.9)	[1]	(6.1)	[1]
Other comprehensive income (loss) before reclassifications	2.3	[1]	2.5	[1]
Amounts reclassified from accumulated other comprehensive income (loss)	(1.8)	[1]	1.1	[1]
Accumulated other comprehensive income (loss), net of tax, ending	(3.4)	[1]	(2.5)	[1]
Pension and other postretirement benefits [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), net of tax, beginning	(321.5)	[2]	(170.5)	[2]
Other comprehensive income (loss) before reclassifications	(5.9)	[2]	0.5	[2]
Amounts reclassified from accumulated other comprehensive income (loss)	11.7	[2]	6.0	[2]
Accumulated other comprehensive income (loss), net of tax, ending	$ (315.7)	[2]	$ (164.0)	[2]

[1] See Note 15 for more information.

[2] See Note 13 for more information.

XML

Recently Issued and Adopted Accounting Pronouncements and Regulatory Items (Policies)

3 Months Ended

Mar. 31, 2015

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

New Accounting Pronouncements

New accounting guidance and regulatory items

In April 2015, the Financial Accounting Standards Board ("FASB") issued ASU 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this new standard require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this standard. We are required to adopt this standard in the first quarter of 2016. Early adoption is permitted. The amendments should be applied on a retrospective basis. ASU 2015-03 will impact our consolidated balance sheet.

In February 2015, the FASB issued ASU 2015-02, Consolidation: Amendments to the Consolidation Analysis. This new standard changes the consolidation evaluation for entities that are required to evaluate whether they should consolidate certain legal entities. We are required to adopt this standard in the first quarter of 2016. Early adoption is permitted. The standard permits the use of a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption, or a reporting entity may also apply the amendments retrospectively. We are evaluating the effect that ASU 2015-02 will have on our consolidated financial statements. We have not yet completed the assessment to determine the effect of the standard on our ongoing financial reporting.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This new guidance will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. We are required to adopt this standard on January 1, 2017; however, in April 2015 the FASB voted to propose to defer the effective date of the new revenue recognition standard by one year. If deferred, the provisions of this standard would be effective for interim and annual periods beginning after December 15, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. We are evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures. We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.

Recently adopted accounting guidance

In April 2014, the FASB issued its updated guidance on the financial reporting of discontinued operations. This new standard changes the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Additionally, expanded disclosures about discontinued operations will be required to provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. This guidance impacts disclosures within an entity's financial statements and notes to the financial statements. We have adopted this guidance prospectively this quarter.

XML

Income Taxes (Tables)

3 Months Ended

Mar. 31, 2015

Income Tax Disclosure [Abstract]

Schedule of Effective Income Tax Rate Reconciliation

The below chart provides reconciliation between our reported effective tax rates and the EAETR.

	Three Months Ended March 31
	2015								2014
(in Millions)	Before Tax			Tax			Effective Tax Rate % Impact		Before Tax		Tax		Effective Tax Rate % Impact
Continuing operations	(110.2		)	(49.1		)	44.6	%	131.6		34.6		26.3	%
Discrete items:
Acquisition related charges (1)	190.7			70.3					3.1		0.8
Currency remeasurement (2)	6.3			(2.8		)			—		—
Other discrete items	21.8			7.3					9.9		3.4
Tax only discrete items (3)	—			3.0					—		—
Total discrete items	$	218.8		$	77.8				$	13.0	$	4.2
Continuing operations, before discrete items	108.6			28.7					144.6		38.8
Estimated Annualized Effective Tax Rate (EAETR)							26.4	%					26.8	%

___________________ 

(1) Acquisition related charges for the three months ended March 31, 2015 are primarily taxed at domestic tax rates resulting in material tax benefit. Charges include a $180.1 million loss on the hedge of the acquisition purchase price of Cheminova A/S, as noted in footnote (2) below hedge gains or losses are treated discretely for tax purposes. For more information on the hedge loss refer to Note 3.

(2) Represents transactions gains or losses on currency remeasurement, offset by the associated hedge gains or losses. Transaction gains or losses are considered non-taxable permanent items and their associated hedge gain or losses are treated discretely for tax purposes.

(3) Includes the tax effect of currency remeasurement associated with our foreign statutory operations that in accordance with GAAP income tax accounting guidance shall be treated discretely for tax purposes.

XML

Equity

3 Months Ended

Mar. 31, 2015

Equity [Abstract]

Equity

Equity

Refer to the table below for a reconciliation of equity, equity attributable to the parent, and equity attributable to noncontrolling interests for the three months ended March 31, 2015:

(in Millions, Except Per Share Data)	FMC Stockholders’ Equity			Noncontrolling Interest			Total Equity
Balance at December 31, 2014	$	1,530.5		$	33.5		$	1,564.0
Net income (loss)	(46.8		)	1.3			(45.5		)
Stock compensation plans	8.1			—			8.1
Excess tax benefits from share-based compensation	1.7			—			1.7
Shares for benefit plan trust	(0.2		)	—			(0.2		)
Net pension and other benefit actuarial gains/(losses) and prior service costs, net of income tax (1)	5.8			—			5.8
Net hedging gains/(losses) and other, net of income tax (1)	0.5			—			0.5
Foreign currency translation adjustments (1)	(39.7		)	(0.3		)	(40.0		)
Dividends ($0.165 per share)	(22.1		)	—			(22.1		)
Repurchases of common stock	(2.9		)	—			(2.9		)
Balance at March 31, 2015	$	1,434.9		$	34.5		$	1,469.4

____________________

(1) See condensed consolidated statements of comprehensive income (loss).

Accumulated other comprehensive income (loss)

Summarized below is the roll forward of accumulated other comprehensive income (loss), net of tax.

(in Millions)	Foreign currency adjustments			Derivative Instruments(1)			Pension and other postretirement benefits (2)			Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2014	$	(50.4	)	$	(3.9	)	$	(321.5	)	$	(375.8	)
2015 Activity
Other comprehensive income (loss) before reclassifications	(39.7		)	2.3			(5.9		)	$	(43.3	)
Amounts reclassified from accumulated other comprehensive income (loss)	—			(1.8		)	11.7			$	9.9
Accumulated other comprehensive income (loss), net of tax at March 31, 2015	$	(90.1	)	$	(3.4	)	$	(315.7	)	$	(409.2	)

(in Millions)	Foreign currency adjustments			Derivative Instruments (1)			Pension and other postretirement benefits (2)			Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2013	$	(25.3	)	$	(6.1	)	$	(170.5	)	$	(201.9	)
2014 Activity
Other comprehensive income (loss) before reclassifications	—			2.5			0.5			$	3.0
Amounts reclassified from accumulated other comprehensive income (loss)	49.6			1.1			6.0			$	56.7
Accumulated other comprehensive income (loss), net of tax at March 31, 2014	$	24.3		$	(2.5	)	$	(164.0	)	$	(142.2	)

____________________

(1)     See Note 15 for more information.

(2)    See Note 13 for more information.

Reclassifications of accumulated other comprehensive income (loss)

The table below provides details about the reclassifications from Accumulated Other Comprehensive Income and the affected line items in the condensed consolidated statements of income (loss) for each of the periods presented.

Details about Accumulated Other Comprehensive Income Components	Amounts Reclassified from Accumulated Other Comprehensive Income (1)						Affected Line Item in the Condensed Consolidated Statements of Income (Loss)
	Three Months Ended March 31
(in Millions)	2015			2014
Foreign currency translation adjustments:
Divestiture of FMC Peroxygens (3)	—			(49.6		)	Discontinued operations, net of income taxes
Derivative instruments:
Foreign currency contracts	$	8.7		$	(0.9	)	Costs of sales and services
Energy contracts	$	(1.3	)	$	1.0		Costs of sales and services
Foreign currency contracts	$	(4.4	)	$	(1.6	)	Selling, general and administrative expenses
Total before tax	$	3.0		$	(1.5	)
	$	(1.2	)	$	0.4		Provision for income taxes
Amount included in net income	$	1.8		$	(1.1	)
Pension and other postretirement benefits (2):
Amortization of prior service costs	$	(0.4	)	$	(0.4	)	Selling, general and administrative expenses
Amortization of unrecognized net actuarial and other gains (losses)	$	(12.7	)	$	(7.2	)	Selling, general and administrative expenses
Recognized loss due to settlement and curtailment	$	(5.3	)	$	(1.6	)	Selling, general and administrative expenses (4)
Total before tax	$	(18.4	)	$	(9.2	)
	$	6.7		$	3.2		Provision for income taxes
Amount included in net income	$	(11.7	)	$	(6.0	)
Total reclassifications for the period	$	(9.9	)	$	(56.7	)	Amount included in net income

____________________

(1) Amounts in parentheses indicate charges to the condensed consolidated statements of income (loss).

(2) Pension and other postretirement benefits amounts include the impact from both continuing and discontinued operations. For detail on the continuing operations components of pension and other postretirement benefits, see Note 13.

(3) The reclassification of historical cumulative translation adjustments was the result of the divestiture of our FMC Peroxygens business during the quarter ended March 31, 2014. The loss recognized from this reclassification is considered permanent for tax purposes and therefore no tax has been provided. See Note 9 for more information. In accordance with accounting guidance, this amount was previously factored into the lower of cost or fair value test associated with the 2013 Peroxygens' asset held for sale write-down charges.

(4) The $5.3 million loss due to curtailment for the three months ended March 31, 2015 related to the disposal of our FMC Alkali Chemicals division and was recorded to Discontinued operations, net of income taxes in the condensed statements of income (loss).

Dividends and Share Repurchases

For the three months ended March 31, 2015 and 2014, we paid $20.1 million and $18.0 million, respectively, in dividends declared in previous periods. On April 16, 2015, we paid dividends totaling $22.1 million to our shareholders of record as of March 31, 2015. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of March 31, 2015.

During the three months ended March 31, 2015, we did not repurchase any shares under the publicly announced repurchase program. At March 31, 2015, $250.0 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.